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Summary 
Human health monitoring, disease diagnosis and therapeutics rely on the detection of 
biomolecules. In this regard, Synthetic Biology approaches based on tailored molecular 
receptors and actuators can create powerful biosensing platforms. To achieve an optimal 
biosensor, the composition of such receptor/actuator scaffolds requires both careful design and 
thorough screening. Thus, my PhD studies focused on construction principles that render 
modular fusion proteins powerful biosensors.  
Central to the functionality of fusion proteins are the domain-connecting peptidic linkers. While 
the importance of linkers is known, methods to systematically screen the underlying amino acid 
space are scarce. Therefore, a novel DNA assembly method was devised that enables 
straightforward cloning of large and diverse linker libraries. By applying the strategy to 
synthetic protein switches, I identified multiple potent ligand-responsive proteases. 
The importance of linkers was further assessed by investigating the behaviour of nanopore 
scaffolds based on the β-barrel transmembrane protein FhuA ΔcΔ5L. The linker between the 
transmembrane domain and engineered terminal receptor tags emerged as a crucial parameter, 
impacting both open probability and intermolecular interaction ability of the nanopore in 
artificial lipid bilayers. An engineered ΔcΔ5L variant could irreversibly catch a second fusion 
protein while embedded into the bilayer, demonstrating biosensing at the single molecule level.  
While biological nanopores are highly specific, their lack of stability complicates their use in 
application-oriented biosensors. Considering this, a strategy to stably immobilize fusion protein 
receptors in solid-state nanopores was developed in collaboration with Ivana Duznovic from the 
Materials Analysis group. Highly specific nanobodies attached to conical nanopores in track-
etched poly(ethylene terephthalate) (PET) membranes allowed sensitive discrimination of 
analytes by current-voltage (I-V) measurements. The developed nanobody-nanopore platform 
constitutes a highly modular biosensing system and can potentially be combined with lab-on-
chip devices.   
In the first chapter, I embed my dissertation in the context of Synthetic Biology and Nanosensors 
while outlining the content of the following chapters. The second chapter describes the 
development of a cloning strategy for protein linkers and its application to synthetic protein 
switches. The third chapter deals with the biological nanopore scaffold ΔcΔ5L, while the fourth 
chapter describes the development of solid-state nanopore biosensing platform.      
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Zusammenfassung 
Die Detektion von Biomolekülen ist von entscheidender Bedeutung sowohl in der Diagnostik 
von Krankheiten wie auch in der Therapeutik und bei Vorsorgeuntersuchungen. In diesem 
Sinne ermöglicht die Synthetische Biologie die Konstruktion wirkungsvoller Biosensorik-
Plattformen auf Basis von molekularen Rezeptoren und Aktuatoren. Ein optimaler Biosensor 
lässt sich nur durch umsichtiges Design und nach umfassendem Screening identifizieren. In 
meiner Promotion habe ich mich daher intensiv mit Konstruktionsprinzipien befasst, die es 
ermöglichen, aus modularen Fusionsproteinen wirkungsvolle Biosensoren zu generieren.  
Die Proteinlinker zwischen den einzelnen Domänen von Fusionsproteinen sind für die 
Funktionalität Letzterer zentral. Obwohl diese Bedeutung bekannt ist, existieren bisher nur 
wenige Methoden, die eine systematische Untersuchung der Linker erlauben. Daher wurde eine 
neuartige Strategie zur DNA-Assemblierung entwickelt, die das Klonieren umfangreicher 
Linker-Bibliotheken ermöglicht. Bei der Anwendung dieser Strategie auf synthetische 
Proteinschalter habe ich mehrere schlagkräftige Proteasen identifiziert, die auf Liganden 
reagieren.  
Dass Linker auch in einem anderen Kontext von entscheidender Bedeutung sind, wurde durch 
die Charakterisierung verschiedener Varianten der β-Fass Transmembran-Nanopore FhuA 
ΔcΔ5L gezeigt, die in artifiziellen Lipid-Bilayern vermessen wurden. Der Linker zwischen der 
Transmembran-Domäne und maßgeschneiderten terminalen Rezeptorpeptiden stellte sich als 
entscheidender Parameter heraus, der sowohl Offenwahrscheinlichkeit als auch die Fähigkeit 
der Pore, mit anderen Molekülen zu interagieren, beeinflusste. Eine maßgeschneiderte ΔcΔ5L 
Variante verknüpfte sich irreversibel mit einem zweiten Fusionsprotein, während sie im Bilayer 
verankert war. Dadurch wurde aufgezeigt, dass das System als Biosensor im 
Einzelmolekülmaßstab funktioniert. 
Biologische Nanoporen sind zwar hochspezifisch, aber strukturell anfällig. Daher ist ihr Einsatz 
in anwendungsorientierten Biosensoren mit Schwierigkeiten verbunden. Als Alternative wurde 
eine Strategie zur stabilen Immobilisierung von Fusionsprotein-Rezeptoren in ionenspur-
geätzten PET-Folien entwickelt, in enger Zusammenarbeit mit Ivana Duznovic aus der 
Arbeitsgruppe Materialanalytik. Die Anbringung hochspezifischer Nanobodies an konische 
Nanoporen erlaubte die sensitive Unterscheidung von Analyten durch Strom-Spannungs-
Messungen (I-V Messungen). Die entwickelte Nanobody-Nanoporen-Biosensor-Plattform ist 
hochmodular und potentiell kombinierbar mit der Lab-on-Chip Technologie. 
Im ersten Kapitel setze ich meine Dissertation in den Kontext von Synthetischer Biologie und 
Nanosensoren und gehe auf die entsprechenden Berührungspunkte ein, die in den folgenden 
Kapiteln beschrieben werden. Das zweite Kapitel beschreibt die Entwicklung einer 
Klonierungsstrategie für Protein-Linker und deren Anwendung anhand synthetischer 
Proteinschalter. Das dritte Kapitel behandelt die biologische Nanopore ΔcΔ5L, während sich das 
vierte Kapitel der Entwicklung einer Biosensorik-Plattform auf Basis von Festkörper-Nanoporen 
widmet.    
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Chapter 1 
Nanosensors in Synthetic Biology 
1.  Synthetic Biology 
Synthetic Biology has grown to an independent research branch, rooted in multiple Life Science 
and Engineering disciplines. It combines principles from both Engineering and Biology worlds 
and shares large interfaces with Bioinformatics, Medicine and Metabolic Engineering. Due to 
its broad scope, attempts to precisely define Synthetic Biology are always biased towards a 
certain research area, for instance creation of synthetic minimal cells [1], implementation of 
sophisticated (bio-)logic circuits [2,3] or strain development [4]. Yet, it is possible to broadly 
summarize the activities of the researcher working in this discipline: A Synthetic Biologist aims 
to construct useful bio-inspired functionalities in a systematic fashion.   
In this regard, the workflow of a Synthetic Biology project follows the omnipresent pattern that 
is known as the Design-Build-Test or Design-Build-Test-Learn cycle (Figure 1) [4]. An initial 
concept or idea is carefully designed based on available knowledge. This includes available 
data, for instance crystal structures (in case of fusion protein design) [5] or bioinformatic 
models [6,7], but can also be guided by a specific research question [3]. The following 
implementation or “building” is mostly performed by means of biochemical and molecular 
biology methods. When the constructed system is tested, it produces data that can directly be 
used for an improved design, which is often the case in directed evolution approaches [8]. 
Moreover, the gathered data is always linked to an insight or learn effect that can help to 
improve the initial design (Does the system behave as expected? Are there any bottlenecks or 
drawbacks in the current design?). Eventually, new designs based on the gained knowledge will 
be developed.  
 
 
 
 
 Figure 1 The Design-Build-Test-(Learn) cycle.  
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2. The Nano-Prefix in Synthetic Biology 
A recurring motif in many Synthetic Biology areas is the “nano” prefix or -tag. Mostly, this prefix 
relates only briefly to the order of magnitude 10-9. Rather, it refers to the molecular 
environment and aims to stress the small nature of a system. This is highlighted by a compilation 
of nano-tagged words found in titles and abstracts of the Synthetic Biology literature (Table 1). 
My PhD studies focused on two of these nano-tagged concepts: Nanobinders (Chapters 2-4) 
and Nanopores (Chapters 3 & 4). Additionally, nanolight designs were included to visualize 
important project milestones. All concepts are part of the larger nanosensor framework that 
spans the bridge from basic research to application.  
 
Table 1 Synthetic Biology related, nano-tagged keywords appearing in the PubMed database [9].   
Keyword Description 
Example 
References 
Nanobodies 
Minimalized single-domain antibody scaffolds with high affinity for 
various target molecules 
[10] 
Nanocages 
Related to nanoreactors; Self-assembling, hollow protein 
compartments 
[11] 
Nanodiscs 
Artificial lipid environment for cell free expression, purification and 
characterization of membrane proteins 
[12] 
Nanoghosts Artificial membrane-enclosed compartments used to study therapeutic 
approaches 
[13] 
NanoLuc Smaller, engineered version of a natural occurring bioluminescent 
luciferase with broad applications in cell imaging and diagnosis 
[14] 
Nanomachines Higher-order functionalities; combine multiple modules and concepts 
into a larger assembly with a complex purpose 
[15] 
Nanopores 
Membrane proteins that connect two separated volumes, e.g. ion 
channels and toxins; often engineered for specific purposes like 
stochastic sensing 
[16] 
Nanoreactors 
Related to Nanocages; three dimensional scaffolds designed to improve 
biochemical reactions by increasing local concentrations 
[11] 
Nanostructures Assembled from nanobuilding blocks; umbrella term for artificial 
complexes of biological entities 
[15] 
Nanoswitches Keyword mainly applied for DNA-based scaffolds; Generate a 
detectable output in response to an input; subcategory of nanosensors 
[17] 
Nanowires/-
tubes/ 
-fibers 
Protein- or DNA-based elongated architecture; Potential in electronics; 
Includes peptoid nanosheets 
[18–20] 
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3. Nanobinders 
 Nanobodies 
A prominent example of “nanobinders” are Immunoglobulins (Ig), also termed antibodies. 
Y-shaped antibodies form the backbone of our powerful immune system, as they bind their 
target antigens with high affinity and specificity [21,22]. In contrast to humans, 
Immunoglobulins of Camelids and Chondrichthyes consist of only one polypeptide chain [10]. 
This evolutionary phenomenon allowed the development of single-domain antibodies also 
known as nanobodies, VHHs (camelids)  or VNARs (Chondrichthyes) [10,23]. When compared to 
classical hetero-tetrameric IgG-like architectures, these nanobodies offer many advantages: 
They are considerably smaller, can be tuned to a larger number of epitopes and can be 
recombinantly produced at high yields [10].  
Nanobody development involves multiple steps. Most studies start with a camel, dromedary or 
llama immunization to obtain a first VHH library against a target antigen [10,24]. The best 
binders are identified via phage or yeast display [24,25] and their affinities can be further 
improved for instance via directed evolution [26]. The obtained nanobodies are useful tools 
especially in biosensor technologies, with potential applications also in therapeutics [10]. 
Examples include biosensors for viral infection [27] and enzymatic activity [28,29], but also for 
small molecules like toxins [30] and hormones [31]. Nanobodies are also employed as 
stabilizers in hard to crystallize membrane proteins [32].   
In my PhD studies, I prepared multiple nanobodies for surface immobilization (Chapter 4). In 
cooperation with Ivana Duznovic from the Materials Analysis group at TU Darmstadt, we 
devised a nanosensing strategy based on the combination of solid-state nanopores and 
nanobodies.   
 
 Bioconjugation 
An extreme example of “nanobinding” is bioconjugation, which describes the covalent linking 
of a biomolecule and second molecule. Various bioconjugation strategies rely on chemical 
linkage of disulfide bonds or the use of unnatural amino acids (aa) [33]. To facilitate covalent 
protein-protein linkage, protein engineers developed a variety of enzymatic methods. From the 
large number of strategies, two that I used during my PhD studies are introduced here.  
 
 Sortase A 
Sortase A is a Ca2+-dependent protein-sorting transpeptidase found in the gram-positive 
bacterium Staphylococcus aureus. It naturally acts as a “sorting” protease, cleaving between T 
and G of the motif LPXTG (where X could be any aa) and forming a new peptide bond between 
the T moiety and the N-terminus of a poly-G tail in peptidoglycan [34]. In vitro, this reaction is 
often exploited for protein immobilization [35,36]. Moreover, protein engineering studies 
generated Sortase A variants that are no longer Ca2+-dependent [37], have superior catalytic 
activity [38] and allow specific conjugation of primary amines [39].       
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 SpyTag/SpyCatcher 
In nature, microorganisms use isopeptide bonds between proteins to establish highly stable 
architectures, for example pilins and adhesins [40]. The group of Mark Howarth minimalized 
and optimized a system from Streptococcus pyogenes for usage in biotechnological applications 
and named it SpyTag/SpyCatcher [41,42]. Over time, other examples with the same principle, 
like the SnoopTag/SnoopCatcher system [43], were established. 
The main advantage of these Tag/Catcher system is the spontaneous, self-catalyzed isopeptide 
bond formation between the respective interaction partners. In case of the Spy-system, the 
13 aa SpyTag is bound by the 15 kDa SpyCatcher (KD = 0.2 µM) and an isopeptide bond is 
formed between the ε-amino group of a lysine (SpyTag) and the β-carboxyl group of an 
aspartate (SpyCatcher) at a rate constant of 1.7 ± 0.4 x103 M-1s-1 [42,44]. Further protein 
engineering yielded a 12 times faster version SpyTag002/SpyCatcher002 [44].      
The genetically encoded SpyTag/SpyCatcher system has found countless applications in 
Synthetic Biology and Material Sciences, as it is modular [43,45], facilitates protein conjugation 
[16], but also enables the assembly of bioactive gel-like structures [46,47]. In my PhD studies, 
I employed the system for nanopore conjugation (Chapter 3) as well as for protein 
immobilization (Chapter 4).  
 
 Triggered Binding and Proteases 
In the cellular context, a simple ligand binding event at the cell membrane can result in vast 
and multiple reactions inside the cell [22]. Such signal amplification is mediated by timed or 
triggered binding, meaning that a certain response – for instance enzymatic activity – is only 
generated if a specific input – for instance a phosphorylation – is present. In the Synthetic 
Biology world, the implementation of signal amplification remains one of the key aspects for 
successful biosensor design, as has been shown for both whole-cell [48] and in vitro biosensors 
[28,49].   
Importantly, signal amplification systems require tightly controlled ON- and OFF-states. One 
link in the cascade generating an output without the input generally renders the whole 
amplification chain unstable. Thus, the chain should ideally consist of bistable switches that are 
switched either completely ON or OFF. In Synthetic Biology, many bistable switches have been 
realized on the genetic level, for instance in gene circuits [50], while bistable protein switches 
remain a major challenge. Yet, recent progress has been achieved by using autoinhibition 
concepts [5], split-proteins [51] and dimerization domains [2].  
In this regard, proteases are considered the most useful enzyme class for post-translational 
signal amplification [51,52]. In the context of this chapter, proteases can be described as “nano-
scissors”, as they cleave peptide bonds between amino acids. Sequence-specific proteases like 
the Nuclear Inclusion protein A (NIa) proteases from the Potyviridae family cleave very distinct 
motifs [53]. For instance, the TVMV protease recognizes the motif ETVRFQS and cleaves 
between Q and S [54]. In my PhD studies, I constructed several synthetic protease switches that 
respond to small molecules (Chapter 2). As outlined, these switches can serve as potent 
amplifiers in artificial signaling cascades that can be integrated into sensitive biosensor designs.               
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4. Nanopores as Biosensors 
The term nanopore is widely used both in (Synthetic) Biology and Material Science. For 
instance, the term refers to protein channels embedded in lipid bilayer membranes (Chapter 3), 
but also to nanometer-wide apertures in solid materials (Chapter 4) [55]. In the biological 
context, nanopores are highly important for cellular life, as they transfer information from the 
environment into cells and vice versa (examples in Chapter 3).    
Since pioneered by Hagan Bayley and coworkers [56], genetically engineered nanopores have 
become powerful biosensing tools. A prominent example is the rise of the nanopore sequencing 
technology [57]. A few decades after the initial idea was formulated, nanopore sequencing is 
now routinely used for DNA analysis in diagnostics [58], epidemics [59] and genome mapping 
[60]. Nanopore sequencing is based on the concept of stochastic sensing, where the conductivity 
of a given pore responds to an analyte that either blocks, enters or passes the pore lumen [61]. 
Importantly, the duration and shape of the blocking event can be directly linked to the identity 
of the analyte [61–63]. For the nanopore sequencing technology, many optimization steps – for 
instance retardation of the DNA translocation – were necessary to allow proper discrimination 
of the nucleobases [57].     
The heptameric protein toxin α-hemolysin (aHL) was the first nanopore of choice as it has 
multiple superior properties (described in Chapter 3). In the last decade, other useful scaffolds 
like the Mycobacterium smegmatis porin A (MspA) have emerged [64]. In short, the large variety 
of known transmembrane pores, combined with genetic engineering approaches, offers nearly 
unlimited possibilities of molecular sensors. In my PhD studies, I focused on the well-studied 
Escherichia coli outer membrane protein FhuA, precisely on one of its minimalized scaffolds, 
ΔcΔ5L, and investigated the role of attached tags (Chapter 3).        
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Chapter 2  
Functional Linkers in Fusion Proteins 
 
1. Introduction & Background 
Fusion proteins – also called “chimerics” or “chimeras”– form indispensable tools in the field of 
synthetic biology and beyond. Since the late 1980ies it is known that genetic fusion of coding 
sequences that translate into distinct protein domains can result in proteins with higher stability 
or improved function [65,66]. By combination of well characterized protein domains, it became 
possible to construct completely new functionalities, to create artificial response functions and 
to control protein behaviour precisely.   
At the DNA level, genetically encoded fusion proteins are constructed by in-frame connection 
of C- and N-terminal regions. For this task, only two options exist: Either a direct connection of 
the domains or the inclusion of a bridging sequence, named linker or spacer. Direct fusion or 
even truncation of domains can be advantageous for certain applications (see e.g. GluSnFR [67] 
and other FRET sensors [68,69]), especially regarding the fact that many proteins have 
unstructured termini [70]. These termini may even provide enough flexibility that additional 
spacers have no measurable effect [71]. For most fusion proteins to function properly, however, 
linkers are preferred.  
Although primary without function, linkers are far more than simple spacers between two 
protein domains, and this has been emphasized early on in studies on sFvs and related fusion 
proteins [72]. Linker sequences can have severe effects on fusion protein stability, folding 
efficiency and functionality, as highlighted throughout this chapter. Yet, despite recent 
progress, there is still a lack of understanding regarding the relationship of linker structure and 
-function.  
 
 
 
 
Figure 2 Comic representation of the building blocks of synthetic fusion proteins and the dilemma of linker choice.  
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 Linker Properties 
As Kaczmarski and co-authors precisely point out, “(l)inker choice is highly system dependent” 
[73]. When a multi-domain synthetic fusion protein is designed and a linker is needed, 
researchers can choose from a variety of well-known sequence motifs or “templates”, even with 
the help of internet databases [74,75]. The most fundamental criteria when choosing a linker 
are amino acid composition and length, both affecting other important aspects like 
hydrophobicity and secondary structure.  
 
 Amino Acid Composition 
In natural multi-domain proteins, linkers play important roles in enzymatic processes and 
allosteric signalling [76,77]. The use of amino acids (aa) in natural linkers is biased towards 
small, polar uncharged or charged residues, mainly G, S, E, P, A and T [74,78,79]. The study 
of natural linkers laid the foundation for the creation of reliable artificial ones. 
Small amino acids are preferred over large ones as they neither compromise the folding nor the 
structure of the target protein [74]. Especially G-based linkers maintain the mobility of the 
attached domains, as G has no β-carbon and thus is less conformationally restricted than other 
aa [74,80,81]. Although linkers constructed solely of G have been successfully used, long polyG 
chains collapse into globular structures in aqueous solutions [82]. Furthermore, studies show 
that polyG linkers – as  well as longer linkers in general – tend to be non-specifically cleaved by 
endopeptidases [83,84]. Therefore, polar moieties are introduced to achieve better solubility 
[74].  
The most frequently used artificial flexible linkers are based on G/S motifs, for example GGS, 
GGGS or GGGGS repeats [2,5,85–93]. Flexibility of these repeats decreases with increasing S 
content [87,94]. Incorporation of A and TS substitutions are common [8,69,95–98], and 
other aa may be added as well. For instance, Sørensen and Kjaergaard showed that G/S linker 
expansion increases with increasing E or D content due to favourable solvent interactions of 
these charged residues [99,100]. The authors also studied the impact of hydrophobic and 
aromatic aa as well as polyampholyte regions, but the effects on expansion or contraction of 
the linker sequence were negligible.   
Interactions between homopolymeric amino acid stretches have been investigated [101], and 
in contrast to polyG, most of these sequences do not form reliable linkers. For instance, polyA, 
polyQ and hydrophobic stretches in general are prone to aggregation [101–104], whereas polyE 
and polyS adopt disordered and unstructured conformations [102,105]. There are, however, 
few exceptions. PolyN is a shield against unspecific proteolysis [83] and seems to prevent linker 
collapsing, as recent fusion proteins with Green Fluorescent Protein (GFP)-reporters suggest 
[106]. In general, the molecular environment greatly affects the overall structure of 
homopolymeric stretches [102,105]. 
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Another special case is polyP. Proline itself 
influences the folding kinetics of the nascent 
protein chain to a great extent [107] and is 
often found in hinge regions or turns due to 
its helix-breaking properties [107,108]. In 
aqueous solution, poly-L-proline mainly folds 
into a left handed PPII-helix [80,109] that acts 
like a rigid “ruler” [108,110]. An idealized 
PPII-helix (Figure 3) spans 3.1 Å per residue 
and 3 residues per turn, in contrast to α-
helices with 1.5 Å per residue and 3.6 residues 
per turn [110]. Because of this behaviour, 
researchers use polyP stretches as rigid linkers 
to tightly control the spacing of distinct 
domains [111–115]. Caution is needed when 
adding such rigidity to a system, as this may 
disturb the mobility of attached domains 
[116]. Also, it has to be considered that 
stretches of consecutive prolines can result in 
ribosome stalling during translation [117]. To 
circumvent this but still maintain stiffness, 
residues of polyP can be substituted with A, E, 
K or T in an alternating manner 
[74,76,118,119].  
 
 
Figure 3 Example of a left-handed PPII helix 
(middle) with the sequence LLTPPPPPLFPPPFF. 
Adapted from PDB 1VZJ using UCSF Chimera [120]. 
 
Generally, stiffness and expansion of the linker sequence increase with increasing P content 
[100,121]. By combination of flexible G/S or G/S-like elements with P, semi-flexible linkers 
can be constructed. These include for example stretches of G, S and P [122] or G, S, A and P 
[123,124], but also alternating polyP and G/S “hinges” [125]. PASylation motifs – stretches 
composed solely of P, A and S – have also been proposed as linkers [126,127]. The term 
PASylation is derived from PEGylation, a technology that improves the pharmacokinetic 
properties of therapeutic peptides or proteins but relies on PEG instead of aa [126,128]. 
PASylation motifs are chemically inert and do not aggregate; hence, they have been established 
as fully genetically encoded alternatives for PEGylation [13,129,130]. 
Another P containing motif, (GPGGA)n, forms semi-flexible, elastic “spring”-like linkers and was 
derived from the spider silk protein flagelliform [131]. In a FRET-biosensor study from Jones 
et al., (GPGGA)8 proved superior than both flexible and rigid α-helical linkers [98]. 
Interestingly, the rigid linkers used in this study were based on (MALEK)n, a newly devised 
motif that incorporates aa that are entropically less affected than others when folded into a 
rigid helix [132]. 
However, the most common rigid protein spacer apart from polyP is the (EAAAK)n motif, 
originally introduced as a linker by Arai et al. [133,134]. Between pH values of 4-9, E and K are 
ionized and thus able to form salt bridges based on their electrostatic interactions, whereby the 
structure folds into a monomeric, elongated α-helix [133,135,136], resembling natural 
occurring rigid helices (Figure 4). For n=3, the motif has about 80 % helicity [133,135]. The 
motif starts with E rather than K because negatively charged aa at the N-terminus have been 
shown to improve α-helix formation in isolated α-peptides [136,137]. Although there is 
evidence that (EAAAK)n linkers are prone to hydrolysis at pH 6-7 [119,138], they have been 
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used in countless applications in synthetic biology and protein design, in particular as 
donor/acceptor separator in FRET-based biosensors [73,114,139–144], but also in therapeutic 
proteins [74,119,145]. Similar to P and G/S mixtures, combinations of rigid (EAAAK)n stretches 
with flexible G/S-sequences result in semi-flexible linkers [141–144]. 
 
Figure 4 Example of a natural α-helix that spans 
50 Å, found in ribosomal protein L9 (PDB: 1DIV) 
[136]. Visualized with UCSF Chimera [120]. 
Other rigid α-helices apart from (EAAAK)n 
include ER/K helices [136]. In less “strict” 
patterns, these also occur in natural proteins, 
for example in myosin X and VI [136,146]. 
Like in (EAAAK)n, the spacing (i, i+4) is 
important, and E4K4 repeats form stable 
helices while E2K2 repeats do not [136,147]. 
ER/K linkers have mainly been employed by 
the Sivaramakrishnan group in FRET-based 
sensors and to modulate the effective 
concentration of binding partners, e.g. GPCRs 
and G-proteins [146,148,149]. Interestingly, 
“pure” EK-based sequences share the anti-
fouling properties of PASylation motifs and 
can stabilize target proteins [150]. An 
extensive experimental analysis of the 
behaviour of E4K4, K4E4 and similar α-helices – 
also regarding flanking sequences – was 
performed by the Woolfson lab in 2015 [147], 
leading to a large collection of de novo 
designed helical peptides [151]. Recent 
bioinformatical analysis of natural occurring 
single α-helices complemented these 
experiments [152].  
A rigid motif based on a natural epitope is the sequence KLYPYDVPDYA [153]. Via MD-
simulations, the YPY stretch in this motif was found to act as a stiff turn element, and since then 
the 11 aa helix has been integrated in FRET sensor scaffolds for cAMP [153], L-lysine [154] 
and glucose [155].      
As linkers are increasingly recognized as important fusion protein features, unusual sequences 
emerge or are proposed. These include repeat motifs like polyGQ, claimed to be semi-flexible 
[156], and polyNQ, showing anti-fouling behaviour similar to polyEK and other zwitterionic 
peptides [157,158], but also large, structured “linker domains” as part of a separation strategy 
[159,160]. The artificial motif (EAQA)n for instance has pH responsive properties and was 
introduced into a maltose-dependent β-lactamase switch [161]. 
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 Linker Length 
With a plethora of different linker motifs to choose from, the question arises: What is the 
optimal length to connect the domains in a fusion protein?  
In natural proteins, linkers have an average length of 5 to 15 aa [78,79]. Average needs to be 
stressed here, as for instance linkers in very large natural multi-enzyme complexes range from 
5 to over 700 residues [162]. Longer linkers appear to be generally more hydrophilic than 
shorter ones [74,78]. Again, it must be emphasized that many interdomain linkers fulfil crucial 
roles in natural proteins [163]. 
In artificial fusion proteins, the length of the linker is at least equally important as its sequence. 
Although there are few exceptions where linker length has little effect on the fusion proteins 
performance [71,164], in general, small modifications lead to drastic changes in activity 
[95,115,119,124,165,166] and/or stability [2,92,121,165]. Length plays a less important role 
for flexible G/S-linkers than for rigid ones, as a recent study on GFP fusion nanobodies suggests 
[93]. Linker length is especially important for efficient labelling an coupling [94] as well as in 
the area of synthetic protein switches, where structural changes of receptor domains must be 
transferred to other parts of the fusion protein [5,90,123,167].  
Most of the time, finding the optimal linker length and composition is a screening process rather 
than a result of a priori design [5,84,122,140,168,169]. Protein modelling has the potential to 
aid in this perspective, as recent progress suggests [6,16,96]. However, the difficulty regarding 
modelling is the high flexibility of linker stretches, which lets them behave as unstructured 
polymers [82,87,100]. For instance, simulations showed that beyond the size of a dodecamer 
(12xP), polyP is better compared to a worm-like chain rather than a stiff rod [111,162]. Also 
ER/K helices behave as worm-like chain modules [146], however, helicity increases the more 
EK repeats are present [147].  
In one particular case, the FRET efficiency of a fusion protein was only enhanced after an 
accidental 22-aa insertion [170]. In another case, one single linker-optimized construct was 
unpredictably superior to 175 other fusion proteins [67]. To conclude, high-throughput 
screening remains the method of choice when searching for the optimal linker or linker 
combination, especially for complex systems with more than two functional domains.  
 
 How Linkers Affect Stability and Mobility of Fusion Proteins 
 Linker Effects on Fusion Protein Stability 
The structural modularity of chimeric proteins creates the impression that protein domains can 
be handled as “building blocks” or LEGO pieces [171]. Per this rationale, the properties of one 
subunit would be unaffected when tethered to another subunit. However, this only holds true 
for few examples [171]. In the majority of cases, protein fusion leads to complex changes in 
thermodynamics and folding behaviour, resulting in both stabilization and destabilization, 
depending on the fusion partners and the linkers [171–173].  
As the protein subunits experience constraints on their mobility due to tethering, they may 
thermodynamically prefer an unfolded state over a folded state [171,172]. Although this 
intrinsic destabilization may be “rescued” or even surpassed by the stabilizing effects of the 
interface between neighbouring domains [171–173], this is rather the exception than the rule 
[74,122,127,174].   
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Linkers can efficiently reduce strain caused by inter-domain vicinity. Thereby, fusion protein 
expression may be increased, as independent folding is enabled [74,127,175]. However, the 
effect of linkers on fusion protein stability is highly system dependent, since both linker length 
and composition are important parameters influencing domain interfaces and domain folding 
kinetics [81,176]. 
Some design recommendations – rather than strict rules – can be considered. For instance, 
hydrophilic aa in linker sequences effectively prevent unfolding and aggregation, both in 
flexible as in rigid α-helical linkers [81]. As proline is a secondary amino acid and lacks the 
amide proton, PolyP linkers form an exception; they are less prone to aggregation [109]. 
Regarding linker length, extremely long linkers tend to be unstable [100], although linkers 
exceeding 100 residues are useful for certain applications [97,143,146]. In cases where such 
long linkers are needed, structured “linker domains” also hold potential [159,160].  
Linkers constitute domain-bridging elements that are generally solvent exposed, which makes 
them accessible targets for unspecific cleavage by endopeptidases in vivo and proteolysis in 
general [119]. Especially for G/S based flexible motifs, the propensity to be cleaved increases 
with linker length [83,84]. Nevertheless, sometimes it is key that fusion proteins can be 
irreversibly splitted into distinct domains, either by the action of proteases or changes in the 
proteins environment. From this perspective, linkers provide a perfect frame for designed 
cleavage sites due to their accessibility. Applications include, but are not limited to, synthetic 
amplification cascades and programmable protein circuits [28,51,177] as well as in vivo drug 
delivery [74,178].  
Some reviews pooled cleavable linkers into a separate linker class [74,76]. Yet, if protease 
recognition sites and similar responsive sequences are treated as domains – as they clearly fulfil 
a distinct function other than spacing –, only the residues connecting these sites with other 
domains would act as linkers. For the sake of clarity, the term “cleavable linker” should thus be 
avoided and instead named “cleavage site” or “cleavable domain” when speaking of purely 
genetically encoded fusion proteins.  
 
 Linker Effects on Domain Mobility  
It is important to notice that proteins in solution always exist in forms of conformational 
ensembles rather than single states [82,179]. All possible conformational states are given 
a priori (they are “pre-encoded”) by the sequence, and the probability of each state is 
determined by statistical thermodynamics [179]. The distribution within the conformational 
ensemble changes if the protein backbone is perturbed, for example by ligand binding [180]. 
In this regard, binding can have allosteric effects on protein conformation or electrostatics as a 
result of favourable changes in enthalpy or entropy, or both [179–181].  
Acting as transducers, linkers mediate between the aforementioned forces of stabilization and 
destabilization and translate structural changes caused by perturbations between tethered 
domains [179,182]. Linkers with higher flexibility can more easily change between different 
structural states and therefore propagate forces acting on the protein backbone faster [76,179]. 
Molecular simulations suggested that the impact of a linker’s length on its dynamics, stiffness 
and its neighbouring domains appears to be larger than the impact of its amino acid sequence. 
For instance, Arviv and Levy observed that the folding behaviour of two connected domains 
gets coupled more pronouncedly when linker rigidity increases [172]. Their results were later 
complemented by the Cieplak group, whose all-atom and coarse-grained molecular dynamics 
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simulations revealed a clear inverse proportionality between linker size l and elastic stiffness κ, 
while the overall sequence identity had minor impact – with exception of the rigid polyP [162].  
Experimental studies relativized these in silico findings. Ruiz et al. showed that both linker 
length and composition are highly important for optimal catalytic activity of cellulases, 
demonstrating that protein mobility can be governed by specific aa inside the linker  [77]. 
Adamson et al. screened both linker identity and length in affimer-based enzyme switches and 
identified a medium length, flexible (GSG)7 linker as the optimal solution [183]. Another 
example is a study on sFvs by Klement et al., where changes in aa composition had a greater 
effect on the proteins functionality than changes in linker length, as P-rich linkers outperformed 
flexible G/S-linkers [121].   
In a fusion protein, the strong interplay between linkers and domains must not be 
underestimated. Kirubakaran et al. examined five different linkers and their influence on the 
properties of the linked domains PDZ and SH3 via molecular dynamics simulations [184]. They 
showed that linker identity and size is similar important to the fusion proteins behaviour as the 
domain order (PDZ3-SH3 or SH3-PDZ3). This dependency adds an additional layer of 
complexity to a priori fusion protein design. 
To conclude, both stiffness and aa composition affect the mobility of linkers and thus of the 
whole protein. Linkers with higher flexibility can facilitate conformational transitions by 
lowering the respective energetic barriers [76,179]. The consequences of allosteric force 
propagation within a fusion protein can be manifold, ranging from small amino acid 
reorientations to structural rearrangement of whole domains. Considering these aspects, the 
Nussinov group suggested a paradigm shift in linker categorization to bring into focus the 
dynamic role of linkers [179]. A summary of the properties of aa and motifs in linkers is given 
in Figure 5.   
 
 Beyond Simple Peptidic Linkers 
In the previous paragraphs, all discussed linkers are formed by “raw” amino acid stretches. In 
other words, no additional step other than protein translation is required to render the linker a 
functional unit. However, these linkers can be further modified. For example, disulfide bridges 
formed by cysteines can be exploited [74,178], and chemical cross linkers can be used to 
stabilize rigid α-helical linker motifs [185].     
The use of non-peptidic linkers in fusion proteins is a well-studied alternative to genetically 
encoded linkers. Non-peptidic linkers include for instance PEG [186] and DNA [187]. In the 
latter case, the rigidity of DNA linkers can be adjusted by ssDNA (behaving flexible) and dsDNA 
(behaving rigid). As in multi-domain proteins with simple aa linkers, the performance of a given 
fusion product/molecule is also highly dependent on linker length [186–189]. This is both true 
in solutions and near surfaces (described in Chapter 4). 
Non-peptidic linkers offer more possibilities to add functionalities to a fusion protein than 
simple aa linkers. However, considering that linker space can be unpredictably peaked [67], 
high-throughput screening of genetically encoded linkers is preferred if the application does not 
rely on a specific, unusual functionality in the linker.  
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Figure 5 Qualitative amino acid effects on linker properties summarized from sections 1.1 and 1.2. A: Individual amino 
acid properties; Anchor: Stability; Drop: Solubility; Dotted arrows: Flexibility. B: Heat map of motifs as a function of 
length or content variation on a qualitative scale from beneficial/unaffected (green) to problematic (red).  
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 Assembly Strategies 
One particular example for an extensive linker characterization study has been published by 
the Tsien group [67]. In this work, 176 linker variants were systematically screened to optimize 
a FRET-based sensor. However, only one single linker gave superior results, leading the authors 
to conclude there could be no clear a priori prediction of the optimal linker composition.  
Considering this, it is desirable to screen the linker space of a given fusion protein. A variety of 
cloning strategies have been proposed or have the potential to be employed for the cloning of 
linker coding regions. These strategies range from restriction enzyme based to completely 
enzyme-free. To anticipate the following overview, linker cloning is a demanding task due to 
the inherent properties of those aa that are mostly used as bridging elements. The repetitive 
codon pattern of prominent linker aa like G, S, E, P, A and K, may lead to complications during 
cloning. 
 
 Restriction Enzyme-based Strategies 
The concept of the BioBrick assembly marked a milestone in standardization attempts, 
allowing linking of basic genetic parts into larger composite parts [190]. Variants thereof have 
been developed to generate fusion proteins, in particular the Freiburg standard (BBF RFC 25) 
and the BglBrick standard [191]. Due to the chosen restriction enzymes, domains are separated 
either by T-G (Freiburg) or by G-S (BglBrick). While both scars comprise small and hence 
unproblematic aa, they pose constrains regarding the screening of very small linkers. Apart from 
the special case of two connected domains (linker length: 2), the smallest possible linker would 
contain five aa.     
In a straightforward approach, Li et al. constructed a 32-linker library consisting of EAAAK and 
GGGS repeating units to analyse linker flexibility and FRET efficiencies between CFP and YFP 
[141]. The units were assembled using two restriction sites, for Not1 and BamH1, resulting in 
25-aa long linkers. In a similar study, BamH1 was used by Evers et al. [85] to partial digest a 
long GGSGGS-based linker, thereby generating a small library of nine fusion proteins. However, 
both strategies are limited to restriction sites within the linker sequence, limiting the possible 
sequence space for linker screening.   
PCR-free assembly of long, repetitive sequences has also been described, for example by Scior 
et al. [192]. They achieved cloning of poly-Q, poly-A and poly-N by combining the use of 
synthetic oligonucleotides with the advantages of Type II S restriction enzymes, thereby 
enabling seamless cloning. Starting from Q11, repetitive sequences coding for up to Q110 were 
cloned by the authors. Briefly, the plasmid is linearized via a unique BsmB1 site following the 
poly-Q sequence, thereby generating fitting overhangs for annealed oligonucleotides that code 
for another poly-Q building block. After ligation of the backbone and the oligonucleotides, the 
original poly-Q sequence becomes elongated and can be reused for another round of cloning. 
This method has the potential to assemble longer linkers composed of a strict pattern before 
subcloning them between domains of interest. Moreover, with a PCR-free strategy, 
recombination or annealing issues may be circumvented that arise due to the high 
Guanine/Cytosine content of G, A and P codons.   
However, for higher order protein fusions, e.g. linker-based fusions of more than two domains, 
a modular strategy is more straightforward. Such a modularity is especially useful for plasmid 
and expression optimization. 
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One recent example of such a strategy is the Modular Protein Expression Toolbox (MoPET) 
proposed by Weber et al. [193] and based on Golden Gate assembly [194]. The main advantage 
of MoPET is that the specific sequence linking different functional modules can be as short as 
one amino acid. Nevertheless, the overlaps resulting from Type II S restriction must be distinct 
from each other, meaning that the succession and place of modules in the coding region must 
be clearly defined.  
Although it was not proposed to clone linkers, the PRe-RDL method (recursive directional 
ligation by plasmid reconstruction) [195] offers many advantages: Originally used to assemble 
oligomers of elastin-like polymer sequences, it is in principle seamless and sequence-
independent. Again, the strategy heavily relies on Type II S restriction enzymes, in this case 
BseR1 and Acu1. As the method is non-hierarchic, it may also be employed for higher order 
protein fusions, for example four domains with three linkers. PRe-RDL involves multiple cloning 
rounds with gel band excision steps and is therefore somewhat more time-consuming compared 
to other strategies.  
 
 PCR-based Strategies 
To screen for the optimal length of a defined linker between two domains, PCR-based methods 
work faster than PCR-free strategies, as the “length library” can be generated during the 
amplification of the sequence. To mention a recent example, Norris and co-workers [84] have 
described the protaTETHER method. The method intentionally exploits the promiscuous 
binding of a short forward primer having only one repeat of linker codons to a longer 
complementary reverse primer having four to eight repeats of the respective linker codons. 
Thereby, a PCR produces a variety of products with different linker lengths. These products 
overlap with the vector containing the domains to fuse. Thus, after annealing and 
transformation, the resulting library of fusion proteins can be screened for the best candidate 
depending on the application. Yet, a new set of specific oligonucleotides must be designed for 
every new construct, somewhat limiting the modularity. 
The PATCHY method (primer-aided truncation for the creation of hybrid proteins) introduced 
by the Möglich group relies on a one-pot PCR with a mix of staggered primers to generate a 
gene library with sequence truncations between the coding sequences of two functional 
domains [196]. While this approach is systematic, it is limited to a certain linker position. As in 
other approaches, it is likely that screening of repetitive Guanine/Cytosine stretches in the 
classical linker space could lead to problems during assembly.   
 
 Combination of PCR and Restriction  
An approach to circumvent the step by step optimization of linker cloning was performed by 
Ibraheem et al. [95]. To improve FRET-based biosensors, they generated linker libraries with 
length from 0 to 20 based on G, A and S aa. Theoretically, 640 variants were constructed using 
an approach that combined PCR and restriction digest. Because specific restriction enzymes are 
needed to unite linkers and domains following PCR, small “scars” remained, flanking the 
insertion sites of the linkers.  
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 Perspectives 
The functionality of a multi-domain fusion protein is highly dependent on the domain-
connecting linker(s). Inspired by naturally occurring motifs, artificial linkers have been 
developed that ensure separation, solubility, stability and mobility of single domains. New 
motifs have been proposed that could become useful linkers in the future, for instance the EK-
helices or polyampholytic stretches [147].  
The assembly of multi-domain fusion proteins and their linkers remains a challenge due to the 
repetitive nature of conventional linker amino acid codons. Considering this, the Synthetic 
Biology community would benefit from a reliable fusion protein assembly method that allows 
(nearly) full factorial linker space coverage. To meet this need, my colleagues and I developed 
a cloning strategy that I applied to construct potent protease switches. The workflow and results 
are presented hereafter in section 3 and have been published in condensed form in [123].  
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2. Methods 
 Standard Methods 
Liquid Escherichia coli cultures were routinely grown in LB medium at 37 °C and 180 turns/min 
in appropriate shakers for plasmid amplification. For long term storage of E. coli strains, glycerol 
cultures were generated. To do so, 500 µl of 50 % (w/v) sterile glycerol solution and 500 µl of 
the respective overnight culture were gently mixed, flash frozen and stored at -80 °C.  
To transform chemically competent E. coli cells via heat shock, the cells (100 µl aliquots) were 
thawed on ice and 0.2-2 µg of the desired plasmid DNA was added. The mixture was stored on 
ice for 30 min, incubated at 42 °C for 45-60 s and stored on ice for another minute before pre-
warmed (30 °C) SOC medium was added. The cells were grown for 1 h at 37 °C and then plated 
on LB-agar with the respective antibiotic. 
PCRs were routinely performed in 50 µl reactions using in-house purified proofreading 
polymerase (Sup Table 1). Gibson assembly [197] either with commercially synthesized DNA 
(IDT or GenScript) or in-house DNA was executed according to the manufacturer (NEB). 
Plasmid preparations were performed with M&N NucleoSpin® Plasmid Kits. Ligations were 
performed in 12 µl reactions overnight at 16 °C or at 30 °C for 3 h. 
For agarose gel electrophoresis, 0.5-1.5 % (w/v) melted agarose in TAE buffer was 
supplemented with Midori Green Advance (Nippon Genetics). Samples were loaded after 
dilution with loading dye (6x) and run at 110-120 V for 30-45 min in Gelsystem Mini M 
chambers (VWR) before recording via E-BOX (Vilber).  
Successfully cloned plasmids were routinely sequence-verified by commercial DNA sequencing 
at Microsynth Seqlab.  
SDS-PAGE after Laemmli [198] was performed using either precast 4-20 % gradient gels 
(Bio-Rad) or self made gels with 5 % stacking gel and 12 % running gel unless stated otherwise. 
Running buffer was always prepared as 10x stock (250 mM Tris, 1.92 M Glycine, 1 % (w/v) 
SDS). Sample loading dye was prepared as 2x or 5x stock. In case of precast gels, runs were 
performed at max. 200 V for 35-40 min. In case of self-prepared gels, runs were performed at 
max. 140 V for 45-75 min.  
 
 Library Cloning 
All cloning enzymes were purchased from New England Biolabs (NEB). For cloning of fusion 
protein libraries, the developed iterative Functional Linker Cloning (iFLinkC [123], section 3.2) 
was performed. Functional domains (FDs) in plasmid backbone pFD, and peptide linkers in 
plasmid backbone pL2 comprise the starting point of iFLinkC. Functional domains and linkers 
were cloned into the respective backbones using standard cloning strategies, e.g. hybridization 
of annealed oligos, restriction and ligation, and Ligase Cycling Reaction (LCR) [199,200] as 
described in Table 8 in the result section. For combining Linkers and FDs, restriction digestion 
was performed depending on the desired direction of the parts (e.g. N-terminal linker and C-
terminal domain or vice versa). iFLinkC relies heavily on 2 bp overhangs generated by the 
unusual Type II S enzymes Bts1 and BsrD1 [201]. The minimal linker formed by iFLinkC is 
comprised of one G only. Unless the last functional domain that is cloned to the C-terminus of 
the fusion protein has a stop codon, the translated protein ends with the final three aa GIA. 
Bbs1 and Bsa1 restriction sites were used for additional linearization to inhibit religation of the 
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donor plasmid. Sequences of empty pFD, pL2 and pFlinkC-XE (work name: pDEST) plasmids 
are attached to the supplement.  
The restriction digestion strategy is described in detail in section 3.2. The addition of rSAP 
(recombinant shrimp alkaline phosphatase) to one of the restriction reactions is recommended 
to avoid religation events (Table 2). The subsequent separation of plasmid fragments was 
performed via agarose gel-electrophoresis for optimal results. After gel extraction and clean-up, 
ligation was performed at 16 °C overnight using T4 ligase. Heat-competent E. coli Dh10β were 
transformed with 2-3 µl of the ligation reaction. In the case of libraries, 40 µl aliquots were 
plated on agar plates to assess cloning efficiency and while the remainder of the transformation 
reaction was used to inoculate 10 ml of overnight culture.    
Assembled libraries were cloned into pFLinkC-XE via Bts1 and Spe1/Nhe1 following the same 
pipeline of restriction digest, gel extraction and ligation. E. coli Dh10β were transformed with 
the assembled libraries for storage purposes while ultracompetent E. coli BL21(DE3) were 
transformed with the libraries via electroporation for screening purposes. Details regarding 
restriction digest are given in Table 3.  
 
Table 2 Step-by-step cloning table for restriction digest of FDs and linkers. BsrD1 digest was performed in PCR cyclers to 
prevent lid condensation. rSAP should only be added to one of the reactions. All restriction enzymes and buffers were 
purchase from New England Biolabs (NEB).     
Component Amount / Volume Incubation Add Incubation 
pL2 
containing 
Linker(s) 
Up to 2 µg 
total DNA* 
1 h 65 °C 
1 µl 
Spe1/EcoR1** 
1 h 37 °C BsrD1 1 µl 1 µl Bsa1 
NEB Buffer 
2.1 (10x) 5 µl (1 µl rSAP) 
ddH2O to 50 µl  
     
Component Amount / Volume Incubation Add Incubation 
pFD 
containing 
Functional 
Domain(s) 
Up to 2 µg 
total DNA* 
1.5 h 37 °C 
1 µl Bbs1 
0.5 h 37 °C Bts1 1 µl (1 µl rSAP) 
Spe1/EcoR1** 1 µl  
CutSmart 
buffer (10x) 5 µl  
ddH2O to 50 µl  
     
* If libraries are to be generated, plasmids are used in equimolar amounts 
** FDs larger than 300-350 bp are best cloned via Spe1, smaller FDs should be 
cloned with EcoR1 to facilitate downstream agarose gel excision 
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Table 3 Step-by-step cloning table for final cloning of a fusion protein (library) into the expression vector pFLinkC-XE.  
Component Amount / Volume Incubation Add Incubation 
pFLinkC-XE Up to 2 µg  
1.5 h 37 °C 1 µl rSAP 0.5 h 37 °C 
Bts1 1 µl 
Nhe1 1 µl 
CutSmart 
buffer (10x) 5 µl 
ddH2O to 50 µl 
 
Component Amount / Volume Incubation 
Fusion protein 
(library) in 
pL2/FD 
Up to 2 µg  
1.5 h 37 °C 
Bts1 1 µl 
Spe1 1 µl 
CutSmart 
buffer (NEB) 
(10x) 
5 µl 
ddH2O to 50 µl 
 
 Ligase Cycling Reaction  
LCR primers were phosphorylated following the protocol from [200] (Table 4), followed by 
adapted PCR (Table 5). PCR products were purified via agarose gel electrophoresis and 
respective kits. A Dpn1 digest was performed for 30 min at 37 °C, combined with the dilution 
of the PCR products to 12 nM. Scaffold oligonucleotide connector (SOC) mix was prepared with 
100 nM SOC primer each, and LCR was prepared (Table 6) and performed in a PCR cycler 
(Table 7), followed by E. coli transformation.  
Table 4 LCR Primer phosphorylation 
Component Amount (µl) Final Concentration 
100 µM Forward Primer (Stock) 1,5 3 µM 
100 µM Reverse Primer (Stock) 1,5 3 µM 
10 U/µl T4 Polynucleotide Kinase (T4 PNK) 1 0.2 U 
10X T4 Ligase Buffer 5 1X 
dH2O 41  
Total 50  
Incubation: 37°C for 30 minutes   
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Table 5 Adapted PCR for LCR cloning. Top row: Number of reactions. All other numbers in µl.  
PCR reactions 1 2 4 6 …  
DNA-Template 
(Plasmid) 
20 ng/µl 
1 2 4 6   
Phosphorylated 
primer mix 8 16 32 48   
dNTPs 1 2 4 6   
GC Buffer 10 20 40 60   
dH2O 29,5 59 118 177   
Phusion 
Polymerase 0,5 1 2 3   
 
Table 6 LCR reaction adapted from [199,200].  
Component Amount (µl) 
12 nM DNA-Parts 
(backbone, inserts) 4 
100 nM SOC Mix  6 
10x Taq Ligase Buffer 2 
40 U/µl Taq DNA Ligase 2 
H2O 6 
Total 20 
 
Table 7 LCR program.  
Temperature                Time  
1.     95ºC                      2 min 
Repeat 30x 2.     95ºC                      30 s 
3.     60ºC                      2 min 
4.     55ºC                      10 min  
6.     10ºC                      Standby  
 
 Electrocompetent E. coli BL21(DE3) 
100 ml SOB medium are inoculated with BL21(DE3) to OD600 ≈ 0.15 and grown to OD600 ≈ 0.5 
before cells are stored for 15 min on ice. Cells are centrifuged at 4000 xg, 4 °C, 15 min, 
resuspended in 50 ml cold H2O. These steps are repeated once, before cells are resuspended in 
25 ml cold glycerol (10 % w/v). After a final centrifugation step as before, pellets are 
resuspended in 300-400 µl cold glycerol (10 % w/v), flash frozen in N2(l) and stored at -80 °C.    
For transformation via electroporation, 1 µl plasmid DNA (50 ng/µl) was mixed with 50 µl cold 
glycerol (10 % w/v), mixed with 50 µl competent cells and incubated for 5 min on ice, followed 
directly by ≈ 7 ms electro-shock at 1.81 kEV, 300 Ω and 25 µF. 1 ml of SOC medium was added. 
After 1 h at 37 °C, cells were plated on agar plates with the appropriate antibiotics.   
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 Chemically competent E. coli 
200 ml of SOB medium were inoculated with 4 ml of an overnight E. coli culture and stirred at 
min. 180 rpm at ≈ 20 °C. When the OD600 reached 0.5-0.6, the culture was incubated on ice for 
10 min, followed by centrifugation at 2500 xg, 4 °C, 15 min.  Pellets were resuspended in 5 ml 
TB buffer (4 °C) and centrifuged a second time. Pellets were resuspended in TB buffer 
supplemented with 7% DMSO, incubated on ice for 10 min, aliquoted, flash-frozen in liquid 
nitrogen (N2(l)) and stored at -80 °C.  
 
 Protein Purification 
Protein switches were expressed from respective pFLinkC-XE (pDEST) plasmids as MBP-fusion 
in E. coli BL21(DE3) at 1 l LB scale, containing the appropriate antibiotic (100 µg/ml 
ampicillin). IPTG was added at an OD600 of 0.5, and expression continued for 4.5 h at 30 °C. 
Cultures were harvested via centrifugation and stored at -20°C. At the day of purification, the 
cells were resuspended in 40 ml of buffer W each (150 mM NaCl, 100 mM Tris-Cl, 1 mM EDTA 
pH=8) and crushed via four passes through an Emulsiflex C3 (Avestin). After centrifugation at 
25000 xg for 1 h at 4 °C, the sample was filtered through a 0.45 µm syringe filter. An ÄKTApure 
system and a 1 ml StrepTrap HP column (GE Healthcare) was used to purify the proteins. The 
columns were equilibrated with 8 CV of buffer W. After protein loading, the columns were 
washed with 8 CV of buffer W. The protein was eluted with 5 CV buffer E (150 mM NaCl, 
100 mM Tris-Cl, 2.5 mM desthiobiotin, 1 mM EDTA, pH=8) at 0.5 ml fractions and the 
concentration estimated via nanodrop-measurement. Protein aliquots were flash frozen in N2(l) 
and stored at -80 °C until needed. 
 
 Fluorogenic Protease Substrate Peptides and Affinity Clamp Peptide Ligands 
Protease substrate ANA-peptide (see [5]) and affinity clamp peptide ligand were synthesized 
by GenScript. ANA-peptide was dissolved in DMSO to a final concentration of 8 mM and stored 
at -80 °C, affinity clamp peptide ligand was dissolved in DMSO to a final concentration of 
10 mM and stored at -20 °C.  
 
 Reverse ITC 
Reverse ITC was performed on a Malvern MicroCal PEAQ-ITC at the Hausch research group 
(TU Darmstadt). Freshly purified protein switch 2_B3 was concentrated to 70 µM with Vivaspin 
500 centrifugal filters (Sartorius). 10 µM rapamycin solution in buffer E with 0.05 % DMSO 
was titrated with the protein in the same buffer. Data were analyzed using MicroCal PEAQ-ITC 
analysis software.  
 
 Ligand Titration Experiments 
Apparent Kds of TVMV protease-based switches were measured by means of ligand titration. In 
case of the best rapamycin switch 2_B3, 10 nM of 2_B3 were sufficient to determine ANA-
peptide cleavage induced fluorescence using the TECAN Spark platereader. Initial rates 
extraction, plotting and non-linear regression fit was performed according to [5]. The 
derivation of the regression fit equation is attached in the supplement of this chapter (Sup Text 
1).   
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 Library Assay  
Fusion protein libraries in pFLinkC-XE were transformed into E. coli BL21(DE3) cells (NEB) by 
means of electroporation and plated on LB plates with 100 µg/ml ampicillin. Resultant colonies 
were used to inoculate 500 µl of modified minimal autoinduction medium (N-5052) made of 
0.5% glycerol, 0.05% glucose, 0.2% lactose, 50 mM KH2PO4, 50 mM Na2HPO4, 10 mM 
(NH4)2SO4, MgSO4, and 1x trace metal solution [202] with antibiotics in 96-deepwell plates 
(Faust). Depending on addition of casaminoacids, cells were cultivated for 48 or 72 h at 37 °C 
in a microwellplate shaker (Heidolph) at 1200 rpm. 100 µl of each culture were saved in form 
of glycerol stocks. The remaining cells were spun down, and the plate stored at -20 °C until 
used.  
Lysis was performed according to [203] with modifications. Briefly, pellets were thawed and 
resuspended in 100 µl buffer W with 1 mg/ml lysozyme and 1 µg/ml DNase. This suspension 
was incubated for 2 h at 1200 rpm and 30 °C. After centrifugation (2500 xg, 4 °C, 20 min) the 
supernatant was used for the following assay. 
The lysate-based library assay was performed in 150 mM NaCl, 100 mM TRIS-Cl pH=8, 4 mM 
DTT, 5 mM EDTA and rapamycin. 20 µl of protein-containing lysis supernatant were added to 
90 µl of assay buffer containing no or 5 µM rapamycin, respectively, in black 96-flat bottom 
plates. Proteins were incubated in these buffers for 5 min at RT under slight shaking, before 
addition of 90 µl assay buffer containing 5 µM ANA-peptide. ANA-peptide contains a 
fluorophore (a 7-methoxycoumarinyl-4-acetyl group) that is quenched by an intramolecular 5-
amino-2-nitrobenzoyl group unless the latter is cleaved off via TVMV protease, leading to a 
measurable increase of fluorescence. Fluorescence increase was measured in a TECAN Spark 
platereader (Tecan) at gain 80, Z-position 20000 µm, 30 °C, excitation 330 nm and 
emission 405 nm in appropriate time intervals.  
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3. Results 
 Protein engineering – Starting Point Rapamycin-switch 
Synthetic protein switches share a modular pattern. Both receptor and actuator domains of such 
fusion proteins can in principle be exchanged by others, leading to new switching behaviours. 
One known protease switch is the module TVMVpE217-PDZG37-FN3GPG-AITVMV [5]. In this switch, 
the two-domain affinity clamp receptor module PDZG37-FN3GPG can recognize and bind small 
peptide ligands, leading to structural rearrangements within the protein backbone [90,204]. In 
the OFF-state, the activity of the N-terminal actuator TVMV protease (TVMVp) is tightly 
repressed by its autoinhibitory domain (AITVMV) at the C-terminus of the fusion protein. In this 
switch, ligand binding by the receptor module releases the AITVMV from TVMVp, thereby 
activating the protease.  
 
Figure 6 Comic representation of the autoinhibited protease switch TVMVpE217-PDZG37-FN3GPG-AITVMV from [5]. 
Following the architecture of this prototype scaffold, a new protein switch was designed in the 
first months of my PhD studies. While the actuator TVMVp and its autoinhibitory domain AITVMV 
were maintained in the construct, FKBP12 and FRB were chosen as receptor domains. Both 
domains have been used before in artificial protease cascades [5], but not as part of a single 
chain switch. FKBP12 (hereafter abbreviated as FKBP) is a 12 kDa FK506 binding protein that 
binds the small immunosuppressant rapamycin with extraordinary affinity (KD = 0.2 nM) 
[205]. The complex is then bound by FRB (FKBP-rapamycin binding domain), a protein derived 
from a domain of mTOR, forming a ternary complex [205]. 
Additional changes were made to improve the architecture and increase success chances. The 
domain order of TVMVp and AITVMV was reversed, leaving AITVMV closer to the N-terminus than 
the protease to prevent background activity that might be caused by incomplete translation or 
non-specific proteolysis of the large fusion protein [5,123]. The MBP gene was included 
upstream (5’) of the switch coding region as a solubility enhancer [206], separated from the 
switch by a TEV protease cleavage site. Additional affinity tags were included for purification 
purposes. The initial domain orientation FKBP-FRB was chosen after structural analysis in UCSF 
Chimera [120]. The main criteria for the design were the vicinities of the respective domain 
termini. Using UCSF Chimera [120] and the available crystal structures of the distinct domains, 
first approximations of the appropriate linker lengths were made. 
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Figure 7 Comic representation of the proposed autoinhibited protease switch AITVMV-FKBP-FRB-TVMVp. 
Thus, the starting point for the rapamycin inducible protease switch was designated as MBP-
TEVsite-strep-SGG-AITVMV-GPGAS-FKBP-GL(GGGS)3ET-FRB-SGGRGS-TVMVp-GGS-6xHis (linkers in super-
script). Restriction enzyme sites were introduced in the initial linker coding sequences to enable 
fine-tuning of the switch later. The sequence was ordered as a gblock (IDT) named gAG6 and 
inserted into pASK-IBA3 via Gibson assembly. 
The corresponding AG6 protein was expressed in E. coli BL21(DE3) and purified via its 
StrepTagII. The respective SDS-PAGE is shown in Figure 8. The additional bands in the elution 
fraction indicate either incomplete translation or unspecific hydrolysis. This phenomenon 
recurred in purifications of other large multi-domain proteins used in this work.  
In a first proof-of-concept experiment, 400 nM of AG6 were mixed with 5 µM of TVMVp 
substrate (ANA-peptide) and 0 or 5 µM of rapamycin, respectively. ANA-peptide contains a 
fluorophore (a 7-methoxycoumarinyl-4-acetyl group) that is quenched by an intramolecular 5-
amino-2-nitrobenzoyl group unless the latter is cleaved off via TVMVp, leading to a measurable 
increase of fluorescence. The slopes of the resulting RFU/min graph were 4.08 ± 0.04 for 5 µM 
rapamycin and 1.13 ± 0.02 for 0 µM rapamycin, respectively (Figure 8).  
 
  
Figure 8 Purification and characterization of AG6. Left: SDS-PAGE of ÄKTA purification. A discrepancy to the expected 
size of AG6 (97.2 kDa) is likely caused by insufficient heating. Marker in kDa. Right: TECAN measurement of ANA-
peptide conversion by AG6 in absence (grey) or presence (black) of rapamycin. Error bars represent standard deviation 
of triplicates. 
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These results demonstrate twofold. Firstly, the architecture of the rationally designed fusion 
protein switch allows for a repression of TVMVp by AITVMV in the basal state. Secondly, they 
showed that upon rapamycin binding by the affinity clamp module FKBP/FRB, AITVMV is to some 
extent released from the active center of the protease, leading to higher turnover of ANA-
peptide. Thus, AG6 constitutes a first single chain rapamycin-inducible protease switch. 
 
 Conceiving a Linker Cloning Strategy 
Considering the role of linkers in fusion protein mobility (section 1.2.2), further optimization 
of the AG6 switch at the linker sites could potentially lead to improved switches with respect to 
activity and inducibility. However, while it is possible to rationally design a fusion protein 
scaffold using available crystal structures, rational design of a fusion protein’s mobility 
represents a task considerably more demanding. As discussed in the introduction (section 1.2), 
there is still a lack of understanding how allosteric forces or structural changes are propagated 
through the protein backbone, in particular for multi-domain fusion proteins.   
Therefore, a generalizable method was developed that enables high-throughput screening of 
linker space in multi-domain fusion proteins to accelerate the process of finding improved 
switch variants. The method was termed iterative Functional Linker Cloning (iFLinkC). It relies 
on Bts1 and BsrD1, two unusual Type II S restriction enzymes that generate two-nucleotide 
overhangs close to their binding site [201]. When the sites are placed correctly, linker libraries 
– starting from a minimal linker of one glycine – can be fused to protein domains in a modular 
fashion via restriction and ligation (Figure 9). Importantly, iFLinkC is not limited by linker 
identity, and e.g. proline-helices or PASylation motifs [126] can be treated the same way as GS-
rich sequences.  
 
 
 
Figure 9 Overview of the iFLinkC method to generate multi-domain fusion proteins. Depending on the size of the 
functional domain (FD), two cloning workflows are possible, both resulting in the same plasmid with a linker-FD 
combination that carries the identical restriction sites as the initial plasmids. This allows to attach additional linkers / 
FDs in an iterative and combinatorial manner. The cloning process can be performed in parallel to save time during the 
construction of large fusion proteins and/or libraries. A comparable figure was published in [123].     
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It is important to notice that by design, linkers can only be attached to FDs and vice versa due 
to the nature of the two-nucleotide overhangs. For instance, fusion of two FDs without at least 
the 1xG linker in between results in a 1 bp frameshift (Figure 10). After construction in 
pL2/pFD, the fusion protein or fusion protein library is cloned into an iFLinkC compatible 
expression vector that contains a promoter, ribosome binding site, start codon and terminator, 
for instance iFLinkC-XE, via restriction digest with Bts1 and Nhe1/Spe1 and subsequent 
ligation. 
 
 
Figure 10 Cloning sites of the respective iFLinkC plasmids. Binding sites of restriction enzymes are colored. The first and 
last aa of pFlinkC-XE are indicated. After insertion of a fusion protein library, aa MG remain at the N-terminus and GIA 
at the C-terminus unless a stop codon is explicitly introduced at the end of the last functional domain.   
 
 Generation of iFLinkC Backbones 
The original pFLinkC-XE plasmid (working name: pDEST) was designed to be essentially a 
pET32a(+) backbone with a new multiple cloning site and an mRFP insert as an additional 
selection marker. The important modifications from the pET32a(+) backbone are: 
- Removal of all Bts1, BsrD1, Bbs1 and Bsa1 sites from the backbone 
- Removal of f1 bacteriophage ori 
- Insertion of an EcoR1 site between KanR and ori 
- Insertion of an Mfe1 site between pBR322 ori and cloning site 
In the scope of her master thesis, Anastasia Weyrich optimized pFLinkC-XE to contain the coding 
sequence for the green fluorescent fusion protein mNeongreen-(GGS)2-CfaN as a selection 
marker, as the mRFP coding sequence lead to unexpected difficulties during cloning. The pFD 
and pL2 plasmid were designed to be essentially pET24(+) backbones with a new multiple 
cloning site. The important modifications from the pET24(+) backbone are the same as for 
pFLinkC-XE, with the additional removal of the T7 promoter sequence. The sequences of the 
empty plasmids are available in the supplement of [123]; the cloning sites are depicted in Figure 
10. 
Linkers and functional domains were cloned into the respective plasmids by means of Gibson 
assembly, oligo annealing, Ligase Cycling Reaction (LCR) or restriction cloning (partial 
digestion from larger linkers) as listed in Table 8. 
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Table 8 Shown are the functional linkers (italic) and domains used in the first libraries of iFLinkC and the respective 
method that was used for cloning into pFD / pL2. LCR: Ligase Cycling Reaction; oligo: Oligo cloning; Gibson: Gibson 
Assembly.  
insert method insert method insert method 
G LCR GGSGGSG Restriction 
from larger 
linker 
AITVMV LCR 
GG LCR (GGS)3G oligo FKBP Gibson 
GGG LCR (GGS)4GSG oligo FRB Gibson 
GGSG LCR G(P)7G oligo TVMVp Gibson 
GPG LCR G(TP)4TG  Restriction 
from larger 
linker  
MBP-TEVsite-
strep-AITVMV 
Gibson 
GPPPG oligo GGASPAGG Restriction 
from larger 
linker 
ePDZ-B1 Restriction 
(A. Weyrich) 
GSPAG LCR GGASPAAPAPAG oligo FN3 Restriction 
(A. Weyrich) 
  GGA(EAAAK)2AGG Restriction 
from larger 
linker 
StrepTag-II oligo 
 
 iFLinkC Optimization 
Prior to the generation of a large rapamycin-switch library, efficiency tests were performed. As 
described in the method section, restriction with Bsa1 in combination with BsrD1 as well as 
restriction with Bbs1 combined with Bts1 enable the excision of small ≈ 20 bp fragments during 
the iFLinkC procedure. This in principle allows “one pot reactions” by sequential action of ligase 
and Exonuclease III (ExoIII) after separation of the desired DNA from the small fragments via 
magnetic beads or PEG precipitation instead of agarose gel excision. Consequently, iFLinkC 
should be automatable. The efficiency of these alternatives (PEG precipitation, magnetic beads, 
“one pot reaction”) was compared to gel extraction of cleaved DNA substrates. Albeit less time 
consuming, none of these strategies came close to the superior efficiency of the agarose gel 
extraction method.  
The reasons for this are manifold. For instance, neither restriction nor ligation reactions achieve 
100% efficiency, therefore original plasmid remains in the reaction up until transformation. 
Furthermore, the small ≈ 20 bp fragments may not be completely removed and cause ligation 
artifacts. For the one pot reaction, trace amounts of linear side products – despite the usage of 
ExoIII – may interfere with plasmids during transformation or may be otherwise processed to 
plasmid artifacts in E. coli. On the contrary, agarose gel extraction allows evaluation of 
restriction efficiency during the cloning procedure, while simultaneously separating desired 
DNA fragments from undesired. Thereby, ligation artifacts are minimized, leading to an overall 
higher number of correct clones after transformation. Downscaling of the reactions to very small 
volumes, for instance in suitable robotic platforms, might improve the efficiency of the 
alternative methods.  
After thorough optimization of the workflow and the material mainly performed by Anastasia 
Weyrich in the scope of her master thesis, the described iFLinkC method was applied for a fusion 
protein library cloning. A rapamycin switch library was generated in four steps as depicted in 
the following scheme (Table 9, Table 10). In the last step, the assembled library was cloned 
into pDEST (pFLinkC-XE).  
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In the library, the domain orientation of the original AG6 switch was maintained (AITVMV-FKBP-
FRB-TVMVp). As described in the introduction, linker lengths can have extreme effects on 
fusion protein performance, therefore the “allowed” lengths of the three library linkers were 
chosen based on the successful AG6 switch (L1: 5 aa, L2: 16 aa, L3: 6 aa). Seven small linkers 
were allowed for the “outer” positions L1 (AITVMV-FKBP) and L3 (FRB-TVMVp), while 15 linkers 
with up to 16 aa were allowed for L2 (FKBP-FRB) (Table 9). Thus, the library had an overall 
diversity of 735 variants. The C-terminal 6xHis-tag that was part of the initial AG6 was omitted 
in the library. 
Table 9 Linker sub-libraries used in the rapamycin-switch library.  
Notation Linkers included 
Linker (7) 
 
G, GG, GPG, GGG, GGSG, GPPPG, GSPAG 
 
Linker (15) 
Linker (7), (GGS)2G, (GGS)3G, (GGS)4GSG, GGASPAGG,  
GGASPAAPAPAG, G(P)7G, G(TP)4TG, GGA(EAAAK)2AGG  
 
Table 10 Assembly scheme of the rapamycin switch library.  
Cloning Step 1 (parallel) 
 
Substrate 
Processed 
with enzymes 
  
Linker (7) in pL2 
BsrD1 + 
Spe1 + rSAP 
  
TVMVp in pFD Bts1 + Spe1 
  
  
Linker (15) in pL2 
BsrD1 + 
Spe1 + rSAP 
  
FRB in pFD Bts1 + Spe1 
  
  
Linker (7) in pL2 
 
BsrD1 + 
Spe1 + rSAP 
  
FKBP in pFD Bts1 + Spe1 
 
 Cloning Step 2 (parallel)  
 
Substrate 
Processed 
with enzymes 
  
MBP-(TEVsite)-
strep-AITVMV 
BsrD1 + 
EcoR1 
  
Linker (7)-FKBP 
Bts1 + 
EcoR1 
  
  
Linker (15)-FRB 
BsrD1 + 
Spe1 + rSAP 
  
Linker (7)-TVMVp 
Bts1 + Spe1 
+ Bbs1-HF 
 
 
 
 
  
Cloning Step 3 
 
Substrate 
Processed 
with enzymes 
  
MBP-(TEVsite)-
strep-AITVMV-Linker 
(7)-FKBP 
BsrD1 + 
EcoR1 
+ Bsa1-HF 
  
Linker (15)-FRB-
Linker (7)-TVMVp 
Bts1 + 
EcoR1 
+ Bbs1-HF 
 
 Cloning Step 4 (to pDEST / pFLinkC-XE) 
 
Substrate 
Processed 
with enzymes 
  
Assembled Library Btsa1 + Spe1 
  
pDEST-T7-UTR-
mNeongreen-
(GGS)2-CfaN 
Btsa1 + Nhe1 
+ rSAP 
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 Library Screening Procedure 
High-throughput screening of protein libraries in 96-well format can be performed with E. coli 
lysates. A procedure was developed based on the assay described by Santos-Aberturas et al. 
[203] (section 2.10). As before, protease activity was measured by fluorescence increase 
resulting from the processing of initially quenched ANA-peptide.  
First, the assay was tested with the AG6 protein. 10x 300 µl LB medium in a 96 deep-well plate 
were inoculated with 30 µl of BL21(DE3) carrying the AG6 expression plasmid and induced 
manually with 0.75 mM IPTG after 4 h. Expression occurred overnight, and on the next day the 
protocol described in section 2.10 was used to harvest and lyse cells. Although in the first 
experiment over the course of 80 min, the presence of 5 µM rapamycin had no significant effect 
on ANA-peptide turnover, as determined from the slope in RFU/min, protease activity was 
observed, showing that expression of the protein and the activity assay work in principle. 
 
 
 
Figure 11 First 96-well plate test of AG6 rapamycin switch with (black) or without (grey) rapamycin added. Shown are 
the relative fluorescence units (RFU) that increase over time due to the TVMVp domain cleaving the ANA-peptide 
substrate. Presence of rapamycin yielded no significant higher ANA-peptide turnover. Error bars represent standard 
deviation of triplicates. 
The assay was optimized by Anastasia Weyrich during her Master thesis. In particular, the 
addition of 5 mM EDTA in the final assay buffer proved to be important to prevent unspecific 
cleavage of the assay substrate ANA-peptide. Moreover, the usage of modified minimal auto-
induction medium N-5052 simplified the overall workflow.  
A figure with plotted RFU/min slopes is given in the supplement (Sup Fig 1), while the library 
lysate screening results are summarized in Table 11. Among 233 screened variants, about 30 % 
showed higher protease activity by the addition of rapamycin. About 6 % showed very little 
basal protease activity and were denoted as “tight”. In Figure 12, example traces for selected 
variants are shown. It must be emphasized that the library has a high plasticity (Sup Fig 2), 
ranging from variants with poor inducibility to very powerful rapamycin switches, and that this 
plasticity is generated solely by the domain-connecting linkers.   
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Table 11 Summary of rapamycin-switch 
library screening 
Parameter Quantity 
Possible variants 735 
Screened colonies 233 
Religands 47 
Inducible variants 69 
 Thereof: tight 14 
Sequenced variants 35 
 
 
 
 
 
Figure 12 Example traces of lysate screening experiments. Shown are ANA-peptide conversions for switches 1_A9 and 
1_C9 respectively in absence (grey) or presence (black) of 5 µM rapamycin. Linkers of the respective switches are indicated 
as insets. Values were normalized to negative control. Similar figures were included in the publication [123].  
 
The first library contained a considerable number of pFLinkC-XE religands which could be 
identified prior to screening due to the expression of mNeongreen-(GGS)2-CfaN (Figure 13). 
The high number might be caused by insufficient time of enzymatic cleavage in the last cloning 
step or lack of rSAP activity. 
 
 
 
Figure 13 96-deep well plate of screening #1 under blue light 
after centrifugation. Religands of pFLink-XE could be identified 
as they expressed the fluorescent control protein mNeongreen-
(GGS)2-CfaN. 
 
Selected inducible variants were expressed in larger scale, purified via StrepTagII and measured 
at defined concentrations. For some proteins, the deviations from the lysate assay were 
considerable (see 3-A1 in Table 12), however, the tendency of the lysate screening could be 
reproduced for all purified proteins. Reasons for deviations may be caused as well by the lysate 
screening assay (cell growth in deep well plates, expression and cell lysis variations), but also 
R
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by instability of the large multi-domain proteins during purification, as can be seen for 3_F3 in 
Figure 14.  
 
Table 12 Summary of FKBP-library screening experiments; comparison of lysate screening and purified screening results. 
Maximum x-fold induction was calculated from the initial linear range. The initial linear range was variant-specifically 
chosen and dependent on the moment the fluorescence signal exceeded background noise.  
Variant L1 L2 L3 
x-fold 
induction 
(Lysates) 
x-fold 
induction 
(Purified) 
1_A9 GPG G(TP)4G GPG > 80  150.6 ± 5.1 
2_B3 GPG G(P)7G GPG 72.5 ± 13.7 87.1 ± 6.0 
3_F6 GPPPG G(TP)4G G 68.3 ± 17.0 69.7 ± 8.9 
3_A1 GPPPG GPPPG GG 64.4 ± 21.0 18.7 ± 1.0 
1_C9 GPG GGA(EAAAK)2AGG GSPAG > 60 36.9 ± 0.7 
3_C9 GPG GGG GSPAG 53.9 ± 9.2  
2_E7 GPG G(P)7G G 41.0 ± 6.6  
3_F3 GPG GSPAG GGG 38.5 ± 7.5  
3_H4 GPG (GGS)4GSG GPPPG 21.6 ± 3.4  
2_G2 GPPPG GGA(EAAAK)2AGG GG 16.8 ± 1.9  
2_E3 GSPAG GGA(EAAAK)2AGG GSPAG 11.9 ± 0.9  
1_A7 GPPPG GG GGSG 5.0 ± 0.4  
2_G1 GSPAG GGA(EAAAK)2AGG GPPPG 4.2 ± 0.5  
1_A8 GGSG GPG GGSG 4.1 ± 0.5  
1_D11 GPPPG GG GSPAG 3.6 ± 0.5  
1_C11 GPPPG (GGS)4GSG GSPAG 3.6 ± 0.3  
1_D7 GSPAG GGASPAAPAPAG GSPAG 3.2 ± 0.1  
1_D10 GPPPG GPG GSPAG 3.0 ± 0.2  
3_A3 GSPAG GGSG GPPPG 2.8 ± 0.4  
3_D6 GSPAG GGG GPPPG 2.6 ± 0.1  
1_D4 GPPPG GPG GSPAG 2.6 ± 0.1  
1_E8 GSPAG (GGS)4GSG G 2.4 ± 0.2  
 
 
 
 
 
 
Figure 14 SDS-PAGE of six purified rapamycin-switches with expected sizes of about 95 kDa. Bands at 48-63 kDa 
indicate instability of the large multi-domain proteins, in particular in the case of 3_F3. M: Marker BlueStar Prestained 
(Nippon Genetics). Size in kDa. 
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An important question concerns the reproducibility of the lysate screening results. When LB 
medium was used and manual induction was performed, the data showed the same trend as in 
the original screening but nonetheless differed considerably (Table 13). This once again 
underlines the variance caused by using lysozyme as high-throughput screening lysis reagent 
and E. coli in general, and shows the importance of additional characterization of single variants 
in purified form. However, the assay is sufficient to identify well performing switches that can 
be characterized in detail in purified form.  
 
Table 13 Lysate screening reproduction results. Error calculated using Gaussian error propagation. In contrast to the 
induction ratios in Table 12, the linear fit considered all data points from the range 10-40 min objectively. 
Variant 
x-fold induction 
n=2 
Variant 
x-fold induction 
n=2 
1_A9 21.3 ± 1.4 2_E3 5.1 ± 0.2 
2_B3 18.2 ± 1.1 1_D7 4.9 ± 0.1 
2_E7 17.8 ± 0.9 3_F6 4.9 ± 0.2 
3_A3 14.9 ± 12.3 2_G2 4.1 ± 0.3 
1_C9 11.9 ± 0.6 1_D11 4.1 ± 0.3 
3_F3 10.4 ± 0.3 1_A7 4.1 ± 0.3 
3_H4 8.9 ± 0.6 2_G1 3.8 ± 0.1 
1_C11 8.8 ± 1.7 1_E7 3.2 ± 0.1 
3_C9 8.0 ± 0.6 1_A8 2.9 ± 0.2 
3_A1 7.0 ± 0.8 3_D6 2.6 ± 0.1 
1_E8 5.5 ± 0.2 1_D4 2.4 ± 0.1 
1_D10 5.2 ± 0.3   
 
 Biophysical Characterization of Switch Behaviour  
The switch variants with the highest fold-induction were examined closer. Sequencing 
identified a recurring GPG linker at the position L1 directly downstream of AITVMV. Combined 
with the observation that those switches were exceptionally repressed in the OFF-state, this lead 
to the assumption that the GPG motif serves as an elongation of AITVMV, improving its affinity 
towards TVMVp.  
To test this hypothesis, AITVMV was ordered as a peptide along with three C-terminal elongated 
variants (+G, +GP, +GPG). These peptides were titrated against 200 nM SH3-TVMVp (a 
TVMVp variant with an N-terminal SH3-domain) in presence of 5 µM ANA-peptide substrate. 
Titration curves were fitted by a non-linear regression per  
    ∙  
	
	 
  ∙ 1 


1 
 

 (1) 
   
which describes the enzyme kinetics for a competitive inhibitor [22] to obtain Ki values, where 
V (=Y) denotes the reaction velocity, Vmax the maximum reaction velocity, cs the substrate 
concentration and ci (=X) the inhibitor concentration. KM was fixed at 65 µM as in [5]. 
The Ki of unmodified AITVMV (REYVRFAP) was determined as 133 µM ± 12 µM (Sup Fig 3), a 
value that approximates the originally reported Ki of 196 µM ± 26 µM [5]. For AITVMV+G, the 
Ki was in the same order of magnitude (186 µM ± 15 µM). However, AITVMV+GP and 
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AITVMV+GPG showed a Ki of 4.5 µM ± 0.3 µM and 3.0 µM ± 0.2 µM, respectively (Figure 15). 
Thus, the elongation of AITVMV by these two residues improves its affinity towards TVMVp by 
nearly two orders of magnitude. This explains the strongly repressed OFF-state and the high 
fold-induction. This phenomenon may be caused by an additional interface between the motif 
and the protease, generated by the additional proline. In this regard, a molecular docking 
simulation and/or a crystallographic study could elucidate the underlying principle and could 
facilitate development of future autoinhibitory modules for other proteases.    
    
 
 
 
Figure 15 AI-peptide inhibition. SH3-TVMVp (200 nM) was titrated with three different AI-peptides. The legend depicts 
the R2 values of the corresponding fits together with the determined Kis. Standard errors derive from duplicate 
measurements. A similar figure was included in the publication [123].    
 
 Apparent Rapamycin Affinity 
The tested multidomain switches comprise two separate modules: The receptor module 
(FKBP/FRB) and the actuator module (AITVMV/TVMVp). Banaszynski et al. have thoroughly 
investigated the affinities involved in the assembly of the ternary FKBP/FRB/rapamycin 
complex [205]. Briefly, rapamycin first binds with high affinity to FKBP (KD = 0.2 nM), together 
forming a complex that is then bound by FRB (KD = 12 nM). In case of the large multidomain 
switch, this binding induces large conformational changes throughout the protein backbone. 
However, the biophysical forces behind this reorganization work against the stable complex of 
the actuator module. As shown in the previous paragraph, AITVMV+GPG for instance is bound 
by TVMVp with an affinity in the low µM range.  
The phenomenon of this “conformational conflict” was observed when switch 2_B3 was titrated 
with rapamycin. The initial reaction rates were plotted as a function of rapamycin concentration 
and an apparent KD of 20.7 ± 2.6 nM was determined (Figure 16). Importantly, the data had 
to be fitted to a quadratic equation (Sup Text 1) because rapamycin is depleted from the system 
during the reaction due to its high affinity towards FKBP [205,207].  
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Figure 16 Titration of 10 nM 2_B3 switch with rapamycin in presence of 5 µM ANA-peptide revealed an apparent KD of 
20.7 ± 0.3 nM for the rapamycin-switch interaction. Linkers of 2_B3 are indicated as inset. Standard errors derive from 
duplicate measurements. A similar figure was included in the publication [123].    
Thus, binding of rapamycin by the switch is seemingly twice as weak as FRB binding to the 
FKBP/rapamycin complex, which is the rate limiting step in the original receptor module. To 
investigate if the switch architecture constrains FKBP mobility and thereby weakens rapamycin 
recognition, a reverse isothermal titration calorimetry (ITC) experiment was performed. 2_B3 
fusion protein at 68 µM was dissolved stepwise into 10 µM rapamycin solution, and the KD along 
with the molar binding enthalpy ΔH were calculated using the MicroCal Analysis software. For 
N=1 binding pocket, values were determined as KD = 0.86 ± 1.25 nM and ΔH = -95.7 ± 
3.82 kJ/mol (ΔG = -51.8 kJ/mol). This underlines that the binding of rapamycin by FKBP is 
not hampered by the switch architecture. The discrepancy between the obtained ΔH and 
literature values for FKBP/rapamycin binding (ΔH ≈ -60 kJ/mol [208]) is most likely caused by 
the conformational reorganization of the fusion protein backbone or differences in the buffers 
used.  
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Figure 17 Reverse ITC measurement of rapamycin-switch 2_B3. A) Raw data trace with adjusted baseline. B) ∆H as a 
function of molar ratio, calculated in MicroCal Analysis. I acknowledge Christian Meyners for support during the 
experiment and analysis.  
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 ePDZ-b1/FN3 Protease Switch 
To prove the modular principle of the iFLinkC method and to develop a single chain protease 
switch with a second receptor module, FN3 and ePDZ-b1 were employed. As FN3 domains can 
be evolved to bind various peptide targets [204], the PDZ-FN3 affinity clamps constitute highly 
modular receptors, rendering them useful for the development of synthetic protein switches 
that react to a variety of peptide inputs. 
In contrast to the known switch TVMVpE217-PDZG37-FN3GPG-AITVMV [5], the orientation of AITVMV 
and TVMVp was reversed in the design of this work. The orientation of PDZ and FN3 was 
maintained for structural reasons, as in reverse order, the affinity clamp would not be able to 
form [90,204]. Thus, the overall structure of the library is MBP-TEVsite-strep-SGG-AITVMV-L1-ePDZ-
b1-L2-FN3-L3-TVMVp.  
The same linker space was screened as in the rapamycin switch library. Seven short linkers were 
allowed at positions L1 and L3 and 15 linkers with up to 16 aa at position L2. Due to a 
misinterpretation of the protein sequences [5], the FN3 domain started with an additional 
glycine, meaning that in all screens, L2 was one aa longer than intended (for instance, GPGG 
instead of GPG).  
Although twice as many colonies were screened as in the rapamycin library, no reproducibly 
inducible variant was found. Strikingly however, in 156 cases the addition of the peptide ligand 
led to a repression of protease activity (Table 14). In 17 cases, the activity was repressed down 
to 25 % of the initial value without ligand, meaning a 4-fold repression. Example ANA-peptide 
conversion traces of purified repressible switches are shown in Figure 18, while details of the 
10 sequenced variants are given in Table 15.  
In a second library screening performed by Luca Brenker during his bachelor thesis, another 
178+206 variants were tested with slight modifications regarding the linker space. Variants 
that seemed inducible did not yield the same result when tested again or in purified form.   
 
 Table 14 Screening results of ePDZ-b1/FN3 
protease switch library. 
Parameter Quantity 
Possible variants 735 
Screened colonies 467 
Religands 0 
Repressible variants 156 
Thereof: up to <0.25 
repressible 17 
Sequenced variants 10 
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Table 15 Summary of ePDZ-b1/FN3-library screening experiments; comparison of lysate screening and purified screening 
results. Maximum x-fold induction was calculated from the initial linear range. The initial linear range was variant-
specifically chosen and dependent on the moment the fluorescence signal exceeded background noise. 
Variant L1 L2 L3 
x-fold 
repression 
(Lysates) 
x-fold 
repression 
(Purified) 
5_H8 GG GPGG GG 16.6 ± 9.9  
5_F7 GG GPGG GGSG 10.3 ± 2.5  
2_H7 GG GPGG GG 7.9 ± 1.2 8.3 ± 1.0 
2_A5 GGG GPGG GGSG 6.1 ± 1.3 14.3 ± 1.5 
5_A12 GG GPGG GGG 5.5 ± 1.2 7.6 ± 0.4 
2_F6 GGG GPGG GGG 5.2 ± 0.3  
5_C6 GGG GGGG GGSG 3.4 ± 0.5  
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Figure 18 Example traces of strongly repressible ePDZ-b1/FN3 single chain protease switches. Shown are ANA-peptide 
conversions by switches 2_A5 and 2_H7 respectively in absence (grey) or presence (black) of peptide ligand. Linkers of 
the respective switches are indicated as insets. Purified switches were present at 200 nM. Values were normalized to 
negative control. 
 
 Effects of N-terminal MBP are negligible 
All multidomain-protein switches contain an N-terminal MBP as solubility enhancer that is 
separated from the switch by a TEV protease site. This large protein may influence the switch 
behaviour due to surface clashes or constraints on the proteins mobility.  
In two independent experiments, of which one was conducted by Anastasia Weyrich, purified 
rapamycin switches were incubated with or without TEV protease and subsequently assayed 
with ANA-peptide. For all switches except one (clone V1, AITVMV-GGASPAGG-FKBP-(GGS)2G-FRB-
(GGS)2G-TVMVp), removal of MBP had neither an effect on activity nor inducibility. For clone V1, 
MBP removal slightly decreased rapamycin inducibility, however, within the experimental 
error. Therefore, the stabilization introduced by MBP appears to outweigh possible constraints 
on mobility of the multidomain architecture.   
 
 Construction of a FRET-based TVMVp Sensor Protein 
In all described experiments, commercial ANA-peptide was used as a substrate to assay TVMVp 
activity. For future applications of TVMVp-switches, however, other substrates must be 
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considered and developed. As a first alternative for protease activity sensing, a protein FRET-
sensor based on the fluorescent proteins YPet and CyPet was devised, with the structure CyPet-
FKBP-TVMVsite-FRB-Ypet. In presence of TVMVp, the protein gets cleaved into CyPet-FKBP and 
FRB-YPet, resulting in a reduced FRET effect (ex. 415 nm, em. 527 nm). Rapamycin addition 
restores the FRET effect by reassembly of the architecture via FKBP-FRB interaction.   
 
 
 
Figure 19 Validation of FRET-based TVMVp sensor CyPet-FKBP-TVMVsite-FRB-Ypet (CTY). Shown are emission spectra 
of 100 nM CTY (dark blue), 100 nM CTY with 500 nM TVMVp (black) and 100 nM cleaved CTY with 100 nM rapamycin 
(turquoise).   
The sensor was constructed, and the concept successfully verified by Anastasia Weyrich and 
Lisa Gertig in the scope of a practical course. While the protein is useful for testing TVMVp 
activity, it was not cleaved by FKBP-FRB-TVMVp-switches. As an experiment with modified 
FRET-sensors suggested, this is most likely caused by sterical hindrance and/or inaccessibility 
of the cleavage site or TVMVp active center, respectively. This hypothesis is supported both by 
a control experiment where TVMVp was not able to cleave CyPet-GPGAS-TVMVsite-GGRGSS-YPet, 
while it cleaved a sensor with an additional internal FRB domain, CyPet-GPGAS-TVMVsite-KLGG-
FRB-SGGRGSS-YPet (cloned by Tim Maier) (Figure 20), and by studies of Anastasia Weyrich on 
different linkers between TVMVsite and the two fluorescent proteins. 
 
Figure 20 Cleavage of TVMVsite is affected by protein architecture. Shown are the ∆RFU values at 527 nm (extinction: 
415 nm) as a function of time. Fluorescent proteins were added at the same concentration.   
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 Summary and Discussion  
By rational design based on crystal structures and published scaffolds, a rapamycin-inducible 
protease switch was successfully constructed and validated. Yet, the initial switch showed only 
marginal inducibility that could only be observed with purified protein and not in E. coli lysates 
(Figure 8, Figure 9). This was attributed to the interdomain linkers, as the domain order was 
apparently appropriate for transferring rapamycin-induced conformational changes in the 
FKBP-FRB receptor module to the protease and AITVMV domain. 
While some modular cloning strategies exist to alter a single linker between two domains of a 
fusion protein (as discussed in section 1.4), none of them allow differentiated and thorough 
screening of multiple linker positions. Thus, a new method was devised based on classical 
restriction and ligation, however with the use of specialized Type II S restriction enzymes 
(section 3.2). 
With the developed iFLinkC strategy, a large linker space both in terms of identity and length 
can be screened in short time [123]. Linkers can be treated as modular building blocks and 
combined to linker libraries, as they are stored in plasmid backbones that allow construction of 
desired fusion proteins in an iterative and parallel fashion. Moreover, it is possible to exchange 
the current minimal linker of one glycine to another amino acid (pair) if the cleavage sites of 
BsrD1 and Bts1 are adapted, yet, this would lead to a second set of storage and assembly 
plasmids incompatible to the current pL2 and pFD. 
Although the available linker space was not screened to completion, I identified many 
rapamycin-inducible variants showing x-fold induction of >40 in bacterial lysate assays, some 
of them performing even better in purified form (Table 12). The discrepancy between lysate 
screening and purified protein screening can have several reasons. For example, residual E. coli 
proteins may tend to unspecifically interact with the switches in lysate-based experiments, 
reducing their overall activity. Generally, the proteins mobility – both in terms of diffusion and 
conformational flexibility – is likely reduced in the highly crowded in vivo environment that the 
lysate adopts [209]. For instance, molecular crowding conditions can even render the reverse 
reaction of a protease-catalyzed process favourable, leading to an equilibrium shift from 
proteolysis towards peptide bond synthesis [210]. The occurrence of this phenomenon in the 
TVMVp switch studies is unlikely, especially as the substrate is small. Nevertheless, it should be 
considered that the results from less crowded in vitro environments resemble the switch activity 
under idealized conditions.   
In the best FKBP-FRB protease switches, the AITVMV motif was extended by GP via the L1 linker. 
This extension proved to lower the Ki of the autoinhibitory motif more than one order of 
magnitude (Figure 15), leading to a highly repressed OFF-state which in turn explains the high 
x-fold induction in presence of rapamycin. While the exact reason for the improved inhibition 
remains uncertain, the findings underline the importance of a tight OFF-state for molecular 
switches in general.    
The second switch library based on a PDZ-FN3 affinity clamp did not yield an inducible variant 
despite exhaustive screening. This was unexpected, as an inducible single polypeptide TVMVp 
PDZ-FN3 switch has been published [5]. By comparing the designs of this work and [5], an 
explanation can be derived. The switch from Stein and Alexandrov was based on an N-terminal 
protease and a C-terminal AITVMV, while this respective orientation was reversed in my design 
to prevent residual protease activity caused by incomplete translation. Moreover, both heavy 
truncation of L1 between the N-terminal protease and ePDZ-b1 together with a precisely tuned 
L2 between ePDZ-b1 and FN3 were necessary to yield an inducible variant [5]. Strikingly, the 
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same domain orientation but different linkers created a repressible variant, comparable to the 
ones identified here (Table 15). This demonstrates twofold: Firstly, the domain orientation in 
synthetic protein switches can have fundamental impact on switch behaviour. Secondly, some 
cases demand very short linkers (like ESG in [5]) or even a direct domain fusion [67].  
The TVMV protease served as a potent actuator module in all experiments. While it successfully 
cleaved the quenched substrate upon activation by an allosteric ligand, the additionally 
gathered data (Figure 19, Figure 20, also Master thesis Anastasia Weyrich) call for caution. 
Processing of the relatively small ANA-peptide does not necessarily compare to processing of a 
TVMVp cleavage motif that is embedded into a larger fusion protein. In the latter case, the 
cleavage site can be sterically blocked, both by the substrate protein or the protease fusion 
protein, leading to an apparently reduced catalytical activity. Importantly, these results were 
all obtained from in vitro experiments. The mentioned molecular crowding situation could 
further impact the potential of protease switches in vivo.          
Altogether, the results of this study highlight the importance of high-throughput and fractional 
factorial linker screening approaches. For the tested architecture AITVMV-L1-ePDZ-b1-L2-FN3-L3-
TVMVp, an inducible variant may be found if the lengths of all linkers are screened in a full 
factorial fashion (e.g. from 1 up to 15). However, there is no guarantee that the chosen domain 
orientation allows a switch-ON behaviour at all. Yet, the identified repressible PDZ-FN3 
protease switches comprise useful tools for multiple applications, for instance programmable 
protein circuits [51,177] or responsive biohybrid materials [3].             
As a perspective, the developed iFLinkC strategy could be applied to screen and characterize 
unusual linker motifs, like the mentioned (EAQA)n, E/RK helices or even larger “linker domains” 
(see section 1.1). The large potential of the still not fully explored linker space will allow the 
construction of powerful synthetic fusion proteins and thus pave the way for novel and 
improved switches, biosensor scaffolds and alike.   
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4. Supplement Chapter 2 
 
Sup Table 1 PCR calculator. All numbers in µl.  
 PCR reactions 
Component 1 2 4 6 8 10 12 
DNA template (10-30 ng/µl) 1 2 4 6 8 10 12 
Forward Primer (10 µM) 2,5 5 10 15 20 25 30 
Reverse Primer (10 µM) 2,5 5 10 15 20 25 30 
dNTPs 1 2 4 6 8 10 12 
GC buffer 10 20 40 60 80 100 120 
ddH2O 33 66 132 198 264 330 396 
Phusion Polymerase 0,5 1 2 3 4 5 6 
 
 
 
 
 
Sup Fig 1 Example for raw results from high-throughput lysate screening. Shown are the slopes in RFU/min during 
reaction start (10 min) of rows E and F of a screened plate. Inducible variants with tight basal state like F3 are clearly 
discriminated from inactive ones like E8.  
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Sup Fig 2 Global plasticity of the FKBP-FRB rapamycin switch library screening (lysate experiments). The 233 variants 
that were screened are plotted from the one showing the highest x-fold induction to the lowest.  
 
Sup Fig 3 AI-peptide inhibition. SH3-TVMVp (200 nM) was titrated with REYVRFAP. The legend depicts the R2 value of 
the corresponding fit together with the determined Ki. Standard errors derive from duplicate measurements.  
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Sup Text 1 Derivation of the Fit-function applied in Figure 16.  
Symbol Meaning 
vmax Maximal reaction rate  
v Reaction rate 
kcat Turnover number 
[ET] Total enzyme concentration in steady state 
KD Equilibrium dissociation constant 
[ES] Enzyme-substrate-complex concentration in steady state 
[RL] Receptor-ligand-complex concentration in steady state 
[L] Free ligand concentration in steady state  
[LT] Total ligand concentration in steady state 
[RT] Total receptor concentration in steady state 
v0 Initial reaction rate 
 
The maximal reaction rate of an enzymatic process is defined [22] as 
    ,  
   
while the actual reaction rate is 
   .  
   
Combination of both equations gives 
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Assuming that the rate limiting step of the ANA-peptide reaction is the cleavage by the TVMVp 
domain, [ES] of this reaction equals [RL], the concentration of the receptor-ligand complex 
build by rapamycin and the switch. Under idealized conditions and with a 1:1 interaction 
between a single ligand and a single receptor site, [RL] can be expressed [207] as  
    

 
 
  
   
However, due to the high affinity of FKBP to rapamycin, free rapamycin is depleted during the 
reaction, hence the idealized condition [L] = [LT] is not met. Thus, [RL] has to be written [207] 
as  
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Considering the initial background activity of the switch in absence of rapamycin, the final 
fitting function – substituting [ES] with [RL], [ET] with [RT] and combining equations (S1) and 
(S2) – thus reads as 
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where v is plotted as a function of [LT] in Figure 16 to determine the apparent KD of the 
rapamycin/switch interaction.  
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Chapter 3  
Investigations on FhuA-based Nanopores 
1. Introduction & Background 
The molecular switches developed and discussed in the previous chapter could convert 
environmental inputs into orthogonal signals and reactions. Such conversion is one of the key 
principles that allow microorganisms to interact with their environment. Receptors in cell 
membranes forward information from the outside of a cell to its interior, leading to a variety of 
responses. Generally speaking, compartmentalization of a given volume by a lipid bilayer 
membrane counts as one of the main features of cellular life [211]. 
During evolution, cells have developed many strategies to react to environmental inputs. An 
exceptional example is the alternation of current flow by membrane-anchored proteins. For 
instance, small ion channels that are embedded in the membranes of axons are responsible for 
the propagation of an action potential through neurons [22]. The unique properties of 
transmembrane protein pores have made them great templates for biosensors. These proteins 
are also named “nanopores” [212], although this term is ambiguous as it is also used in solid-
state material science [213,214].  
Nanopore sensing allows single-molecule analytics in real time, converting complex processes 
into readily detectable signals [62,215]. When embedded in artificial lipid bilayers, polymer 
membranes [64,216] or combinations thereof [217], a binding event or a passage of a molecule 
triggers changes in its conductance, leading to a change in electrical current, blocking frequency 
or similar [218,219]. 
As discussed earlier (Chapter 1), one of the most prominent examples is the evolution of the 
nanopore sequencing technology. The simple concept of  DNA or RNA translocation through 
the aperture of a protein nanopore lead to multiple successful products in point-of-care 
diagnostics [212,220,221]. Nanopore sensing is however not limited to nucleic acids. Its 
applications range from characterization of enzyme activities [63,219,222–224], antibodies 
[225,226] and analytes like toxins [227] to the detection of proteases [63,189,223], peptides 
[228,229] and even conformational changes of single molecules [230].  
For the sake of clarity, I will concentrate on peptide and protein nanopore scaffolds that can be 
recombinantly produced in microorganisms and are composed of canonical amino acids (aa). 
“Non-natural” nanopore scaffolds that resist easy recombinant production, including gramicidin 
[231], melittin [232] and peptide nanotubes [233,234] are omitted from this overview. Solid 
state nanopores and solid/biological chimeras are discussed in Chapter 4.   
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1.1 Nanopore examples – bottom up 
Bottom up nanopore engineering is driven by the aforementioned need of new biosensors, but 
also by the search for new antibacterial and anticancer compounds [235]. However, de novo 
design of not only nanopores, but integral membrane proteins in general, is challenging due to 
the complexity of protein folding as well as lipid/protein and protein/protein interactions and 
interfaces, respectively [236,237].  
    
1.1.1 Antimicrobial peptides 
While the potential of antimicrobial peptides in clinical applications is considered high [235], 
efforts to generate controllable and stable “minimal” nanopores are still hampered by a lack of 
structure-function relationship understanding [238]. This is intriguing, since artificial, minimal 
pore forming peptide sequences based on the gramicidin scaffold have been investigated since 
1973 [236,239,240]. Today, new active pore-forming peptides are mainly found by high-
throughput-screening of peptide libraries [235,241] or with the help of simulations [242]. Yet, 
it remains obscure to assess how to engineer completely new, stable nanopores out of 
antimicrobial peptides.  
 
1.1.2 cWza 
A strong driving force behind the de novo design of nanopores are computational approaches, 
for example from the Woolfson lab. In cooperation with the Bayley lab, they derived a 35-aa 
consensus peptide sequence from the transmembrane spanning domain D4 of the E. coli 
polysaccharide transporter Wza. This artificial scaffold, named cWza, inserted as a parallel 
oriented octamer into lipid bilayers. Depending on the applied membrane potential, cWza 
showed different conductivity states, which the authors proposed to be due to different octamer 
structures cWza can form in the membrane. It was possible to introduce certain mutations to 
the scaffold. Put together, these experiments are a successful minimalization approach based 
on artificial peptides. [243]      
 
1.1.3 Holins 
dsDNA bacteriophages that infect gram-negative bacteria lyse their hosts by the help of three 
protein families: Holins that form “holes” or pores in the inner membrane, endolysins or murein 
hydrolases that degrade the peptidoglycan layer, and spanins that disrupt the outer membrane 
[244]. Membrane permeabilization by holins is preceded by their accumulation in the 
cytoplasm, followed by induction of membrane lesion [244].     
Holin engineering was pioneered by Lella and Mahalakshmi in 2016. By reversing nearly the 
whole 28-aa sequence of the first transmembrane domain (TM1) from the mycobacteriophage 
D29 holin, they created the functional ion-conducting channel rTM1 [245]. Its behaviour could 
be further altered by small sequence modifications. However, the exact mechanism of pore 
forming as well as the pore stoichiometry remained unclear. Such data would support further 
nanopore engineering of holins.    
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1.2 Nanopore examples – Top down 
Engineering of natural existing nanopores is mandatory for achieving a desired function and 
thus a functional biosensor. The engineering scope can range from very small changes in the 
protein backbone to complete redesign. For instance, translocation and sensing of analytes is 
fine-tuned by the addition of charges [228,246–248] or adapters [249–251]. Flexible protein 
loops outside the membrane lumen may impact the nanopore behaviour [252], however, they 
can be exploited [186,253,254] or deleted [228,255] to gain desired functionalities. Extreme 
alterations in the structure of the nanopore itself include enlargement [250,256,257] and 
diminution [258–261] by mutation, addition or deletion of subunits or beta-strand, 
respectively. Combinations of nanopores and large sensing domains outside the membrane 
represent particular challenging tasks [16,262]. In the following, a review of some of the best 
characterized nanopores to date is given, categorized by their structural identity. This overview 
is not exhaustive, especially as companies are currently heavily screening and optimizing 
nanopores [263].   
 
1.2.1 Artificial scaffolds 
1.2.1.1 phi29 connector  
The phi29 connector protein was the first example for an engineering approach in which a 
nanopore protein was created from an otherwise not membrane-bound protein [264]. It 
assembles into a homododecamer with its narrowest constriction 3.6 nm in diameter [265]. 
Phi29 connector served as a platform for DNA translocation [264] and small molecule sensing 
[266]. However, phi29 connector does not insert spontaneously into lipid bilayers [265].   
 
1.2.2 Beta-pore-forming toxins 
1.2.2.1 α-hemolysin 
The concept of nanopore sensing points back to the characterization of the homo-heptameric, 
beta-pore-forming toxin α-hemolysin (aHL) from the human pathogen Staphylococcus aureus. 
It was originally named after its property to lyse erythrocytes [267]. Since its structure has been 
solved in 1996 [268], aHL served as a scaffold for countless biosensor concepts 
[16,56,189,246,249,251,262,269,270] and has been used as a standard pore-forming channel 
during device development studies [271,272].  
In its active heptameric form, aHL has a characteristic mushroom-like shape, with a crown-like 
outer-membrane part and a transmembrane beta-barrel containing the main constriction 
(2.6 nm diameter) [265,268]. Experiments with aHL and its rationally designed variants are 
straightforward, as they are stable and insert spontaneously into lipid bilayers [265,271]. 
Furthermore, aHL can be precisely genetically engineered to recognized diverse target 
molecules [56,189]. Nevertheless, aHL has limitations. Purification of heteroheptamers is 
laborious [16,262] and the relatively narrow constriction of 2.6 nm limits sensing applications 
based on translocation.  
 
1.2.2.2 Aerolysin 
Aerolysin is a beta-pore-forming toxin from Aeromonas hydrophila and, similar to aHL, forms 
heptameric pores [248,273]. The 3D structure of its active pore complex by means of Cryo-EM 
shows a channel with a constriction of 10-17 Å [248,273]. When compared to aHL, aerolysin 
 
 
   49 
   
offers the advantage of a broad cap that does not block the transmembrane pore like the 
crown/vestibule domain of aHL [227], however, the channel is considerably longer (10 nm 
compared to aHLs 8.5 nm) and its interior is largely charged [248,273].   
Although lipid bilayer experiments with aerolysin date back to 1990 [274], engineering efforts 
regarding this scaffold are still young, owed to the fact that its high resolution structure was 
solved only in 2016 – 20 years after that of aHL [273]. In a study where the “blank” aerolysin 
pore has been used to sense peptide translocation, it was demonstrated that the pore is 
relatively insensitive towards serum components [227]. Recently, rational design of aerolysin 
allowed investigations about selectivity and translocation processes, suggesting that aerolysin 
will emerge as a tuneable biosensor scaffold [248,275].  
 
1.2.3 Alpha-pore-forming toxins 
1.2.3.1 Cytolysin A  
Among the largest protein nanopores characterized to date is the dodecameric alpha-pore-
forming toxin ClyA found in E. coli and Salmonella entera strains [276,277]. Its structure was 
solved in 2009 [277]. One ClyA subunit – mainly a-helical – has a size of about 34 kDa and 
undergoes extreme structural changes when assembling into pore complexes [276]. The pore-
forming homododecamer forms a hollow cylinder sitting on the lipid membrane, with a 
diameter of 35 Å at the narrowest constriction [276]. As aHL, ClyA has been used to probe new 
membrane-based devices [278].   
Proteins larger than 20 kDa can be electrophoretically trapped inside the ClyA lumen 
[250,257,279]. This phenomenon has been used to analyse protein interaction and analyte 
recognition at a single-molecule level [230,280,281]. A directed evolution approach has led to 
ClyA variants that assemble into nanopores of varying diameter, thus broadening the 
possibilities of analyte recognition and characterization [257]. Recent progress in 
understanding its assembly and pore-forming mechanism [282] paves the way to improved 
rational design of ClyA.      
 
1.2.3.2 Fragaceatoxin C 
The crystal structure of FraC, an alpha-pore-forming toxin produced by sea anemones, was 
published in 2015 [283], yet its conical shape and beneficial single constriction of 16 Å has 
already drawn the attention of nanopore engineers. FraC monomers consist of two parts, an a-
helical transmembrane domain at the N-terminus in combination with a C-terminal, beta-sheet 
rich domain called the beta-core [283]. They assemble into pore-forming homooctamers [283]. 
Like ClyA, FraC has been engineered through directed evolution approaches. Its potential 
applications range from DNA analysis [247] to peptide length analysis [261] and protein-
fingerprinting [229].  
 
1.2.4 Inner membrane proteins 
1.2.4.1 MspA 
The monomeric porin A of the gram-positive Mycobacterium smegmatis (MspA) was chosen as 
candidate nanopore scaffold for DNA sequencing mainly due to its geometry [284]. With a 
central constriction of about 1 nm length and width it forms the perfect aperture for ssDNA, 
and in contrast to aHL it lacks any additional crown-like constriction. MspA is extremely robust 
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to environmental conditions and amenable to genetic engineering [284], and evolved as one of 
the most promising DNA sequencing nanopore scaffolds [285].  
 
1.2.5 Outer membrane proteins 
1.2.5.1 Interlude – Outer membrane protein biogenesis 
In gram-negative bacteria like E. coli, the biogenesis – simply put: the journey – of outer 
membrane proteins (Omps) to their target is a highly complex process [286]. It involves 
translocation of the peptide chain over the inner membrane, chaperone-assisted transport 
through the periplasm, and assembly of the protein into the asymmetric bilayer that forms the 
outer membrane [286].  
Firstly, the unstructured Omp peptide chain is transported actively across the inner membrane 
by the general secretory system (Sec translocon). The SecYEG complex serves as the 
translocation channel, and translocation is mediated by the ATPase SecA as well as the proton 
motive force [287,288]. Omp recognition and targeting is mediated by an N-terminal signal 
sequence that gets cleaved off during this process [288–290]. These particular signal sequences 
contain three distinct motifs but are otherwise not conserved [289]. 
Following translocation, chaperone proteins like SurA and Skp bind the Omp chain in the 
periplasm, by this means creating a dynamic chaperone-substrate ensemble that prevents 
misfolding [291–293] [320–322]. Finally, the Omp folds into its correct structure in the outer 
membrane, heavily assisted by the beta-barrel assembly machinery (BAM)-complex [286,294]. 
Similar to the N-terminal signal sequence important for SecYEG translocation, a species-specific 
motif at the C-terminus allows the Omp to be recruited by the BAM-complex [294–296].     
 
1.2.5.2 OmpG 
Multiple structures of the monomeric porin OmpG from E. coli were described in 2006 and 
2007, revealing a 14-stranded beta-barrel with an inner constriction of 12x15 Å [297]. 
Pioneered by the work from Min Chen, who became a leading expert on this scaffold, and Syma 
Khalid [298], the OmpG architecture was successively optimized and engineered into a quiet 
and stable nanopore [252,297,298]. To date, OmpG has proven a reliable biosensor for small 
molecules [186,298], antibodies [186,225] and protease activity [63]. OmpG has been 
amenable to large changes in its structure, like minimalization [260] and re-combination [299].  
In contrast to other nanopores, analyte sensing is translocation-independent and identified by 
changes in current fluctuation (gating) events [186]. Therefore, the impact of the beta-sheet 
connecting loops has been investigated in detail experimentally and in silico [252,297,300].  
 
1.2.5.3 FhuA 
FhuA and its derivative scaffolds are discussed in detail in the following section.       
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1.3 FhuA based nanopores 
1.3.1 The FhuA scaffold 
FhuA belongs to one of the first studied membrane proteins, dating back to experiments from 
Max Delbrück in the 1940ies [301]. Until 1980, it was known as the TonA protein, after phage 
T1 (T one) that exploits the protein to infect E. coli, while the “A” stands for a specific phenotype 
[301]. In 1980 its name was changed to FhuA, as it is involved in ferric hydroxamate uptake 
[302]. Specifically, it is responsible for siderophore uptake in general and serves as a target 
and/or receptor for many phages (e.g., T1, T5 and φ80), toxins (Colicin M) and some 
antibiotics [301,303].  
FhuA is located in the outer membrane of the gram-negative E. coli. Two crystal structures of 
natural FhuA solved in 1998 presented a barrel-shaped protein consisting of 22 antiparallel 
beta-sheets with surface-exposed connecting loops and an N-terminal, globular cork (or plug) 
domain filling the barrel [304,305]. With its dimensions of 69 Å height, 46 x 39 Å cross section, 
714 aa and about 79 kDa (without the signal sequence), FhuA ranks among the largest known 
beta-barrel proteins [304,306]. In E. coli, native FhuA (wtFhuA) is expressed with an N-terminal 
33-aa signal sequence (+sig) that ensures its export from the cytoplasm to the periplasm via 
the SEC pathway (section 1.2.5.1). During further biogenesis, this signal sequence is cleaved 
off. The hydrophobic membrane region has a height of 25 Å [306].  
 
 
Figure 21 Ribbon representation of the wtFhuA structure. A: Side view; B: View from the periplasmic side. The β-barrel 
is depicted in beige, the cork domain is highlighted in green. Images were generated using UCSF Chimera [120] and PDB 
file 4CU4 [307].  
 
Ligand interaction and translocation is mediated by an interface between the loops, the barrel 
itself and the cork [304,308]. The cork domain shares a large inner surface with the barrel 
[303,304]. During ligand uptake, the cork is rearranged and pulled out of the barrel in a 
concerted motion involving the action of TonB, a key cytoplasmic membrane-anchored protein 
[309–313]. The relation between the FhuA cork and barrel domain deserves a special remark, 
as they can reconstitute into functional FhuA when expressed separately [314,315]. However, 
the cork itself is unstructured and fairly unstable in solution [315,316]. Moreover, MD 
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simulations revealed that the cork is not important for stabilizing the beta-barrel architecture, 
in contrast to the hydrogen bond network formed by neighbouring beta-sheets [317,318].  
Artificial bilayer (black lipid membrane, BLM) experiments with wtFhuA date back to 1993, 
even before its 3D structure was solved [319]. wtFhuA does not show channel activity when 
inserted into artificial lipid bilayers unless a ligand is added [320] or the protein is stressed by 
urea [312,315]. However, deletion of the cork domain as well as deletion of certain loops 
transform FhuA into an ion-conducting nanopore. While deletion of the cork domain alone is 
not sufficient to create stable channels in artificial bilayers [321], additional deletion of loop 
residues leads to stable channels with conductance between 1.5 and 3 nS in 1 M KCl [319,322].  
There are diverging opinions regarding the tendency of FhuA and its variants to insert 
spontaneously into artificial lipid bilayers. While the Finkelstein group states that an osmotic 
gradient is important for proper FhuA insertion1 [312,315], experiments by the Braun 
[319,322] and Movileanu [255,323] groups claim the insertion process to be spontaneous. This 
contradiction might result from different purification protocols, or – even more likely – from 
different FhuA scaffolds used. For instance, the Movileanu group demonstrated evidence that 
their variant ∆c∆5L always inserts with the periplasmic loops first [226,323,324].  
 
1.3.2 FhuA ∆c∆5L 
The Movileanu group successively transformed FhuA into a quiet nanopore scaffold. They 
deleted the cork and replaced loops 3, 4, 5, 10 and 11 with a short, flexible 5 aa motifs, creating 
the FhuA ∆c∆5L variant as a result [255,323] (mislabelled ∆c∆4L in the original publications 
according to [228]). Since then, this engineered nanopore scaffold has been employed in 
various membrane protein investigations and biosensing studies [226,228,324–327]. 
As a nanopore scaffold, ∆c∆5L offers reasonable advantages: It is monomeric and stable, has a 
quiet electric signature with high open probability and an exceptional high conductance – 
leading to a favourable signal-to-noise ratio [228,255,323]. Its size is 44 x 31 Å, with internal 
average dimensions of 26 x 39 Å [323]. The interior channel walls of ∆c∆5L are mainly acidic, 
hence the pore is cation-selective [228,255,323]. Although the N-terminal 33-aa Omp signal 
sequence is still present in ∆c∆5L, it was claimed that it does not influence the open state of the 
nanopore to a relevant degree [228].   
 
1.3.3 Other FhuA scaffolds 
∆c∆5L is not the only FhuA scaffold constructed by the Movileanu group. Wolfe and colleagues 
created ∆c∆5L-25N and dcd7L-30N to render the scaffold weakly anion-selective, without 
negative effects on stability and other biophysical properties [228]. In their nomenclature, 25N 
and 30N correspond to the numbers of charge neutralising mutations in the ∆c∆5L scaffold. In 
follow-up studies, Thakur and colleagues created H6[PA]3FhuA, which is basically ∆c∆5L with 
a 6xHis tag and a rigid linker at the N-terminus instead of the 33-aa Omp signal sequence [226]. 
H6[PA]3FhuA was used to investigate antibody binding at the single molecule level [226]. The 
minimal scaffold, tagless (TL or t)-FhuA, was characterized in detail and served as a platform 
for additional biosensor constructs (Table 16) [226,324,327].  
                                                     
1 although they did not use wtFhuA but D336C FhuA, which they claimed to behave identical to wtFhuA, 
referencing [313]     
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The studies from the Movileanu group underline that ∆c∆5L and TL-FhuA are amenable for 
protein engineering. Furthermore, they claimed that purified and denatured FhuA scaffolds can 
easily be refolded into functional beta-barrels via rapid dilution into detergent solutions 
[255,325]. Other variants constructed by the Schwaneberg group, for instance FhuA Δ1-160 
variants with increased pore size [328] are not conceptualized as stochastic biosensors but as 
improved catalysts for organic chemistry [306,329] and chiral separators [330].   
 
Table 16 Compilation of studies that successfully used FhuA variants as biosensors. 
FhuA variant Analyte / Event detection Publications 
TL-FhuA Barstar (RNase barnase inhibitor) [324,327] 
TL-FhuA Anti-His antibody [226] 
∆c∆5L Positively charged polypeptide [228,323] 
∆c∆5L 
Interaction between HIV-1 Nucleocapsid NCp7 and 
DNA aptamer 
[323] 
∆c∆5L IgG digestion by pepsin [323] 
FhuA Δ1-160 variants 
with increased pore size 
PEG derivates [328] 
 
 
1.4 Interlude – Addressing Bilayer Instability 
As outlined, transmembrane proteins are promising biosensor scaffolds due to their excellent 
specificity. Yet, their dependence on lipid bilayers is a drawback regarding their incorporation 
in miniaturized sensing devices, as lipid bilayers are dynamic and limited in their electrical, 
mechanical and temporal stability [217]. Thus, alternatives for and stabilized versions of lipid 
bilayers have been developed. For instance, lipid bilayers tethered to a surface via long aliphatic 
linkers show better stability and storability [331]. Other approaches include photo-
polymerization  [217,332], gel encapsulation [271], scaffolding via actin-filaments [333], 
substitution of the lipid bilayer with polymers [64] and alternative electrolytes [270].    
A promising yet challenging concept is the combination of lipid-embedded biological nanopores 
with solid-state nanopores (SSNs). Since early studies with small biological channels and 
polymer membranes [334], platforms for highly parallelized membrane protein 
characterization have been realized [335]. It remains to be seen if the fabrication and readout 
process can be further optimized to enable construction of reliable point-of-care devices.  
 
1.5 Perspectives 
The success of nanopore sequencing underlines the potential of stochastic sensing. Researchers 
continue to find and characterize whole new nanopore families, for example the actinoporins 
[336]. New nanopore scaffolds continue to emerge, both via the top-down and bottom-up 
approaches, that will ultimately lead to improved design for miniaturized devices.  
During my thesis, I focused on the FhuA ∆c∆5L scaffold from the Movileanu group. Firstly, the 
published purification pipeline was reproduced and applied to ∆c∆5L variants carrying terminal 
peptide tags. Following the rationale of modularity, these responsive tags were conceptualized 
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as recruiting and attachment points for specific secondary protein receptors. By this strategy, a 
set of novel stochastic sensors was envisioned based on the robust transmembrane scaffold 
∆c∆5L. Two responsive tags were tested: SnoopTag (described in section 3.2.2, Chapter 1) and 
SmBiT86. SnoopTag showed the best performance and allowed irreversible capturing of a 
SnoopCatcher fusion protein. A third tag, SpyTag, was tested by Sebastian Schaupp during his 
Master Thesis, but respective ∆c∆5L variants inserted very poorly into lipid bilayers, if at all.  
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2. Methods 
Standard methods are described in section 2.1, Chapter 2.  
 
 Purification of soluble proteins 
LgBiT and SnoopCatcher-NBGFP were purified via their respective StrepTagII. In case of LgBiT, 
E. coli BL21(DE3) were transformed with the corresponding pET32-Strep-LgBiT plasmid. An 
overnight culture was used to inoculate 1.5 l LB medium to OD600=0.1. At OD600=0.4, 0.5 mM 
IPTG (final concentration) was added to induce expression. Expression was performed for 4 h 
at 37 °C. In case of SnoopCatcher-NBGFP, an overnight BL21(DE3) culture carrying pET24-
SnoopCatcher-GGSSG-NBGFP-strep was used to inoculate 2x 1 l LB medium to OD600=0.1. At 
OD600=0.48, 0.5 mM IPTG was added to induce expression. Expression was performed for 16 h 
at 24 °C. Further downstream purification was the same as described in section 2.6, Chapter 2, 
with the exception that KCl was used instead of NaCl for all buffers.   
 
 Purification of insoluble proteins / inclusion bodies 
E. coli BL21(DE3)omp8 (kindly provided by Klaus Hantke, Universität Thübingen) [337] or 
BL21(DE3) cells were transformed with the respective FhuA and ∆c∆5L variants in pET32 
(Table 17). A 100 ml O/N culture was inoculated with a single colony. On the next day, 
transformed cells were grown at 37 °C in a larger volume (1-2 L) LB +100 µg/ml ampicillin 
until an OD600 of 0.5-0.6 was reached, after which they were induced with 0.5 mM IPTG. After 
4 h of expression at 37 °C, cells were harvested via centrifugation and stored at -20 °C. For 
purification of ∆c∆5L variants from inclusion bodies, an adapted protocol from Thakur et al. 
[226] was used. Briefly, cells were resuspended in 300 mM KCl, 50 mM Tris-Cl pH=8, 
5 mM EDTA, lysed by four passes through an Emulsiflex (Avestin) at 1500-2000 bar and 
centrifuged at 4000 xg and 4 °C for 20 min. Pellets were washed two times with 300 mM KCl, 
50 mM Tris-Cl pH 8, 5 mM EDTA, followed by two washes with 300 mM KCl, 50 mM Tris-
Cl pH=8, 5 mM EDTA, 0.5 % (v/v) Triton X-100 and one wash with 50 mM Tris-Cl pH=8. After 
each wash step, a centrifugation step (11200 xg, 4 °C, 20 min) was performed.  Afterwards, the 
inclusion bodies were dissolved in 500 mM KCl, 50 mM Tris-Cl pH=8, 8 M Urea and incubated 
for 2 h at room temperature. Aggregates were removed by centrifugation. The remaining 
supernatant was filtered (0.2 µm) and applied onto a Ni-NTA column equilibrated in 500 mM 
KCl, 50 mM Tris-Cl pH=8, 8 M Urea. After a 5 CV washing step with the same buffer plus 
10 mM Imidazole, protein was eluted over a 10 mM – 200 mM Imidazole gradient in the same 
buffer. Purified proteins were dialyzed against 5 l of ddH2O overnight with one buffer exchange, 
flash-frozen and lyophilized overnight (Alpha 2-4 LD plus, Christ). Sealed, lyophilized samples 
were stored at 4 °C until refolding.   
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Table 17 Relevant plasmid list for FhuA related experiments 
Plasmid Used for Acknowledgements 
pASK-IBA3-ColicinM(D226A)-sfGFP-
strep 
Microscopy  
pET24-wtFhuA Microscopy  
pET32-∆c∆5L6xHis Lipid bilayer studies  
pET32-Strep-LgBiT Lipid bilayer studies Constructed by Claudia Kreher 
pET32 +sig∆c∆5L6xHis Lipid bilayer studies  
pET32 +sig∆c∆5L-SmBiT866xHis Lipid bilayer studies  
pET32 6xHisSnoopTag-+sig∆c∆5L Lipid bilayer studies 
Constructed by Sebastian 
Schaupp 
pET32-6xHisSnoopTag-10Link-∆c∆5L Lipid bilayer studies 
Constructed by Philipp Kemp 
and Marco Bechtel 
pET32 +sig∆c∆5L-2Link-SnoopTag6xHis Lipid bilayer studies 
Constructed by Sebastian 
Schaupp 
pET32 +sig∆c∆5L-10Link-SnoopTag6xHis Lipid bilayer studies 
Constructed by Philipp Kemp 
and Marco Bechtel 
pET24 SnoopCatcher-GGSSG-NBGFP-strep Lipid bilayer studies 
Constructed by Sebastian 
Schaupp 
 
 Protein refolding 
Lyophilized proteins were dissolved in 200 mM KCl, 50 mM Tris-Cl pH=8, 8 M Urea to a final 
concentration of ≈ 4 mg/ml. After incubation for 2 h at RT, they were diluted fortyfold into cold 
refolding buffer (200 mM KCl, 50 mM Tris pH=8, 0.5 % (w/v) DDM) and incubated for about 
48 h at 4 °C. Protein aggregates were removed by centrifugation at 16000 ×g at 4 °C for 10 
min. An aliquot was directly used for bilayer experiments, while the others were flash frozen 
and stored at -80 °C.   
 
 Vertical lipid bilayer experiments 
Electrical recordings were carried out at the Plant Membrane Biophysics group headed by Prof. 
Thiel with a workbench setup described in [338]. The chamber setup is schematically depicted 
in Figure 22. Briefly, two custom made polytetrafluorethylene (PTFE) chambers, each holding 
2.5 ml, were separated by a 25-µm-thick PTFE membrane having a central aperture of about 
100 µm. ≈ 2 µl of a 1% hexadecane in n-hexane solution was applied to the rim of the hole from 
both sides. 800 µl of buffer solution was filled into each chamber, followed by 35 µl of 15 mg/ml 
1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC, Avanti Polar Lipids) in n-pentane. After 
about 5 min the chambers were filled up to 2.5 ml with buffer solution. The bilayer was formed 
via the pseudo painting/air bubble technique [339]. After a stable bilayer was formed, protein 
was added to the trans chamber (grounded in all experiments) starting at a chamber 
concentration of 0.1 µg/ml which was increased over time if no protein inserted. In all bilayer 
experiments, Ag/AgCl electrodes were used. The current between both chambers in response 
to applied voltages was recorded with an L/M-EPC7 (List-Medical) patch clamp amplifier 
connected to a preamplifier with a gain of 5 mV/pA and low-pass filtered at 1 kHz. After 
digitalization on a 16-bit LIH 1600 A/D converter (HEKA) the signal was recorded on a personal 
computer employing the PATCHMASTER software (HEKA) and a LIH 8+8 data acquisition 
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device [340]. Recorded current traces were analysed with Nest-o-Patch [341] and 
PATCHMASTER software (HEKA) and visualized with Prism 7 (GraphPad).  
   
 
Figure 22 Schematic drawing of the lipid bilayer measurement chamber setup (not to scale). Two chambers, trans and 
cis, are separated by a PTFE membrane (25 µm thickness) with a ≈ 100 µm aperture. A DPhPC lipid bilayer is drawn 
over the aperture by the pseudo painting/air bubble technique [339]. Protein was always added to the grounded trans 
chamber.   
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3. Results 
 Visualization of wtFhuA   
A first step towards thorough understand of a protein is to visualize it in its natural context. 
wtFhuA was overexpressed in BL21(DE3) cells (NEB) and incubated with the purified fusion 
protein Colicin M(D226A)-sfGFP (superfolder GFP, [342]) while observed under the confocal 
laser scanning microscope (CLSM). The Colicin M D226A mutant employed here still binds to 
the cork of wtFhuA but is catalytically inactive [343,344]. In a control experiment with cells 
overexpressing corkless FhuA, no binding of Colicin M(D226A)-sfGFP was observed, whereas 
the latter accumulated at membranes with wtFhuA as seen by local fluorescence increase 
(Figure 23).  This small experiment enabled an indirect visualisation of the FhuA scaffold and 
proved the functionality of its 33-aa signal sequence.   
 
 
 
Figure 23 Imaging of wtFhuA at the outer membrane of BL21(DE3) E. coli by binding of Colicin M(D226A)-sfGFP. 
Shown are the merged images of bright light and (blue light fluorescence) channel. I acknowledge Wadim Weber for 
CLSM handling and image recording. 
 
 Setting up a purification pipeline for FhuA variants 
 FhuA purification in the literature 
Since its crystal structure was solved in 1998, many purification protocols for FhuA and its 
variants have been described. Briefly, these protocols can be divided into two approaches: The 
outer membrane extraction method and the inclusion body purification.  
Membrane-extraction using detergents is the original method of choice and is still used in some 
groups to date [304,315,345]. For this procedure, it is necessary to use E. coli strains that lack 
major outer membrane proteins like LamB, OmpA and OmpF [337], as these are otherwise co-
purified. The strains mainly used are AW740 [346,347] and BL21(DE3)omp8 or omp9  
[255,337]. Incorporation into the outer membrane is reduced in FhuA variants that lack the 
cork domain (e.g. FhuA∆5-160) [319,348]. 
When overexpressed in E. coli, a large portion of translated FhuA forms inclusion bodies, 
especially if the signal sequence is omitted [317]. Thus, FhuA purification via refolding from 
inclusion bodies was proposed in 2011 by both the Schwaneberg [349] and the Movileanu 
2 µm 
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group [255] as an alternative to membrane extraction. Both groups pointed out that the 
inclusion body refolding method improves protein yield considerably while being technically 
and experimentally less challenging than the membrane extraction method [255,349]. 
Importantly, the use of BL21(DE3) instead of BL21(DE3)omp8 leads to higher yields [349]. 
Nevertheless, the Schwaneberg group still employs the outer membrane extraction [350–352] 
as inclusion body purification is incompatible with FhuA variants that contain single free 
cysteines, a feature important for applications in organic chemistry catalysis projects [353].  
Straightforward inclusion body purification and refolding protocols have been established by 
the Movileanu group [228,255]. They introduced a rapid-dilution method for FhuA refolding 
using the mild detergent n-Dodecyl-β-D-maltosid (DDM) [323] derived from an OmpA 
refolding study [354]. Other refolding detergents have been investigated, but along with 1-
lauroyl-2-hydroxy-sn-glycero-3-phosphocholine (LysoFos), DDM is favoured as it does not 
interact with FhuA [325].  
 
 FhuA purification pipeline in the Stein lab 
During my doctoral studies, various inclusion body purification methods for FhuA variants were 
tested. Considering the aim (creation of a nanopore-based biosensor scaffold), outer membrane 
extraction was not pursued due to the above-mentioned reasons:  
- Corkless variants show poor incorporation into outer membranes 
- The 33-aa signal sequence (+sig) would constitute a mandatory N-terminal feature 
- Outer membrane extraction is technically and experimentally more challenging and 
time-consuming while yielding less protein 
The inclusion body purification protocol described by Wolfe et al. [228] proved to be reliable 
for most corkless FhuA variants. Optimization efforts that focused on small detergent screens, 
pursued by Sebastian Schaupp in his Master thesis, did not yield considerable improvements.  
 
 Expression and Purification Results 
FhuA and ∆c∆5L variants were successfully overexpressed in T7 polymerase-based vectors 
pET32 and pET24 (Sup Fig 4). Washed inclusion bodies were resolubilized in 8 M Urea and 
purified via 6xHis-Tag (Figure 24). After dialysis against water, samples were lyophilized and 
stored as solid powder at 4 °C in reagent tubes additionally sealed with Parafilm M. Except for 
SpyTagged variants (Master Thesis Sebastian Schaupp), yields were in the range of 3-8 mg per 
l culture.             
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Figure 24 Example chromatogram of ∆c∆5L inclusion body His-Tag ÄKTApure purification. L, W and E denote Load, 
Wash and Elution parts, respectively. A: +sig∆c∆5L-SmBiT866xHis run via 5 ml HisTrap column. B: +sig∆c∆5L-10Link-
SnoopTag6xHis run via 1 ml HisTrap column.    
 
 Protein refolding with DDM 
All purified ∆c∆5L variants were refolded by rapid dilution into buffer containing DDM [323]. 
Circular dichroism (CD)-spectroscopy under these detergent solvation conditions confirmed 
successful refolding of tagged ∆c∆5L variants (Figure 25). The spectrum shows a clear minimum 
at ≈ 218 nm, confirming the beta-barrel structure of the protein (in this case: 6xHisSnoopTag-
+sig∆c∆5L) [355]. The buffer affects the spectrum at wavelengths below 210 nm, which is a 
known phenomenon caused by high chloride concentrations (200 mM KCl) [356]. 
 
 
 
Figure 25 CD spectrum of 6xHisSnoopTag-+sig∆c∆5L. ≈ 150 nM of protein was measured in refolding buffer (200 mM KCl, 
50 mM Tris pH=8, 0.5 % (w/v) DDM). I acknowledge Philipp Czechowski for performing the measurement at research 
group Reggelin.  
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 Bilayer investigations of ∆c∆5L   
 Insertion efficiency 
It must be emphasized that the process of membrane protein bilayer insertion in vivo is 
fundamentally different from the insertion of purified transmembrane proteins into artificial 
bilayers (see section 1.2.5.1). While insertion of DDM-refolded ∆c∆5L variants into the bilayer 
occurred spontaneously in some cases, insertion was often facilitated by short (10-20 s) high-
voltage pulses (e.g. -160 mV / 160 mV). This approach of “pushing” membrane proteins or 
peptides into lipid bilayers has been described in the literature, not only for FhuA variants 
[312,315] but also for cWza, where the authors applied +100 mV to promote peptide insertion 
[243]. 
Nevertheless, no universally reproducible success route could be derived. This contrasts 
statements from the Movileanu group [323]. In general, the chance of insertion increased with 
higher protein concentration in the chamber, although this led to higher instability of the DPhPC 
bilayer, likely due to higher DDM concentration. As soon as a protein inserted, the high-voltage 
pulse was interrupted, and measurements were started. ∆c∆5L variants inserted as monomers 
and in an oriented manner (with the lipopolysaccharide-facing side first), in agreement with 
literature [226,323,324]. Once inserted, ∆c∆5L variants were stable at applied voltages 
between -80 mV / +80 mV and increasingly noisy at higher voltages, especially at higher 
electrolyte concentrations. Altogether, ∆c∆5L bilayer insertion at vertical PTFE chamber setups 
[338] is a laborious procedure that is only briefly discussed in the literature, if at all [228,255].  
 
 Control: ∆c∆5L6xHis 
As a control, the minimalized ∆c∆5L6xHis protein was tested. ∆c∆5L6xHis lacks the 33-aa signal 
sequence and has a GSGLE(H)6-tag at its C-terminus. The current trace of ∆c∆5L6xHis shows an 
open state corresponding to a conductivity of ≈ 2.3 nS in 500 mM KCl, 25 mM Tris-Cl pH=8, in 
agreement with literature (Figure 26) [228,357]. The observation of long blocking events also 
underlines that even a small tag like the GSGLE(H)6-tag is able to block the pore for time periods 
in the range of seconds. The distinct open state current was also observed for the other ∆c∆5L 
variants, hence it was possible to discriminate inserted protein from detergent pores and 
artefacts.  
 
Figure 26 Example trace of ∆c∆5L6xHis at A -20 mV and B -40 mV in 500 mM KCl, 25 mM Tris-Cl pH=8.    
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 Blocking behaviour of the signal sequence: +sig∆c∆5L6xHis 
In general, the addition of the 33-aa signal sequence to the scaffold improved the insertion 
probability of ∆c∆5L scaffolds. Yet, in the case of the minimal ∆c∆5L6xHis, +sig rendered the 
nanopore more blocked at voltages beyond ± 20 mV. While the trace was comparable to 
∆c∆5L6xHis for -20 mV and while the inserted protein showed the expected conductivity (≈ 4.5 nS 
in 1 M KCl, 10 mM KH2PO4 pH=7.4), current blockades were more frequent e.g. at -40 mV 
(Figure 27). As +sig∆c∆5L6xHis was only measured once, these results are shown to give a 
qualitative overview of the blocking behaviour of +sig.  
Nanopore blocking by the signal sequence (+sig) at negative applied voltages was also 
frequently observed during recordings of other ∆c∆5L variants. The most straightforward 
explanation for this phenomenon is the positive net charge of +sig (+5 e & N-terminal amino-
group) at the given pH (7.4 or 8). In the natural context, such positive charges – especially near 
the N-terminus – are conserved motifs of outer-membrane protein signal sequences and recruit 
unfolded proteins to the lipid membrane for translocation [290] (see section 1.2.5.1). In the 
context of artificial bilayer measurements, this explains the improved insertion efficiency. 
Moreover, the blocking properties of the +sig feature elucidate the actual orientation of ∆c∆5L 
inside the bilayer, as depicted in (Figure 28). The investigation on +sig contrasts observations 
from a publication by the Movileanu group where the authors claimed that +sig addition to the 
nanopore scaffold has little effect on its conductive behaviour [228]. Their statement must be 
relativized, as it only holds true for positive applied voltages.     
  
Figure 27 Representative current traces of +sig∆c∆5L6xHis at -20 mV (A) and -40 mV (B), respectively. The inset in B 
shows a short closing and opening event and a short partially blocked state. Measurements were performed in 1 M KCl, 
10 mM KH2PO4 pH=7.4.    
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Figure 28 ∆c∆5L orientation is elucidated by +sig transient blocking. Termini are oriented towards the grounded 
chamber. At an applied positive voltage (left), positively charged +sig is mainly moving outside the ∆c∆5L lumen, whereas 
+sig is occluding the pore at negative applied voltages (right). The drawing is schematic and not to scale.        
 
 +sig∆c∆5L-SmBiT6xHis 
With the ∆c∆5L scaffold showing an expected behaviour, the investigation focused on the 
attachment of tags that could serve as anchor site for a second (receptor) protein. In principle, 
such second protein can be attached covalently or non-covalently. Both methods have 
advantages and disadvantages; for instance, while covalent attachment is more stable, it may 
impact the structural stability of the membrane protein inside a bilayer to a greater extent.  
SmBiT86 was chosen as a tag that enables non-covalent attachment of a second protein to the 
nanopore. SmBiT86 is a 11-aa small subunit of the engineered split luciferase NanoBiT and 
binds with high affinity (KD = 0.7 nM) to its larger partner LgBiT (18 kDa) [358]. The 
SmBiT86/LgBiT interaction was chosen due to the small size of both interaction partners.  
+sig∆c∆5L-SmBiT866xHis, carrying a C-terminal SmBiT86-tag, inserted into DPhPC bilayers in 
150 mM KCl, 10 mM KH2PO4 pH=7.4 with the aid of an applied voltage. The protein showed 
a voltage dependent open probability (Figure 29, Figure 30). At a positive voltage up to 
+80 mV, the nanopore occupies an open state with a conductivity of 0.49 ± 0.05 nS (N=3), 
while the pore was often transiently blocked by the tags at negative voltages, as observed before 
for +sig∆c∆5L.  
In multiple cases, either the SmBiT866xHis-tag, the +sig or a combination of both tags blocked 
the ∆c∆5L lumen nearly irreversibly, decreasing the open probability for both positive and 
negative applied voltages drastically (Figure 31). In contrast to other ∆c∆5L variants, this 
blocking persisted for minutes even at positive voltages. Another explanation for this 
phenomenon – apart from tag-blocking – might be a collapse of the ∆c∆5L transmembrane beta-
barrel due to applied voltages beyond a certain threshold. Such instability has been observed 
for other engineered FhuA variants (∆c/∆7L-30N in [228]). Altogether, these blocking events 
complicated the identification of LgBiT interactions, as discussed in the following paragraph.   
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To bilayer inserted +sig∆c∆5L-SmBiT866xHis, purified LgBiT (final concentration: 0.5 µM) was 
added to probe if it shows an interaction with the SmBiT86 tag. Multiple (N=3) measurements 
where the current trace appeared to respond to the addition of LgBiT yielded inconsistent and 
unreproducible results, hence the hypothesis that LgBiT interaction should result in distinct 
changes in nanopore behaviour remained inconclusive. In one experiment, an increased open 
probability (0.75 in contrast to 0.21) at +40 mV over the course of two (± LgBiT) 15 min traces 
hinted towards a binding of LgBiT, with the rationale that the SmBiT86-tag is “captured” 
outside the pore lumen and thus prevented from blocking the pore (Sup Fig 5). Yet, these 
findings could not be reproduced with a second inserted +sig∆c∆5L-SmBiT866xHis. Moreover, the 
inherent property of the tags to block the nanopore complicate a clear differentiation between 
LgBiT-caused and intrinsic events. 
In conclusion, the behaviour of bilayer-inserted +sig∆c∆5L-SmBiT866xHis was recorded, showing 
a high open probability at positive applied voltages similar to the other ∆c∆5L variants. The 
mechanism of intrinsic blocking could not be elucidated and is likely caused by persistent tag 
blocking or membrane protein distortion at higher applied voltages. Recruitment of LgBiT by 
the SmBiT86 module of the membrane protein could not be distinguished from background 
events.    
 
  
 
Figure 29 Representative current traces of +sig∆c∆5L-SmBiT866xHis at positive (left) and negative (right) voltages in 
150 mM KCl, 10 mM KH2PO4 pH=7.4. Numbers correspond to applied voltages in mV. O: Fully open state; C: Fully 
closed state. Notice that the presence of only one open and closed state for ∆c∆5L variants is an idealized assumption; for 
instance, sub-states appear at -60 mV and -80 mV.  
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Figure 30 A: -80 mV/+80 mV voltage ramp of +sig∆c∆5L-SmBiT866xHis in 150 mM KCl, 10 mM KH2PO4 pH=7.4. B: 
Open probability of the inserted nanopore calculated via NestoPatch [341]. For calculation, all states not fully closed 
were treated as open.   
 
 
Figure 31 Constitutively and partially blocked +sig∆c∆5L-SmBiT866xHis pore in 150 mM KCl, 10 mM KH2PO4 pH=7.4 at 
applied voltages of +40 mV (left) and +80 mV (right). Blue dashed line represents the expected open state current at 
the applied voltage.   
 
  
 
  
  
66 
 
 Towards covalent attachment: SnoopTag-∆c∆5L variants 
The +sig∆c∆5L-SmBiT866xHis investigation in the artificial lipid bilayer context outlined that the 
discrimination of protein interactions at the single molecule level is challenging, in particular if 
a specific binding event relies on the presence of flexible tags. However, such discrimination 
should become easier if the interaction results in covalent attachment, as this should change 
the nanopore behaviour irreversibly. Thus, 6xHisSnoopTag-+sig∆c∆5L was investigated, a variant 
with +sig separating an N-terminal SnoopTag and the ∆c∆5L scaffold. SnoopTag can form an 
isopeptide bond with SnoopCatcher and thus should enable covalent attachment (see section 
3.2.2, Chapter 1)    
6xHisSnoopTag-+sig∆c∆5L showed a conductivity of 4.4 ± 1.3 nS (N=10) in 1 M KCl, 50 mM Tris-
Cl pH=8 and 0.85 ± 0.14 nS (N=3) in 150 mM KCl, 10 mM KH2PO4 pH=7.4, with the same 
open probability bias towards positive voltages as +sig∆c∆5L and +sig∆c∆5L-SmBiT866xHis (Figure 
32, Figure 33). As discussed, the transient blockages at negative voltages are caused by 
positively charged flexible tags, in this case the long N-terminal tag with a net charge of +6. 
Importantly, these blockages were only transient, as the fully open state occurred occasionally 
(Figure 34, Sup Fig 6). Interestingly, the 6xHisSnoopTag-+sig∆c∆5L nanopore reproducibly 
opened again if positive voltages were applied deliberately (Figure 35). This phenomenon was 
also observed for +sig∆c∆5L-SmBiT866xHis, albeit less pronounced.  
 
 
Figure 32 Representative current traces of 6xHisSnoopTag-+sig∆c∆5L at positive (left) and negative (right) voltages in 
150 mM KCl, 10 mM KH2PO4 pH=7.4. Numbers correspond to applied voltages in mV. O: Fully open state; C: Fully 
closed state. Notice that the presence of only one open and closed state for ∆c∆5L variants is an idealized assumption; for 
instance, sub-states appear at +80 mV and -70 mV. Representative current traces from measurements in 1 M KCl, 50 mM 
Tris-Cl pH=8 are attached to the supplement (Sup Fig 7). 
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Figure 33 Representative open probabilities of bilayer inserted 6xHisSnoopTag-+sig∆c∆5L nanopores in different buffers, 
calculated via NestoPatch [341] over all recorded current traces of distinct single nanopores. A: 150 mM KCl, 10 mM 
KH2PO4 pH=7.4; B: 1 M KCl 50 mM Tris-Cl pH=8. Red diamonds represent the open probability if partially blocked 
states that frequently occur at the respective applied voltages are treated as open.  
  
Figure 34 A: Representative -80 mV/+80 mV voltage ramps of 6xHisSnoopTag-+sig∆c∆5L in 150 mM KCl, 10 mM KH2PO4 
pH=7.4. On the left, the nanopore is blocked and partially blocked by its tag with exceptions at positive applied voltages; 
on the right, the nanopore is only partially blocked at negative applied voltages.    
 
Figure 35 Representative current traces of 6xHisSnoopTag-+sig∆c∆5L demonstrating the response of the N-terminal tag to 
voltage reversal. After applying a negative voltage, the current amplitude drops as the tag becomes arrested inside the 
pore lumen, whereas shortly after applying a positive voltage, the blocking is abolished. This phenomenon is comparable 
to the one described in Figure 28. Shown traces were measured in 150 mM KCl, 10 mM KH2PO4 pH=7.4.    
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The behaviour of the long N-terminal tag was further elucidated by two homology models of 
6xHisSnoopTag-+sig∆c∆5L based on a wtFhuA crystal structure, both created by Patrick Kunzmann 
from the Computational Biology and Simulation group (details on modelling in Sup Text 2). If 
the tag was aligned with the cork of wtFhuA, it folded into a compact, cork-like structure (Figure 
36 B). However, if the tag was not aligned with the cork, it stretched away from the 
transmembrane barrel (Figure 36 A). This finding underlines the high flexibility of the tag and 
its ability to occupy different conformational states. Yet, further simulation attempts did not 
yield sufficient data to confirm the proposed blocking role of the tag in silico.             
 
Figure 36 Homology models of 6xHisSnoopTag-+sigΔcΔ5L. N-terminal tag is colored in blue, C-terminus indicated in red. 
Model A: The N-terminal tag is freely moving outside the pore lumen; Model B: The N-terminal tag is arrested inside the 
nanopore lumen. Images were generated via UCSF Chimera [120]. I acknowledge Patrick Kunzmann for the creation of 
the models. Details are given in Sup Text 2.  
 
The ability to control the tag behaviour of ∆c∆5L variants by voltage changes encouraged 
further investigations. Exchanging the +sig part of the N-terminal tag by a shorter, uncharged 
10-aa linker (SGSGASGGSG) rendered the nanopore less blocked, especially at negative 
voltages (Figure 37). The same correlation of tag length and open probability was observed for 
two C-terminally tagged variants, +sig∆c∆5L-2Link-SnoopTag6xHis and +sig∆c∆5L-10Link-
SnoopTag6xHis (Sup Fig 8, Sup Fig 9, Sup Fig 10). In summary, the propensity of ∆c∆5L scaffolds 
to be intrinsically blocked is directly correlated to the tag length and charge. Yet, a charged tag 
gives the researcher control over the tag behaviour, at least to a certain degree.   
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Figure 37 Representative open probabilities of bilayer inserted 6xHisSnoopTag-10Link-∆c∆5L nanopore in 1 M KCl, 50 mM 
Tris-Cl pH=8 calculated via NestoPatch [341]. Red diamond represents the open probability if partially blocked states 
are treated as open. 
 
Thus, it was probed if the various SnoopTag-∆c∆5L variants can irreversibly catch a 
SnoopCatcher-fusion protein while embedded inside the lipid bilayer. Despite multiple 
attempts, neither nanopore variant that contained small linkers between SnoopTag and ∆c∆5L 
– namely +sig∆c∆5L-2Link-SnoopTag6xHis, +sig∆c∆5L-10Link-SnoopTag6xHis and 6xHisSnoopTag-
10Link-∆c∆5L – showed a distinct, irreversible change in either conductivity or blocking 
frequency upon addition of SnoopCatcher-NBGFP to the measurement chamber. There are 
several possible reasons for this lack of recognition. For instance, the SnoopCatcher protein or 
the SnoopTag might interact unspecifically with DPhPC lipids of bilayer. Yet, considering the 
role of linker length in fusion proteins (section 1.1.2 in Chapter 2), the respective SnoopTags 
of all these variants may not be sterically accessible to the large SnoopCatcher moiety. 
This hypothesis is supported by the reproducible response of bilayer-inserted 6xHisSnoopTag-
+sig∆c∆5L to SnoopCatcher. While this variant is unfavourable in terms of intrinsic blocking, the 
very long spacer between ∆c∆5L and the N-terminal SnoopTag (36 aa) apparently provided the 
necessary conditions for a successful isopeptide bond formation between the interaction 
partners. Precisely, the reaction lead to irreversible current blockades that were distinct to the 
ones created by SnoopTag and +sig alone (Figure 39, Sup Fig 11). Additionally, no irreversible 
conductivity changes or blocking states were observed when SpyCatcher-NBGFP was added to 
6xHisSnoopTag-+sig∆c∆5L. The SpyCatcher fusion protein was employed as an additional negative 
control because the SpyCatcher and SnoopCatcher system do not cross-react [43]. Altogether, 
these observations underline the importance of the linker length between the transmembrane 
(actuator) part and the soluble (receptor) part. This further emphasizes the role of linkers in 
fusion proteins, as discussed in detail in Chapter 2.   
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Figure 38 Representative current traces of 6xHisSnoopTag-10Link-∆c∆5L at positive (left) and negative (right) voltages 
in 1 M KCl 50 mM Tris-Cl pH=8. Numbers correspond to applied voltages in mV. O: Fully open state; C: Fully closed 
state. Notice that the presence of only one open and closed state for ∆c∆5L variants is an idealized assumption; for 
instance, partially blocked sub-states appear at -60 mV.  
 
Figure 39 A: Live event of SnoopCatcher-NB reaction with 6xHisSnoopTag-+sig∆c∆5L, recorded in 1 M KCl 50 mM Tris-Cl 
pH=8 at an applied voltage of 50 mV. B: Representative current traces of 6xHisSnoopTag-+sig∆c∆5L before (black) and 
after (grey) reaction, measured in 150 mM KCl 10 mM KPO4 pH=7.4. For better comparability, time scales of ± Catcher 
traces were normalized to each other.    
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 Conclusion and Perspectives 
In the light of all bilayer experiments that were conducted during my PhD studies, the ∆c∆5L 
nanopore scaffold is per se reliable and offers various target points of specific fine-tuning. ∆c∆5L 
variants respond specifically to (small) changes in terminally attached peptide tags, in 
accordance with studies from the Movileanu lab [226,324,327]. This ability allows detailed 
investigation of charge and length impact on protein nanopore conductivity and blocking at the 
single molecule level. In this regard, the +sig sequence is both blessing and curse, as it facilitates 
protein insertion and specifically responds to applied voltages but is prone to become arrested 
inside the nanopore lumen (Figure 36).  
Multiple aspects complicate quantitative protein interaction studies using ∆c∆5L variants. Small 
and robust receptor modules can be fused to the nanopore on the genetic level [324,327], yet, 
post-translational capturing of a second receptor has limitation and requires linker 
optimization, as shown here for SnoopCatcher-NBGFP. With more modules attached to the ∆c∆5L 
scaffold, discrimination between multiple unspecific blocking events and actual ligand 
interaction becomes elusive. In one recent study, the attachment of an additional adaptor 
polypeptide was necessary to identify protein interactions outside the nanopore [324]. The only 
purpose of this adaptor was to transform the interaction into a detectable current change, 
underlining the complexity of single molecule nanopore biosensing. Considering this, the best 
option of equipping ∆c∆5L with a specific sensing function apparently is a genetic fusion to 
either N- or C-terminus. Yet, this is limited to small domains that are robust to inclusion body 
purification and refolding.     
The ∆c∆5L scaffold is still far from optimized to allow integration into a bilayer-based biosensor 
platform or device. ∆c∆5L is a stable monomer with exceptionally high conductivity, yet, its 
refolding and insertion process, together with its broad conductivity spectrum [357], 
complicate reproducible measurements especially in labile lipid bilayer environments. For 
instance, residual DDM molecules still attached to the beta-barrel are likely responsible for 
observed conductance outliers [325]. Generally, stabilized lipid bilayers [270,271] or lipid 
alternatives like diblock copolymers [64] also tested by the Schwaneberg group [359–361], 
could achieve better reliability of membrane protein-based biosensor devices. 
Without gathering data of other membrane proteins, it is difficult to predict if other scaffolds 
are better suited as modular stochastic biosensors. Judging from their structure and recent 
publications, either ClyA or MspA might be promising alternatives, as both are stable monomers 
and show calm current traces (section 1.2.3.1 and 1.2.4.1). However, considering the depth of 
current industrial nanopore scaffold screening [263] and the large patent landscape [362], 
finding the “perfect” nanopore for a certain application is difficult to say the least.                  
To conclude, FhuA based membrane protein nanopores are stable, tunable and enable real-time 
detection of single-molecule interaction events. Thus, most of the important biosensor 
requirements mentioned in the following chapter are met. FhuA based biosensing, as pioneered 
by the Movileanu group, will undoubtedly become a reliable platform if the current drawbacks 
are overcome. Currently, these include protein handling, long-term stability of bilayer systems 
and unspecific responses of attached tags. The high sensitivity of the system towards charges 
could in principle be used to probe charged peptide ligands, for instance the Alzheimer related 
amyloid-β (1-40) and (1-42) peptides with a net charge of -3 e [363]. In this regard, future 
studies should focus on the robustness of the platform towards biofluids [327]. The inspiring 
success of nanopore-based DNA sequencing [57] serves as an encouraging example of nanopore 
biosensing and highlights its potential for real world applications.      
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4. Supplement Chapter 3 
 
 
Sup Fig 4 SDS-PAGE of selected FhuA variants. Shown are samples of lysed BL21(DE3) cells after overexpression of the 
respective FhuA variants. M: BlueStar prestained protein Marker (Nippon Genetics).     
 
  
Sup Fig 5 Possible LgBiT interaction with +sig∆c∆5L-SmBiT866xHis, observed at +40 mV in 150 mM KCl, 10 mM KH2PO4 
pH=7.4.   
 
 
 
 
Sup Fig 6 Example trace showing a fully open event of 6xHisSnoopTag-+sig∆c∆5L during partially blocked substates at an 
applied voltage of -50 mV in 1 M KCl, 50 mM Tris-Cl pH=8. The conductivity of this specific pore is 4.6 nS.  
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Sup Fig 7 Representative current traces of 6xHisSnoopTag-+sig∆c∆5L at positive (left) and negative (right) voltages in 1 M 
KCl, 50 mM Tris-Cl pH=8. Numbers correspond to applied voltages in mV. O: Fully open state; C: Fully closed state. 
Notice that the presence of only one open and closed state for ∆c∆5L variants is an idealized assumption; for instance, 
sub-states appear at +70 mV and -50 mV.  
 
 
Sup Fig 8 Representative current traces of +sig∆c∆5L-2Link-SnoopTag6xHis at positive (left) and negative (right) voltages 
in 1 M KCl 50 mM Tris-Cl pH=8. Numbers correspond to applied voltages in mV. O: Fully open state; C: Fully closed 
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state. Notice that the presence of only one open and closed state for ∆c∆5L variants is an idealized assumption; for 
instance, blocked sub-states appear at +50 mV and -60 mV. Shown measurements were performed by Sebastian Schaupp 
during his Master Studies.  
 
 
Sup Fig 9 Representative current traces of +sig∆c∆5L-10Link-SnoopTag6xHis at positive (left) and negative (right) voltages 
in 150 mM KCl, 10 mM KH2PO4 pH=7.4. Numbers correspond to applied voltages in mV. O: Fully open state; C: Fully 
closed state. Notice that the presence of only one open and closed state for ∆c∆5L variants is an idealized assumption; for 
instance, blocked sub-states appear at -50 mV. 
 
Sup Fig 10 Representative open probability of +sig∆c∆5L variants with C-terminal SnoopTags. A: +sig∆c∆5L-2Link-
SnoopTag6xHis in 1 M KCl, 50 mM Tris-Cl pH=8; B: +sig∆c∆5L-10Link-SnoopTag6xHis in 150 M KCl, 10 mM KH2PO4 
pH=7.4. The buffer difference is intended for comparison purposes, as in 1 M KCl, +sig∆c∆5L-10Link-SnoopTag6xHis was 
constitutively partially blocked.     
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Sup Fig 11 Change in conductivity of 6xHisSnoopTag-+sig∆c∆5L after SnoopCatcher/Tag reaction in different buffers. 
Shown are overlaid conductivity frequency histograms of 6xHisSnoopTag-+sig∆c∆5L before (black) and after (grey) the 
addition of SnoopCatcher-NB. A: Buffer was 1 M KCl, 50 mM Tris-Cl pH=8.  B: Buffer was 150 mM KCl, 10 mM KPO4, 
pH=7.4  
 
Sup text 2: In silico modelling of 6xHisSnoopTag-+sig∆c∆5L (Patrick Kunzmann, pers. comm.)  
Homology modelling (performed by Patrick Kunzmann) 
Both models were built with the Modeller software and its loopmodel functionality [364,365]. 
As template for both models, the PDB file 4CU4 [307] was chosen, representing a 2.3 Å 
resolution crystal structure of wtFhuA. Model A was created by aligning the long N-terminal tag 
with the cork domain, while model B was deliberately avoiding this alignment. The Snakemake 
software [366] enabled a reliable workflow.        
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Chapter 4  
Bio-Functionalized Solid-State Nanopores  
1. Introduction & Background 
As discussed in the previous chapters, biosensors are powerful tools for a plethora of 
applications. Yet, one of the key challenges is the embedding of molecular switches in some sort 
of device, so they can be applied beyond academics and research. An ideal device must fulfil 
multiple requirements: Easy production and handling, robust performance, and simple, yet 
quick read-out, to name the most important.  
Thus, the symbiosis of Life Sciences and Material Science offers great opportunities in health 
monitoring, point-of-care diagnosis and biosensing in general. Both disciplines rely on each 
other: Life Scientists identify and characterize biomarkers, while Material Scientists provide 
solutions to improve and simplify detection. At the core of this symbiosis lies the ability to link 
biochemical events to readily detectable electrical readouts. Electrical current is a superior 
output for multiple reasons: It happens on the millisecond scale, is highly sensitive and 
supporting electronics are generally smaller and more common than excitation sources or 
photodetectors, leading to better portability [367,368].  
In this regard, miniaturization is a key technology. Especially microfluidic platforms have 
pushed biosensing approaches forward. Such miniaturized systems or microsystems offer many 
advantages. For instance, they allow parallel operation, save samples and material and can be 
produced at large scale [369]. Among these biosensing microsystems, solid-state or 
“synthetic” nanopores (SSNs) have emerged as powerful tools. During fabrication, their 
characteristics like material, geometry and surface charge can be precisely tuned to the desired 
application. Modification of the raw pores with specific receptor molecules introduces a sensing 
capability. Generally, the readout is based on changes in ionic current or rectification behaviour 
upon analyte binding [370–372].  
In this chapter, fabrication and modification techniques of SSNs are discussed, with focus on 
modification with biochemical receptors and biosensing technologies. In cooperation with Ivana 
Duznovic from the Materials Analysis group at TU Darmstadt, a strategy for biofunctionalized 
SSNs was developed and tested. Specifically, I constructed and characterized an optimized 
immobilization peptide and multiple fusion proteins that allow oriented bioconjugation. As 
proof of concept, the biosensing platform was evaluated with nanobodies for the stress 
biomarker α-amylase and two fluorescent proteins. 
 
1.1 Fabrication and properties of raw solid-state nanopores  
The size and diameter of SSNs is highly variable. Depending on the application, preferred 
diameters lie in the range of 1-100 nm [55,373]. Based on IUPAC recommendation, the term 
nanopore is only suited for pores with diameters ≤ 100 nm [374]. Analytical SSNs have been 
implemented in a large variety of materials [55]. The most common include silicon materials, 
mainly silicon nitride [55,373,375] and glass [55,376], and polymer materials like 
poly(ethylene terephthalate) (PET) [370,377–379].  
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The choice of material dictates the adequate fabrication pipeline. For instance, nanopores in 
PET membranes are generated by firstly penetrating them with energetic heavy ions. This can 
be achieved at facilities like the UNILAC (Universal Linear Accelerator) in Darmstadt, Germany 
or the GANIL (Grand Accélérateur National d’Ions Lourds) in Caen, France [378,380]. The 
initial nanopores in the prepared polymer membranes serve as raw material for the generation 
of pores with desired geometries. The choice of adjustment method depends again on the 
material. For SiO2- based nanopores, precise tuning is possible by using defocused electron 
beams [55]. For common PET membranes, chemical etching with NaOH is an inexpensive 
procedure and allows fabrication of various geometries, depending on the etching technique 
[55,381,382].  
The geometry has a strong impact on the electrical behaviour of a nanopore. Due to the 
formation of an electrical double layer at the surface of the pores, conical SSNs show a diode-
like behaviour, strongly reducing the current flow in one direction when a voltage is applied 
(Figure 40) [382,383].  
 
 
 
 
 
Figure 40 Schematic depiction of electrical double layers inside SSNs and rectification behaviour. A: Cylindrical or conical 
pores PET pores with a layer of negative charges (red) develop an electrical layer of positive charges (blue) at the surface 
when exposed to electrolyte solution, rendering the pores anion-specific. B: The electrical double layer leads to a non-
linear I-V behaviour in case of conical pores. The shown current profile (grey dotted line) is obtained if the electrode near 
the large aperture is grounded.  
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This effect is quantified by the rectification factor RF via  
 #   |%&'|
|%('|
 , (2) 
where I(-V) and I(+V) are currents at equal voltage magnitudes but at opposite polarity 
[378,384]. Changes in RF are correlated to changes in the nanopore environment, hence RF is 
a useful factor for characterization of binding processes in SSNs [377,385,386].    
“Blank” fabricated and etched SSNs interact only unspecifically with the surrounding solution, 
for instance via charge attraction or repulsion, thus they do not have any intrinsic sensing 
abilities [55]. While this is useful for certain applications that rely on distinguishable current 
blockades, like DNA translocation [387] or glycan and polysaccharide profiling [375], SSNs can 
be modified with nearly any type of receptor moiety.  
Nonetheless, the surface groups of etched nanopores – e.g. the carboxylic acid groups of PET – 
are amenable for direct modification. This feature enabled development of simple ion and small 
molecule sensors [386,388,389]. However, by applying an additional layer of reactive groups, 
SSNs can be converted into a highly modular immobilization and sensing platform for complex 
analytes.  
 
1.2 Immobilization techniques 
For reasons of clarity, only techniques that allow receptor immobilization on non-porous 
surfaces or inside SSNs are covered in the following. Completely (meso)porous surfaces – 
including (protein) hydrogels [46,47,390], silica gels [391] and polymer meshes [392] – are 
omitted here. A respective review is found in [393].  
 
1.2.1 Activated esters 
Amino groups present in proteins or peptides have nucleophilic character. Thus, they will form 
an amide bond with activated esters. A straightforward approach to couple proteins or peptides 
to surfaces is therefore to activate the surface with an activated ester. A common choice for the 
generation of such activated ester is the consecutive treatment of the surface with 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS) or 
pentafluorophenol (PFP) [377,394]. As activation reagent, PFP is preferred as the reactivity of 
the formed pentafluorophenyl esters  is an order of magnitude higher than that of NHS esters 
[395,396]. An alternative is the use of N,N′-disuccinimidyl carbonate (NDC) and 4-
dimethylaminopyridine (DMAP) [397].  
 
1.2.2 Self-assembled monolayers (SAM) 
A well-studied way of rendering an inorganic (metallic) surface an organic one relies on 
spontaneous self-assembly of distinct molecules at the respective inorganic surface [398]. One 
of the best studied examples is the high affinity of alkanethiols to gold. When the alkanethiols 
bind to a gold surface, they self-assemble into an organized monolayer (SAM) [398]. By 
deliberately using mixtures of different alkanethiol head groups, various receptor moieties can 
be presented on the surface (Figure 41) [373,399]. These receptors can either serve as direct 
sensing moiety or as attachment point for proteins or peptides. Importantly, the alkanethiols 
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function as a useful spacer, thereby reducing unspecific protein binding and fouling (see 
remarks in section 1.4).  
 
 
 
 
 
Figure 41 Concept of self-assembled monolayers (SAM) in the form used by [373]. Triethylene glycol alkylthiols attach 
to a gold surface and self-assemble into structured monolayers. Attached head groups (R) provide specific binding sites. 
Modified after [373].   
 
1.2.3 Enzyme-mediated immobilization 
Immobilization via enzymatic reactions has the advantage of being site-specific. In many cases, 
this is crucial to ensure that the protein is correctly oriented and thus active [400]. Useful 
enzymes include Sortase A [35,401,402], self-labeling tags like the SNAP-tag [401] and the 
engineered SpyTag/SpyCatcher system [403,404]. However, these techniques demand distinct 
modifications of the target protein coding sequence. This complicates matters for difficult-to-
purify proteins like antibodies and may be one of the reasons that enzyme-mediated 
immobilization is less common compared to other techniques.  
 
1.2.4 Click-chemistry 
Another approach for site-specific immobilization relies on abiotic, bioorthogonal chemical 
groups. The Cu(I)-catalyzed and strain-promoted azide-alkyne cycloadditions (CuAAC and 
SPAAC, respectively) are the most prominent examples for biocompatible click-chemistry [401] 
(Figure 42). While SPAAC does not need copper as catalyst and therefore prevents possible 
denaturation reactions [405], the CuAAC method proceeds faster [401]. Both reactions work 
in aqueous solution at neutral pH and room temperature, although higher temperature can 
improve the CuAAC reaction [406].  
If proteins or peptides are to be immobilized via click-chemistry, they must be modified to 
present one of the reactive groups. This is achieved for example by incorporation of unnatural 
aa that carry the bioorthogonal group [401].   
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Figure 42 Common biocompatible click chemistry reactions. A: Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC); B: 
Strain promoted azide-alkyne cycloaddition (SPAAC), here with a bicyclononye derivate. R1 and R2 are variable 
attachments and/or surfaces. Derived from [401].      
 
1.2.5 Unusual techniques 
A rather harsh approach to combine a biological channel with SSNs was described by Balme et 
al. [407]. The authors added a solution of gramicidin A, a channel selective towards 
monovalent cations, to track-etched PVP membranes and impregnated the protein for 6 h at 
72 °C. Thereby, they generated K+ permeable, but H+ impermeable membranes that could 
potentially be used for water purification. Other studies used similar approaches to combine 
biological channels with solid-state membranes [408]. Such studies have generally proof-of-
concept character. Their reproduction is difficult, as the structure of the protein does not 
resemble the one of its actual natural context. Importantly, simple adhesion or impregnation 
will not work for every protein – especially considering surface fouling and orientation problems 
(see remarks in section 1.4).  
 
1.3 Biomolecule functionalization of SSNs  
Many biomolecules have evolved to bind specific ligands or analytes with high affinity. A famous 
example is the recognition of biotin by avidin, an interaction with a KD of 10-15 M [22]. 
Immobilization of such specific receptors on or in SSNs – using the outlined techniques – has 
led to sensor designs for ions, aa and small molecules. Selected key publications are described 
in the following; for an extensive review see [409].  
The described high affinity of avidin to biotin was exploited to test a PET single-nanopore 
system. When biotin was attached to the pore walls via EDC/PFP coupling, binding of 
streptavidin resulted in decreased currents that was not observed with control molecules [410]. 
Based on this approach, the Ensinger group at TU Darmstadt developed a variety of biochemical 
sensors [371,377,385,386,388,389,411].   
One study combined the SAM concept with nanopores [373]. Immobilization of NTA-Ni2+ 
chelates on gold-covered silicon nitride allowed discrimination of his-tagged IgG-antibody 
subclasses while simultaneously revealing cooperative binding effects. To enable stochastic 
sensing, it was crucial to prevent receptor overloading of the pore. 
In many cases – especially for complex analytes – immobilized antibodies are the receptors of 
choice. Respective early examples include the detection of ricin [412] and poly γ-D-glutamic 
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acid [394], followed by the detection of the cancer biomarker glycoprotein CA15-3 [413] and 
cSNAP-25, a cleavage product from botulinum type A [379]. These SSN-sensing studies have 
paved the way for ultrasensitive biosensor devices that can detect analytes even in complex 
samples. One nanofluidic device presented by Liu et al. uses nanoslits instead of nanopores 
(Figure 43) [372]. The authors demonstrate specific detection of Troponin T at concentrations 
down to 300 fM in human serum samples. Furthermore, they claim that fabrication of the 
nanoslit devices is straightforward. A drawback of the sensor is that it is not reusable in its 
presented form.  
Other immobilized biological receptors include enzymes [414], bacterial substrate binding 
proteins [415] and DNA [416]. SSN designs based on immobilized DNA scaffolds were able to 
detect miRNA and DNA with sensitivity as low as 10 fM [417,418] and allowed the construction 
of a double-gated nanopore [416]. Regarding sequencing, sensors based on engineered 
biological nanochannels are leading, as briefly discussed in Chapter 3.  
 
 
 
 
 
Figure 43 Nanoslit-setup from Liu et al. [372]. Antibodies (Y) are immobilized on a triangular glass surface (grey). Presence 
of the corresponding analyte (red diamonds) – possessing a negative surface charge – results in concentration-dependent 
rectification factor (RF) changes. Figure adapted from [372]    
 
1.4 General considerations and challenges in SSN biosensing 
The combination of protein biosensors with SSNs is demanding due to the following aspects:   
- Fouling 
- Orientation 
- Nanoconfinement 
- Storability 
Most proteins are flexible, soluble molecules that become conformationally unstable when 
brought close to a surface, due to unspecific adhesion and absorption [398]. Such protein 
misfolding or denaturation poses a fundamental problem, not only in SSN sensing but in all 
research areas and applications that rely on protein immobilization. To prevent this fouling, 
installation of a spacer between the inorganic surface and the biological moiety is critical to 
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retain the functionality of the latter, especially if sensing requires conformational changes. 
Importantly, spacing does not only prevent fouling but also reduces steric clashes between 
immobilized proteins [393]. In this regard, spacing is similar important in multidomain fusion 
proteins, as discussed in Chapter 2.     
In SSN biosensing, the installation of a spacer is most often achieved during surface preparation. 
For instance, the SAM method allows adjustment of the alkanethiol length to provide a proper 
spacing, and mixtures with “inactive” alkanethiol linkers even ensure spacing between the 
proteins themselves [373,398,419]. In the case of other coupling methods like EDC/(NHS or 
PFP), polymers represent by far the most common spacer [393,415], but peptides have also 
been used [420].   
While spacing ensures that the immobilized protein is functional, it does not automatically 
account for correct orientation. A poorly oriented binding site may not be accessible to analytes 
or substrates, thus impeding the intended biosensing or enzymatic process [400,421]. In this 
regard, coupling via activated esters has the drawback of being unspecific, as all surface-
exposed primary amines of proteins, e.g. lysine ε-amino groups, qualify for the coupling reaction 
[415].  
In short, receptor coupling must proceed site-specific to ensure correct orientation. The SAM 
method allows this, as alkanethiols with specific head groups can be employed [373,398]. If 
applicable, the properties of the protein can be altered to allow enzymatic coupling. Recent 
examples include modification with a Sortase A tag, attachment of a bioorthogonal group for 
click-chemistry [401] or isopeptide bond formation systems [403]. Interestingly, these methods 
have been used for flat surface modification but not (yet) for SSN modification.   
Much effort has been dedicated to interrogating the circumstances in nanoconfinement. 
Phenomena include altered isoelectric points, enrichment or depletion of ions [422]. Forming 
of additional fluidic phases is possible and affects the behaviour of flux and therefore biosensing 
in general [422]. The results of induced changes in the nano-environment are difficult to predict 
and subject of mathematical modeling [423]. Of special concern is the occurrence of elevated 
electrical fields that can lead to protein unfolding in narrow nanopores [424]. In short, the 
conditions inside nanopores are fundamentally different to those in solution [425]. This does 
not imply that nanoconfinement is generally unfavorable, on the contrary, it can also be 
beneficial [426]. Nevertheless, the presence of nanoconfinement adds another layer of 
complexity to SSN biosensing.  
Considering that the success of a biosensor is evaluated by its specificity, sensitivity, stability, 
reproducibility and linearity [427], it is noteworthy that little work has been published with 
regard to storability and reusability of SSN biosensors. Exceptions are already commercially 
available systems that use biological nanopores, for example products from Oxford Nanopore 
Technologies [428]. While protein-catching surfaces can have a shelf life of multiple months 
[429], it is unclear to date if this could also be achieved for protein-modified SSNs.  
 
1.5 Perspectives 
Specific molecular interactions have become easily detectable via the simple readout of current 
changes. Advances in solid-state nanopore (SSN) fabrication, growing understanding of the 
processes in confined environments and tackling of electrical noise problems [430] further 
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strengthened the platform for combination with highly specific but “delicate” biological 
receptors.  
Importantly, research at the interface of Life Sciences and Material Science is highly 
interdisciplinary. In this context, the boarders between both become more and more blurred. 
For instance, nanopore scaffolds are not limited to polymer- or glass materials, but can be 
achieved with biological molecules as well, for instance with DNA [431] or peptides [432]. One 
of the remaining key challenges is the integration of SSN biosensors into microfluidic devices. 
Progress is growing [433,434], and if reliable large scale production becomes feasible, such 
Lab-on-a-chip technologies could potentially revolutionize point-of-care diagnostics.   
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2. Methods 
Standard methods are described in section 2.1, Chapter 2.  
 
 Protein Methods 
Important properties of the proteins used in this chapter are summarized in Table 18. 
Table 18 Properties of proteins used in SSN experiments. Listed are sizes in kDa (and amino acids), theoretical pI and 
netto charge in e. Unless stated otherwise, values of theoretical pIs and netto charges were calculated via ProtParam 
[435]. It must be noted that the netto charge may not resemble the actual surface charge of a given protein but gives an 
approximation.  
Protein / Peptide Size in kDa (aa) 
Theoretical 
pI 
 netto charge in e at 
pH=7  
Tether Peptide 7.5 (72) 10.2 +6 
- As MBP fusion 50 (459) 5.6 -6 
NBGFP-(GGS)2-SpyCatcher002 27.3 (256) 5.0 -9 
NBmCherry-(GGS)2-SpyCatcher002 27.9 (265) 5.1 -7 
NBAmylase-(GGS)2-Spycatcher002 27.6 (261) 4.7 -9 
sfGFP-6xHis 27.8 (248) 6.2 -3 * 
mCherry-strep 29.0 (260) 5.6 -7 
α-amylase (porcine pancreas), 
glycosylated 
51-54 (≈ 475) 6.4/7.5[436]  -3 ** 
    
*according to [437] 
** not including glycosylation 
  
 
 Expression and Purification 
The E. coli BL21(DE3)-RIL/pRK793 strain carrying the TEV protease (the autoinactivation-
resistent mutant S219V [438]) was kindly provided by the Kolmar research group (TU 
Darmstadt). Expression and purification of TEV mainly followed published protocols. A 50 ml 
preculture was used to inoculate 1 l LB medium with 100 µg/ml ampicillin and 25 µg/ml 
chloramphenicol in a 3 l shaking flask to a starting OD600 = 0.05. When OD600 reached 0.3, 
0.5 mM IPTG was added. Expression was performed for 3 h at 30 °C, and the culture was 
harvested via centrifugation and pellets stored at -20 °C. At the day of purification, cells were 
resuspended in buffer W (150 mM NaCl, 100 mM Tris-Cl pH=8) and crushed via four passes 
through an Emulsiflex C3 (Avestin). After centrifugation for 1 h at 14500 xg and 4 °C, the 
supernatant was sonicated for 30 s on ice via a sonicator (Qsonica) to destroy residual DNA. 
The sample was filtered through a 0.45 µm syringe filter. An ÄKTApure system and a 1 ml 
HisTrap HP column was used to purify TEV protease. Elution was performed in steps of 10 %, 
20 %, 50 % and 100 % elution buffer (buffer W with 500 mM imidazole). Protein containing 
fractions were pooled and dialyzed against 3 l of 50 mM Tris-Cl pH=8, 50 mM NaCl, 1 mM 
EDTA and 1 mM DTT using 10 kDa MWCO Slide-A-Lyzer (Thermo Fisher Scientific) for 2 h at 
4 °C. Protein purity was validated via SDS-PAGE. After centrifugation for 10 min at 16000 xg 
and 4 °C, 50 % glycerol was added to reach a final glycerol concentration of 20 %, and aliquots 
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with a protein concentration of about 1 mg/ml were flash frozen in liquid nitrogen and stored 
at -80 °C.  
Sortase A5M, mCherry, NBGFP-(GGS)2-SpyCatcher002 and NBmCherry-(GGS)2-SpyCatcher002 
were produced in E. coli BL21(DE3) transformed with the corresponding plasmid (pET24-
SortaseA5M-strep, pFLinkC-XE-T7-mCherry-strep-LPETGG, pFLinkC-XE-T7-NBGFP-(GGS)2-
SpyCatcher002-GASPAG-strep and pFLinkC-XE-T7-NBmCherry-(GGS)2-SpyCatcher002-GASPAG-
strep, respectively). In all cases, a preculture was used to inoculate 800 ml of LB medium 
containing ampicillin (90 µg/ml) in a 3 l shaking flask, starting at OD600 = 0.1. Protein 
expression was induced with 0.5 µM IPTG at OD600 = 0.6 and performed for 4 h at 25 °C, except 
for Sortase A5M (30 °C). Cultures were harvested via centrifugation and washed once with 
buffer W before stored at -20 °C until used. At the day of purification, the cells were resuspended 
in 40 ml of buffer W each (150 mM NaCl, 100 mM Tris-Cl pH=8) and crushed via four passes 
through an Emulsiflex C3 (Avestin). After centrifugation at 25000 xg for 1 h at 4 °C, the sample 
was filtered through a 0.45 µm syringe filter. An ÄKTApure system and a 1 ml StrepTrap HP 
column was used to purify the proteins (8 CV equilibration, 8 CV wash, 5 CV elution). The 
protein was eluted in buffer E (150 mM NaCl, 100 mM Tris-Cl, 2.5 mM desthiobiotin, pH=8) 
and the concentration estimated via nanodrop. After a final buffer exchange to 100 mM KCl 
and 10 mM Tris-Cl pH=8 via PD 10 columns, protein aliquots were flash frozen in N2(l) and 
stored at -80 °C until needed. 
SpyTag containing Tether Peptide was produced as MBP-fusion protein in E. coli BL21(DE3) 
transformed with the plasmid pET24-MBP-Tether-Peptide-LPETGG. A preculture was used to 
inoculate 2 l of LB medium containing kanamycin (50 µg/ml) in a 5 l shaking flask, starting at 
OD600 = 0.1. Protein expression was induced with 0.5 µM IPTG at OD600 = 0.5 and performed 
for 4.5 h at 30 °C. Cultures were harvested via centrifugation and stored at -20°C overnight. 
The next day, the cells were resuspended in 70 ml of buffer W (150 mM NaCl, 100 mM Tris-Cl 
pH=8) and crushed via four passes through an Emulsiflex C3 (Avestin). After centrifugation at 
25000 xg for 1 h at 4 °C, the supernatant was sonicated for 30s on ice via a sonicator (Qsonica) 
to destroy residual DNA. The sample was filtered through a 0.45 µm syringe filter. An ÄKTApure 
system and a 5 ml StrepTrap HP column was used to purify the protein (8 CV equilibration, 
8 CV wash, 5 CV elution). The protein was eluted in buffer E (150 mM NaCl, 100 mM Tris-Cl, 
2.5 mM desthiobiotin, pH=8) and the concentration estimated via nanodrop. Protein aliquots 
were flash frozen in N2(l) and stored at -80 °C until needed. 
sfGFP, GFP(-30) and Sortase A7M were produced in E. coli BL21(DE3) transformed with the 
corresponding plasmid (pACYCT2-sfGFP-6xHis, pET29-6xHis-(-30)GFP (Addgene #62936) 
and pET24-SortaseA7M-6xHis). Respective main cultures were induced with 0.5 mM IPTG and 
expression performed for 4 h at 37 °C. Cultures were harvested via centrifugation and stored at 
-20°C overnight. The next day, cells were resuspended in cold His-Tag equilibration buffer 
(500 mM NaCl, 20 mM NaPO4, 20 mM Imidazole pH=7.4) supplemented with a protease 
inhibitor tablet and crushed via four passes through an Emulsiflex C3 (Avestin). After 
centrifugation at 25000 xg for 1 h at 4 °C, the respective sample was filtered through a 0.45 µm 
syringe filter and applied on a 1 ml HisTrap HP column that was equilibrated with 10 CV His-
Tag equilibration buffer. Sample was loaded and the column was washed with 8 CV of His-Tag 
equilibration buffer at 5 % elution buffer (500 mM NaCl, 20 mM NaPO4, 300 mM Imidazole 
pH=7.4), before protein was eluted over a 10 CV gradient, starting at 5 % elution buffer and 
ending at 100 %. Protein containing fractions were pooled and buffers exchanged via PD 10 
columns to His-Tag storage buffer (150 mM NaCl, 20 mM NaPO4 pH=7.4), and with the 
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exception of sfGFP (which was stored at 4°C), purified proteins were flash frozen in N2(l) and 
stored at -80 °C until needed.  
 
 Azp-coupling and TEV-cleavage 
Purified proteins were thawed on ice. Azp-coupling reactions were performed in 100 µl 
reactions in 1.5 ml reaction tubes in 100 mM NH4HCO3 buffer. Azp was added from a 1 M stock 
(acetic acid) to a final concentration of 100 mM. Sortase A7M or Sortase A5M was added to a 
final concentration of 10 µM (as estimated via nanodrop) and MBP-Tether-Peptide of about 
60 µM. Azp-coupling reaction was performed for 3 h (Sortase A7M) or 1 h (Sortase A5M) at 
37 °C. Subsequently, the reactions were stopped by addition of 0.2 % formic acid (in case of 
Sortase A7M) or 20 mM EDTA (in case of Sortase A5M) and buffer was exchanged to 50 mM 
Tris-Cl, 2 mM DTT, pH=8 via a Vivaspin 20 filtration unit (Sartorius).    
Purified TEV protease was added to a final concentration of 30 µg/ml. TEV cleavage was 
performed at 18 °C over night under slight shaking. On the following day, successfully cleaved 
peptide was separated from the larger components (TEV, Sortase A7M or A5M, MBP) via 
centrifugation through a Vivaspin 500 (10 kDa MWCO) at 10000 xg in a tabletop centrifuge. 
Peptide purity in the filtrate was examined by a 4-12 % SDS-PAGE analysis.   
 
 In vitro verification of Azp-coupling 
To verify the Azp-tagging of MBP-Tether-Peptide, a copper click-reaction was performed to 
attach a 5-FAM-alkyne to the protein containing the azide-moiety. 15 µM 5-FAM-alkyne and 
about 5 µM MBP-Tether-Peptide were coupled in 100 mM HEPES-KOH pH=7, 0.1 mM CuSO4, 
5 mM sodium ascorbate for 1 h at RT under slight shaking. The reaction was stopped by 
addition of an excess of EDTA relatively to CuSO4. Copper and unreacted 5-FAM-alkyne were 
separated from the sample via Vivaspin 500. An aliquot of the retentate was treated with TVMVp 
in 100 mM HEPES-KOH pH=7, 2 mM DTT, and SDS-PAGE was performed. 
 
 In vitro verification of SpyTag-SpyCatcher reaction 
5-FAM-tagged MBP-Tether-Peptide was subjected to a SpyTag-SpyCatcher reaction. NBGFP-
SpyCatcher002 and 5-FAM-tagged MBP-Tether-Peptide were mixed at an approximately 1:1 
molar ratio in either 100 mM HEPES pH=7 or buffer W and incubated either at 4 °C for 14 h 
or at RT for 1 h, directly followed by SDS-PAGE analysis.   
 
 Fluorescent SDS-PAGE 
Protein samples containing fluorophores were semi-denaturated with heat (10 min 72 °C) and 
loaded on polyacrylamide gels. After the run, fluorescence was recorded at a Gel Imager AI600 
(Amersham).   
 
 Microscale Thermophoresis  
For each measurement, a dilution series of NBGFP-SpyCatcher (2 µM – 0.24 nM) in buffer W 
(150 mM KCl, 100 mM Tris-Cl pH=8) supplemented with 0.05 % Tween 20 to prevent 
unspecific binding was prepared. After mixing with the fluorophore (which concentration was 
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kept constant), capillaries were filled with the respective solutions and inserted into the 
instrument (Monolith NT.115). Measurements were analysed with NT analysis software.    
 
 I-V Measurements 
The setup used for the I-V measurements at the Materials Analysis group, TU Darmstadt, is 
described in [439]. The I-V curves were recorded by applying a scanning triangle voltage 
ranging from -1 to +1 V for three periods, each with 80 data points (1150 ms per point). As 
discussed, the type of the nanopore (cylindrical or conical) impacts the shape of the resulting 
I-V curve (Figure 40 B). All measurements were performed in 0.1 M KCl in 1x PBS, pH=7 unless 
stated otherwise. All measurements were performed by Ivana Duznovic and co-workers. I 
included their data in my thesis for clarity and to allow discussion.    
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3. Results 
 Conceptualization 
As discussed in section 3.1 of Chapter 1, nanobinders like VHHs or nanobodies offer many 
advantages. Despite these advantages, a combination of solid-state nanopores (SSNs) with 
nanobodies as receptors has not been reported to date, in contrast to antibody-functionalized 
SSNs [412,413]. Thus, an immobilization concept was developed in cooperation with Ivana 
Duznovic from the Materials Analysis group with the aim of investigating the feasibility of 
nanobody-SSN biosensor scaffolds. 
Regarding the nanobodies, we chose to test three different nanobodies: An anti-GFP nanobody 
(NBGFP) [440], an anti-mCherry nanobody (NBmCherry, LaM-4 from [441]) and an anti-α-amylase 
nanobody (NBAmylase, AMD9 from [25]). The first two bind to green and red fluorescent proteins 
GFP [442] and mCherry [443] with KDs of 1.4 nM and 0.2 nM, respectively, while the NBAmylase 
binds the stress biomarker α-amylase with a KD of 3.5 nM. The advantage of using fluorescent 
proteins is that an evaluation of the platform via microscopy becomes accessible, whereas α-
amylase is an important biomarker worth detecting in clinics as increased levels may hint 
towards pancreatic diseases [444].           
Regarding the molecular design, spacing and orientation were deemed pivotal. Firstly, a proper 
spacing between the nanobody and the SSN surface will ensure protein flexibility and prevent 
fouling. Secondly, a correct orientation of the nanobody towards the lumen of the pore is 
needed to enable binding of analytes. To ensure both, we introduced a multifunctional spacing 
peptide (“tether”) that gets coupled to the SSN surface via strain-promoted cycloaddition 
(SPAAC). Apart from flexible linker sequences, this Tether Peptide contains the following 
features from N- to C-terminus:  
 
 
1. SH3-recognition motif 
2. SpyTag002 
3. TVMV protease cleavage 
site 
4. StrepTagII for purification 
5. Sortase A motif  
 
 
Figure 44 Tether Peptide amino acid sequence. Numbers correspond to 
listed features. Sortase A motif is LPETGG; the terminal glycines (red) 
are exchanged by azidopropanamine (Azp) during Sortase reaction.   
A crucial part of this Tether Peptide is the SpyTag002 motif that can form an isopeptide bond 
with a SpyCatcher002 fusion protein [44]. As the fusion partner of SpyCatcher002 is modularly 
exchangeable on the genetic level, this approach accelerates screening of suitable receptors and 
the biosensor development pipeline in general.  
The C-terminal LPETGG motif enables enzymatic attachment of a bioorthogonal functional 
group, for example an azide, via improved Sortase A variants [39,445]. Thereby, the Tether 
Peptide can be immobilized site-specifically at its C-terminus, for example via Strain-promoted 
azide-alkinyl cycloaddition (SPAAC) to a dibenzocyclooctyne-amine (DBCO)-functionalized 
surface [446].   
A C-terminal immobilization was deemed superior to an N-terminal immobilization due to 
favored orientation of the proteins: When SpyTag002 is coupled to the nanopore surface via its 
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C-terminus, both N-termini of SpyTag002 and SpyCatcher002 point away from the surface after 
isopeptide bond formation (design A, Figure 45). This implies that a fusion domain at the N-
terminus of SpyCatcher002 will also point away from the surface. Thereby, the chance of 
unspecific surface absorption that could lead to protein fouling is reduced. In contrast, N-
terminal coupling of SpyTag002 and C-terminal domain fusion to SpyCatcher002 will likely 
lead to unfavorable crowding at the nanopore surface, hampering analyte recognition (design 
B, Figure 45). Moreover, the SpyTag002/SpyCatcher002 complex in design A serves as 
additional spacing element between the receptor and the pore wall.  
During preparation of the SSN membrane, the chemical functionalization proceeds 
unspecifically, meaning not only inside the nanopore but also near the aperture at the polymer 
surface. However, specific immobilization of receptors only inside the nanopore would reduce 
background signals and thus improve the biosensing qualities of the scaffold. Following this 
rationale, the TVMV protease (TVMVp) cleavage site and the SH3-recognition motif were 
included in the Tether Peptide sequence. A fusion protein consisting of TVMVp and an SH3 
domain should be able to remove excess receptors on the polymer surface after immobilization, 
while receptors inside the SSN should be less accessible. SH3 acts as an recruiting domain that 
enhances cleavage rates by increasing the local concentration of TVMVp at its substrate [28].  
 
 
Figure 45 Molecular design for oriented immobilization inside solid-state nanopores, exemplified with NBGFP. A) Design 
A: C-terminal immobilization of SpyTag combined with N-terminal attachment of GFP-Nanobody (NBGFP) to SpyCatcher 
(favorable); B) Design B: N- or C-terminal immobilization of SpyTag combined with C-terminal attachment of NBGFP to 
SpyCatcher (unfavorable). Proteins were visualized with UCSF Chimera [120] using PDB entries 3K1K & 4MLS.   
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 Protein purification and characterization 
Typically, protein purification by 6xHis-Tag or StrepTagII yielded 2-4 mg purified protein per l 
culture as depicted in Table 19. Variations are likely a results of used expression vectors, 
experimental conditions and / or protein in general. Due to its small sized (7.5 kDa), Tether 
Peptide was expressed and purified as MBP-fusion (section 2.1.1). 
 
Table 19 Typical yields of proteins used in the SSN project. NB with subscript denotes specific nanobodies. 
Protein 
Size (kDa 
/ AA) 
Expression 
vector 
Purification 
Typical yield of pure protein (per l 
culture) 
Tether Peptide 
(expressed as MBP-
fusion) 
7.5 / 72 pET24 Strep-Tag 5-8 mg 
Sortase A7M 
17.9 / 
156 
pET24 His-Tag 3-4 mg 
Sortase A5M 18 / 158 pET24 Strep-Tag 1-2 mg 
NBAmylase-(GGS)2-
SpyCatcher002 
27.6 / 
261 
pFlink-XE Strep-Tag 2-3 mg 
NBGFP-(GGS)2-
SpyCatcher002 
27.3 / 
256 
pFlink-XE Strep-Tag 4-5 mg 
NBmCherry-(GGS)2-
SpyCatcher002 
27.9 / 
265 
pFlink-XE Strep-Tag 2-3 mg 
SH3-sFv2linker-
TVMVp* 
35.5 / 
322 
pFlink-XE Strep-Tag 2-4 mg 
     
* self-cleaving variant MBP-TVMVsite-SH3-sFv2link-TVMVp-strep. sFv2link: GSEGSTSGSGGGGSGAGSTKG 
 
 
Following a published protocol from [39], an azidopropanamine (Azp) was attached to purified 
MBP-Tether Peptide via Sortase A7M. To verify the reaction success, the product was incubated 
with 5-Fluorescein-alkyne (FAM-alkyne) via copper-catalyzed azide-alkyne cycloaddition 
(CuAAC) [406]. Excess FAM-alkyne was depleted via Vivaspin 500 concentrator. As can be 
concluded by SDS-PAGE (Figure 46), both Sortase coupling and CuAAC were successful. 
Importantly, when the modified Tether Peptide was cleaved from the MBP via TEV protease, 
the large MBP domain lost its fluorescence (lane 3), meaning that Sortase A7M specifically 
attached Azp to the LPETGG motif via C-terminal transpeptidation. The FAM-modified MBP-
Tether Peptide was employed to verify the SpyTag002-SpyCatcher002 coupling reaction. SDS-
PAGE confirmed successful isopeptide bond formation between the modified protein and NBGFP-
(GGS)2-SpyCatcher002 for various conditions (Figure 47).  
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Figure 46 In vitro verification of Azp-coupling. Left: Fluorescent image of the performed SDS-PAGE. Right: Bright light 
image of the same SDS-PAGE. M Marker BlueStar Prestained (Nippon Genetics), label in kDa; 1 MBP-Peptide-Azp before 
Copper-Click reaction with FAM-Alkyne; 2 Coupled MBP-Peptide-FAM, visible as a green fluorescent band; 3 TEV protease 
cleaved MBP-Peptide. TEV appears at about 27 kDa.   
 
 
 
 
Figure 47 In vitro verification of SpyTag-SpyCatcher reaction. Top: Fluorescent image of the performed SDS-PAGE; 
Bottom: Bright light image of the same SDS-PAGE after Coomassie staining. M Marker BlueStar (Nippon Genetics); 1-
4) SpyTag-SpyCatcher reactions under different conditions. 1) 4 °C O/N in HEPES-KOH pH=7; 2) 4 °C O/N in buffer W 
pH=8; 3) RT 1 h in HEPES-KOH pH=7; 4) RT 1 h in buffer W pH=8; 5 NBGFP-(GGS)2-SpyCatcher002; 6) MBP-Peptide-
FAM. Expected sizes: MBP-Tether Peptide 50 kDa; NBGFP-(GGS)2-SpyCatcher002: 27 kDa; Both together: 77 kDa. 
Obtained double and multi-bands result from semi-denaturation of NBGFP proteins that contain disulfide bonds.      
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As an alternative to the Ca2+ independent Sortase A7M, the pentamutant Sortase A5M was 
tested. This mutant has a 140-fold higher activity than wt Sortase [38]. As Sortase A5M requires 
Ca2+ as a cofactor, it can be inactivated by EDTA addition. Sortase A5M proved superior to 
Sortase A7M regarding Azp coupling efficiency (Figure 48). Moreover, no unspecific cleavage 
products were observed in contrast to the Sortase A7M batch reaction. These may result from 
cleavage at aspartyl residues due to the use of 0.2 % formic acid as deactivation agent [447]. 
Finally, the general functionality of purified nanobodies was verified in solution by a simple 
pulldown assay (Figure 49). MBP-eGFP6xHis (71 kDa, final concentration 9 µM, kindly provided 
by Wadim Weber) was mixed with a GST-NBGFP fusion protein (42 kDa, final concentration 
22 µM), diluted in 300 mM NaCl, 50 mM NaPO4 pH=8 and applied onto a prepacked Ni-IDA 
column. The column was washed two times with the same buffer (W1 & W2) and the proteins 
were eluted in two steps with 300 mM NaCl, 300 mM Imidazole, 50 mM NaPO4 pH=8 (E1 & 
E2). As the GST-NBGFP protein did not contain a 6xHis-tag, it remained coupled to MBP-GFP-
6xHis during the pulldown assay, verifying the functionality of the nanobody.   
Although the proteins in this assay are not the same as the ones used for SSN modification, the 
pulldown assay demonstrates that the purification pipeline of the lab yielded correctly folded, 
active nanobodies. In an additional experiment with a supercharged GFP variant, a microscale 
thermophoresis experiment further verified correct binding of sfGFP by purified NBGFP (see 
section 3.5).   
 
  
 
Figure 48 Comparison of Sortase A5M and Sortase 
A7M via fluorescent SDS-PAGE. M: Protein Marker 
BlueStar Prestained (Nippon Genetics), sizes in kDa. 
Sortase A5M shows higher coupling efficiency and less 
side product formation than Sortase A7M.  
 
 Figure 49 Pulldown assay validates the functionality of 
purified GFP-nanobody fusion protein. FT: Flowthrough; 
W1 & W2: Wash 1 & 2; E1 & E2: Elution 1 & 2. Samples 
were analyzed on a Mini-PROTEANTM TGX precast gel (Bio-
Rad). M: Protein Marker BlueStar Prestained (Nippon 
Genetics), sizes in kDa. GST-NBGFP coelutes with MBP-
eGFP6xHis. 
 
 Downstream Processing of Tether Peptide 
With purified and active proteins at hand, Tether Peptide was prepared for coupling to solid-
state nanopores (SSNs). Following Azp attachment via Sortase, MBP was cleaved with TEV 
protease and, together with the Sortase, separated from the small 7.5 kDa peptide via 10 kDa 
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MWCO concentrators (Figure 50). As the downstream process involves multiple buffer 
exchange and concentration steps (see section 3.2), ≈ 1.5 mg MBP-Tether Peptide were used 
for each downstream batch to achieve sufficient amount of modified peptide. The Tether 
Peptide (in 50 mM TRIS-Cl, pH = 8) was then given to Ivana Duznovic and stored at 4 °C until 
coupled to DBCO-functionalized PET SSNs.   
 
 
Figure 50 Tether Peptide downstream processing. A precast TGX gradient gel (Bio-Rad) was used. M Marker BlueStar 
(Nippon Genetics), sizes in kDa; 1 Reaction mix after Sortase A7M reaction; 2 Flowthrough 10 kDa MWCO concentrator 
(step: depletion of residual Azp); 3 After TEV-cleavage (O/N 18 °C); 4 Retentate after TEV cleavage; 5 Filtrate after TEV 
cleavage, containing the desired Tether Peptide.  
 
 Solid-state nanopore modification 
All immobilization experiments and I-V measurements were carried out by Ivana Duznovic and 
co-workers in the Materials Analysis group laboratories. The workflow was divided into four 
consecutive steps: 
1. Asymmetrical pore etching of irradiated PET foils 
2. DBCO coupling via EDC/PFP chemistry 
3. Tether Peptide coupling via SPAAC 
4. Nanobody coupling via SpyTag/SpyCatcher isopeptide bond 
The general feasibility and robustness of the workflow was analyzed both with conical single 
pores and multipore membranes (>104 pores / cm2).  
 
 Single pore membranes  
After each modification step and extensive washing, I-V curves were measured in 0.1 M KCl. 
The results of single pore experiments are shown in Figure 51 and Table 20. Attachment of 
uncharged DBCO led to an expected lower ionic conductance, but also to an unexpected 
rectification factor (RF, equation 1) slightly lower than 1. This phenomenon is most likely 
caused by cation-π interactions between the C-C triple bond of DBCO and K+, leading to an 
apparent positive layer und thus rendering the pore weakly anion selective [448,449]. In the 
next step, coupling of Tether Peptide led to increased conductivity, while the RF remained < 1 
due to the peptides net charge of +6 e at the given pH (= 7). The following attachment of 
SpyCatcher002-NBs with net charges between -6/-8 e resulted in RFs > 1. Importantly, while 
the size of the tip diameter (A: ≈ 45 nm, B: ≈ 26 nm, evaluated by Ivana Duznovic via scanning 
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electron microscopy) impacted the overall conductivity and the nanopores response to 
attachment, the trend regarding rectification remained similar for both geometries. The final 
rectification behaviour thus implies an internal quality control for the success of SSN 
biofunctionalization. 
 
Figure 51 I-V curves during the modification process of SSNs. Rectification behaviour and conductivity change with 
modifications. A: Tip diameter ≈ 45 nm, coupling protein: NBGFP-(GGS)2-SpyCatcher002; B: Tip diameter ≈ 26 nm, 
coupling protein: NBGFP-(GGS)2-SpyCatcher002. Mean values and error bars result from 3 periods of triangular voltage 
recordings (section 2.2). Data were acquired by Ivana Duznovic and her students.   
 
Table 20 Rectification factors (RF) at ± 1 V of the respective I-V single pore measurements in Figure 51. Errors calculated 
via Gaussian error propagation.  
Pore modification RF pore 1 (tip d ≈ 45 nm) RF pore 2 (tip d ≈ 26 nm) 
Blank 3.04 ± 0.16 2.76 ± 0.30 
DBCO 0.61 ± 0.05 0.34 ± 0.14 
Tether Peptide 0.77 ± 0.01 0.37 ± 0.03 
NB-SpyCatcher chimera 2.00 ± 0.50 (NBGFP) 4.22 ± 0.20 (NBmCherry) 
 
 Specificity 
The chambers separated by NB-functionalized SSNs were consecutively filled with different 
dilutions of analyte protein (ranging from 10-15 to 10-6 M in logarithmic manner) in 1x PBS 
buffer, and I-V curves were recorded. Specific current responses correlated to the binding of 
NBs to their cognate protein-epitopes were observed (Figure 52). The data could be fitted to 
distinct sigmoidal binding curves, with the best fit of the GFP-NBGFP interaction data resembling 
the expected dose-response curve. Importantly, the NB-functionalized nanopores were selective 
towards their analyte, as the respective correlation between concentration and conductivity was 
not observed for other analytes (section 3.5). Altogether, this demonstrates the potential of the 
setup to discriminate specific analytes.  
In case of sfGFP/NBGFP, the RF value increased about 30 %, while it did not deviate more than 
≈ 11 % for the other cases (Sup Fig 12). However, it is important to notice that in all cases the 
specific interaction between the immobilized nanobodies and their respective analytes resulted 
in a conductivity increase instead of a decrease. This implies that a higher local concentration 
of the analytes – due to specific binding – influences the charge density near the pore aperture 
and thus the conductivity of the pore.  
c
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Figure 52 Specific recognition of analytes via nanobody-nanopore-sensors. Shown are I-V curves (left) and corresponding 
conductivity plots (right) recorded with respective NB-modified single pore membranes. The concentrations refer to the 
respective analyte. Scales of G vs analyte graphs are logarithmic. Data were fitted with a sigmoidal dose-response-like 
equation in Prism 7 (Graphpad) (details in Sup Table 2).   
 
 Multipore membranes  
Modification experiments on multipore membranes (pore density ≥ 104 / cm2) yielded results 
comparable to the single pore experiments. The RFs at ± 1 V showed the same trends, with 
exception of NBGFP-(GGS)2-SpyCatcher002 coupling that did not result in an inversion of 
rectification (Table 21), albeit in an increase in RF. This suggests that SpyCatcher/SpyTag 
coupling does not proceed consistently over the whole membrane and that a larger number of 
Tether Peptides remain uncoupled to the fusion protein compared to the single pore setup.  
A small increase (≈ 26 %) in the RF value was observed upon addition of the analyte sfGFP to 
the NBGFP-(GGS)2-SpyCatcher002 functionalized multipore membrane. This agrees with the 
single pore experiment (RF increase ≈ 30 %). In contrast to the latter, however, a loss of 
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conductivity (“blocking”) was observed in the multipore setup (data not shown). Possible 
reasons for this finding are discussed in the following paragraph on SSN control experiments 
(section 3.5). 
 
Table 21 Rectification factors (RF) at ± 1 V for measurements on a multipore membrane. Errors calculated via Gaussian 
error propagation.  
 Pore modification RF of the membrane  
Blank 3.33 ± 0.22 
DBCO 0.71 ± 0.07 
Tether Peptide 0.66 ± 0.12 
NB-SpyCatcher chimera 0.83 ± 0.03 
sfGFP addition 1.04 ± 0.06 
 
 
 
The use of multipore membranes together with fluorescent analytes allowed an additional 
analysis of the specific nanobody – target interaction via a confocal laser scanning microscope 
(CLSM). A specific binding of sfGFP or mCherry to their respective nanobodies should result in 
an increased local concentration inside the pores if the biofunctionalization was successful.   
Precisely, analyte dilutions (at ≈ 1 µM) were added to NB-functionalized membranes that were 
fixed on coverslips with 0.5 % agarose solution. After incubation and rinsing (2 times with 
1x PBS buffer), the samples were analyzed via top view and scanning mode (performed by 
Wadim Weber). Strong fluorescent signals were observed inside both conical and cylindrical 
nanopores (Figure 53 A&C), but only if the respective analyte was incubated with its 
corresponding nanobody (Figure 54). For instance, if sfGFP was incubated with NBmCherry 
modified nanopores, only marginal spots of fluorescence were visible, in contrast to bright 
fluorescence in NBGFP pores. sfGFP also showed accumulation in unfunctionalized membrane 
areas (Figure 53 B), likely due to non-specific interactions and/or rinsing limitations, however 
at much lower intensities compared to NBGFP areas. For mCherry, such unspecific accumulation 
may be hidden due to its smaller quantum yield [342,443]. Additional images are provided in 
the supplement (Sup Fig 13). Altogether, the images demonstrate that the extraordinary 
specificity of the nanobodies is preserved when immobilized inside the nanopore confinement.  
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Figure 53 CLSM images of multipore membranes with different geometry and/or modification exposed to sfGFP. A: 
Conical pores modified with NBGFP; B: Unfunctionalized membrane (PET surface); C: Cylindrical pores modified with 
NBGFP; D: Cylindrical pores modified with NBmCherry. CLSM images were recorded, merged and aligned by Wadim Weber.     
 
 
 
 
 
Figure 54 CLSM-images of multipore membranes (107 pores/cm2) modified with specific nanobinders NBGFP and 
NBmCherry. Protein solutions were added on top of the respective membranes, incubated for 30 min and rinsed two times 
with 1x PBS. The respective NB/analyte combination in the respective frame (A-D) is depicted schematically. CLSM images 
were recorded, merged and aligned by Wadim Weber.   
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 SSN control experiments 
Multiple unpredicted phenomena appeared during the development of the SSN-nanobody 
platform and during the measurements – observations that need careful examination. With two 
track-etched PET membranes never being identical – especially after chemical etching –, 
reproduction of the same measurement is limited to qualitative statements with respect to I-V 
correlation and RF values. Nonetheless, the gathered data from the following control 
experiments underline that the principle idea of biosensing with NB-functionalized SSNs is valid 
and reliable.  
It is important to note that charge interactions can have significant effects on the conductive 
behaviour of SSNs. In fact, many studies use charge interactions as a biosensing concept or for 
immobilization approaches [379,450]. Such charge interaction is probably the cause of 
unspecific adsorption of sfGFP and mCherry to Tether Peptide modified SSN lacking any NB 
moiety (Figure 55). The Tether Peptide having a net charge of +6 e at pH=7 attracts both 
sfGFP (formal net charge -3 e) and mCherry (formal net charge -7 e). Moreover, the experiment 
showed that a considerable proportion of analyte remained electrostatically bound to the 
surface despite washing, as the experiment was performed on the same foil but sfGFP was tested 
first. To a certain degree this “memory effect” or clogging was also observed in control 
experiments on cross-reactivity that were performed on single pores (Figure 56). These 
experiments proved that the NBs do not bind to other analytes, however, the conductivity-
concentration correlation for the matching analyte was considerably less pronounced compared 
to Figure 52, likely due to the memory effect caused by measuring the mismatching analytes 
before the matching one. In fact, a correlation for α-amylase recognition by the NBAmylase 
functionalized membrane was barely seen in the cross-reactivity experiment (Figure 56 B).   
 
 
 
 
  
Figure 55 Unspecific interaction of sfGFP and mCherry with immobilized Tether Peptide. After measuring sfGFP 
interaction, the foil was rinsed extensively, followed by mCherry testing. Despite washing, a memory effect was observed, 
likely due to strong electrostatic interaction between positively charged Tether Peptide and negatively charged sfGFP.     
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A 
B 
C 
Figure 56 Cross-reactivity measurements on single pore membranes. A: NBmCherry vs. analytes; B: NBAmylase vs. analytes; 
C: NBGFP vs. analytes. Each I-V measurement is paired with a graph showing the corresponding conductivity at 1 V. In A, 
B and C, the same foil was exposed to two unspecific analytes before being exposed to the correct one; the order from left 
to right corresponds to the time coordinate. The selectivities of the NBs to their respective analyte are preserved after 
exposure to other analytes, although memory effects adversely affect the recognition efficiency (compare to Figure 52).  
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To elucidate the role of protein charge inside SSNs better, sfGFP was compared to a negatively 
supercharged GFP, GFP(-30). From available supercharged GFP variants [451], GFP(-30) was 
chosen because the residues involved in the nanobody interaction are not changed in contrast 
to e.g. GFP(+9) [452], as determined by structure based in silico analysis with UCSF Chimera 
[120,440]. To validate that GFP(-30) is bound by NBGFP, a microscale thermophoresis (MST) 
experiment was performed on a Monolith NT.115. When GFP(-30) was titrated with NBGFP-
(GGS)2-SpyCatcher002, the raw fluorescence values of GFP(-30) increased for NBGFP 
concentrations above a certain threshold, similar to an MST experiment with sfGFP. This 
increase was expected, as the used NBGFP protein has also fluorescence enhancing properties 
and was named GFP-enhancer in one study [440,453].  
 
Figure 57 MST experiments with GFP(-30) and sfGFP. Raw fluorescence of the GFP proteins, held at constant 78 nM 
(GFP(-30)) and 44 nM (sfGFP), respectively, increases when bound by NBGFP. 
 
Subsequently, GFP(-30) was assayed on SSNs with immobilized NBGFP-(GGS)2-SpyCatcher002 
on multipore membranes (104 pores / cm2) and compared to sfGFP in order to understand the 
role of charge interaction in the SSN biofunctionalization context. Both experiments resulted in 
a slight loss of conductivity as observed before for multipores, however, the RF value during 
sfGFP binding only increases slightly (≈ 15 %) over seven orders of magnitude whereas it 
increased drastically in case of GFP(-30) (≈ 66 %) (Figure 58).  
 
 
 
Figure 58 RF values as a function of analyte concentration. Upon NBGFP binding of GFP(-30), RF increases 66 % between 
seven orders of magnitude, while RF is nearly unaffected in case of sfGFP binding.      
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To conclude, the surface charge of the analyte affects the rectification behaviour of 
biofunctionalized SSNs. This has both advantages and disadvantages for the proposed biosensor 
platform. Changes in rectification are considered a reliable readout in the nanopore field 
[372,379,454]. However, the recruitment of charges to the aperture of the nanopore changes 
its conductive behaviour. Thereby current changes upon specific analyte binding may be 
considerably masked by charge effects, leading to a bias in conductivity readout and a hampered 
sensitivity of the system. 
Taking both effects account, it is possible to explain the observed conductivity differences 
between biofunctionalized single pores and multipores. In the multipore context, nanopore 
blocking via binding of analytes outweighs the effect of charges on conductivity, unless an 
analyte with high surface charge is bound (Figure 57). In this case, the considerable RF changes 
may serve as a readout. In the single pore context, the charge changes near the only aperture 
outweigh this blocking and lead to an increase in conductivity if the corresponding analyte is 
present. To assess how strong the charge affects the final current signal is not trivial and should 
be examined in future studies.    
 
 Conclusion and Perspectives 
Both single pore measurements and CLSM data proved the specificity of the nanobody-analyte 
interaction in nanoconfined SSN environments. Two main variables are affecting the detection 
range: Charge interactions and blocking. While blocking outweighs in multipore setups, charge 
interactions play a dominant role in the single pore context. Importantly, considerable 
differences between analytes were observed regarding the correlation between conductivity and 
concentration (Figure 52), underlining the sensitivity of the system towards charge and size 
differences.      
Considering the high modularity with respect to available nanobodies, the results encourage 
further development of nanobody-nanopore devices for biosensing approaches. Remaining 
challenges are reproducible fabrication of the SSN membranes as well as elucidation of the 
interaction between charge, blocking and conductive behaviour. An important aspect concerns 
the stability of proteins in nanoconfinement and electrical fields [424]. Protein engineering 
could address this issue by construction of stabilized receptors.   
For example, receptor stability may be enhanced by a shielding PASylation layer (see section 
1.1.1, Chapter 2) if this strategy does not impact analyte recognition. Regarding SSNs, 
evaluation of other pore geometries (e.g. cylindrical or cigar-shaped [382]) could lead to an 
improved signal-to-noise ratio. In this context, adjusting the properties of the Tether Peptide 
sequence is another promising strategy. For instance, introduction of additional charges in the 
spacing region could reduce any unspecific surface adsorption or intermolecular aggregation of 
the peptide [455], leading to an improved nanobody-labeling of the pore interior. Moreover, 
further experiments with SH3-TVMV protease to specifically deplete protein outside the 
nanopore could render the platform more sensitive. First experiments with the protease did not 
yield considerable results, thus the data were not included in this work.  
The qualitative data gathered in this work demonstrate the feasibility and potential of the 
modular nanobody-nanopore platform. Further optimization will allow precise and quantitative 
analyte sensing. Importantly, the combination of both Material and Life Science pursued here 
represents one of the most promising roads to customizable point-of-care biosensors. 
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4. Supplement Chapter 4 
 
 
 
Sup Fig 12 Rectification Factor (RF) values of direct coupling on single pores (corresponding I-V curves in Figure 52).  
 
Sup Table 2 Fit parameters for specificity SSN measurements depicted in Figure 52. 
Fit function for all data ) 
* − +
1 
 ,-
.

 + 
Sigmoidal fit parameters  
sfGFP  
A 1.837 ± 0.04783 
B 2.35 ± 0.01849 
z 8.097e-013 ± 5.539e-013 
p 0.3943 ± 0.09171 
mCherry   
A 0.9541 ± 0.08357 
B 1.344 ± 0.04893 
z 3.21e-012 ± 6.242e-012 
p 0.1427 ± 0.05681 
α-amylase  
A 2.062 ± 0.5864 
B 2.875 ± 0.0279 
z 1.669e-015 ± 1.022e-014 
p 0.2246 ± 0.1003 
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Sup Fig 13: Complete CLSM image set of multipore membranes with different geometry and/or modification, exposed 
to sfGFP or mCherry. The leftmost images constitute the fluorescent images, the middle ones the bright light images and 
the rightmost the merged images. Rectangles denote the sections shown in Figure 53 or Figure 54, respectively. A: 
Cylindrical pores modified with NBGFP, exposed to sfGFP; B: Cylindrical pores modified with NBmCherry, exposed to sfGFP; 
C: Conical pores modified with NBGFP, exposed to sfGFP; D: Conical pores modified with NBmCherry, exposed to sfGFP; E: 
Cylindrical pores modified with NBmCherry, exposed to mCherry; F: Cylindrical pores modified with NBGFP, exposed to 
mCherry; G: Unfunctionalized membrane area, exposed to sfGFP. CLSM images were recorded, merged, and aligned by 
Wadim Weber.   
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Material  
iFLinkC plasmid cards are available via addgene (www.addgene.org), all other plasmid cards 
and primer sequences are saved on the AG Stein server. Primer oligos were purchased at Sigma 
Aldrich or IDT; gBlocks and longer DNA parts were purchased at IDT or GenScript. All 
restriction enzymes, DNA ladders, DNA loading dyes, PCR buffers and restriction buffers were 
purchased from New England Biolabs (NEB). All standard chemicals used in this work were 
purchased from Carl Roth with exceptions listed in Table 22.  
 
Table 22 Standard chemicals from Suppliers other than Carl Roth 
Chemical Supplier 
Imidazole (>= 99%) Sigma Aldrich 
HABA Sigma Aldrich 
D(+)Lactose 1-hydrate AppliChem 
DPhPC Avanti Polar Lipids (Otto Nordwald) 
Bio-Ethanol Richter Chemie 
Desthiobiotin IBA Life Sciences 
Copper(II)sulfate AppliChem 
Boric acid  AppliChem 
Zinc sulfate AppliChem 
Hexadecane Sigma Aldrich 
n-hexane Sigma Aldrich 
n-pentane Sigma Aldrich 
 
 
Table 23 Laboratory equipment used in this work.  
Instrument Model Manufacturer 
Agarose gel chamber Perfectblue Gelsystem Mini M VWR 
Amplifier L/M-EPC7 List Medical 
Block heater  Touch Screen Block Heater  Thermo Fisher Scientific  
Blue LED table FastGene LED Illuminator Nippon Genetics 
Centrifuge  Microstar 17  VWR  
Centrifuge  Minispin plus  Eppendorf  
Centrifuge  Allegra X-30R Centrifuge  Beckman Coulter  
Electroporator Gene Pulser II in combination with 
Pulse Controller Plus and Capacitance 
Extender Plus 
Bio-Rad 
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Gel documentation imaging 
system  Amersham Imager 600 RGB  GE Healthcare  
 
Vilbert E-BOX-CX5.TS + TFS-
20.Skylite Blaulicht LED-PAD 
 
Vilber  
Gel documentation imaging 
system Gel Imager AI600 Amersham 
Homogenizer for cell 
suspension  EmulsiFlex-C3  
Avestin Europe 
GmbH  
Incubator for microtiter 
plates  Titramax 1000 & Inkubator 1000  Heidolph  
Lyophyll Alpha 2-4 LD plus Christ 
Magnet spinner Magnetrührer VWR LabDisc S040 VWR 
Microtiter plate reader  Spark  Tecan  
Microvolume UV-VIS 
spectrophotometer  NanoDrop-1000 Spectrophotometer  Peqlab  
Microwellplate shaker Titramax 1000 & Inkubator 1000 Heidolph 
Monolith for Microscale 
Thermophoresis Monolith NT.115 NanoTemper 
OD measuring device  Ultrospex® 10 CELL DENSITY METER  Biochrom  
PCR cycler  Labcycler 48 Basic 230V  Sensoquest  
pH-Meter pH-Meter VWR pHenomenal pH1102 VWR 
Pipettes Research Plus  Eppendorf 
Power Supply for agarose 
and SDS gels  PowerPac Basic  Bio-Rad  
Protein purification system  ÄKTApure  GE Healthcare  
Shaking incubator  HT Ecotron  Infors  
Shaking incubator  HT Unitron  Infors  
Sonicator 
Qsonica Q125 (125 W Sonicator, 1/8’’ 
probe) + Sound Enclosure 
 
Qsonica 
Thermal shaker  Cooling Thermal Shaker Touch  VWR  
Tumbler Taumelschüttler Rocker 3D VWR 
Vortex Vortex VWR mixer mini VWR 
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Table 24 Genotypes of Escherichia coli strains used in this work. 
Strain Genotype Reference 
BL21(DE3) 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
New England Biolabs 
(NEB) 
BL21(DE3) 
omp8 
B F- hsdSB (rB-, mB-) gal dcm ompT λ(DE3) 
ΔlamB 
ompF::Tn5 ΔompA ΔompC 
[337], provided by Klaus 
Hantke 
DH10B 
Δ(ara-leu) 7697 araD139 fhuA ΔlacX74 
galK16 galE15 e14- ϕ80 Δ(lacZ)M15 recA1 
relA1 endA1 nupG rpsL (StrR) rph spoT1 
Δ(mrr-hsdRMS-mcrBC) 
New England Biolabs 
(NEB) 
 
 
 
Table 25 Relevant consumables used in this work 
Consumables Denotion Manufacturer (Supplier) 
96-well plates BRANDplates Brand 
Aluminium Foil Aluminium Foil VWR 
Buffer exchange columns PD 10 Desalting columns GE Healthcare (VWR) 
Centrifugal Concentrator Vivaspin 500 & Vivaspin 20 10000 kDa MWCO PES Sartorius 
Cuvettes Cuvettes 10x4x45 mm Sarstedt 
Dialysis cartridges 10 kDa MWCO Slide-A-Lyzer  Thermo Fisher Scientific (VWR) 
Disposable hypodermic 
needle 100 Sterican® Gr.1  B. Braun 
Disposal Bags Disposal Bags 200x300 mm Carl Roth 
DNA stain for Agarose gel 
electrophoresis Midori Green Advance Nippon Genetics 
Falcons 15 & 50 ml Sarstedt & VWR 
Gel and PCR cleanup NulceoSpin Gel and PCR Clean-up Macherey-Nagel 
Gibson Assembly Mastermix Gibson Assembly® Master Mix NEB 
Microscale Thermophoresis 
Capillaries 
MonolithTM NT.115 Series 
(1000) NanoTemper 
Midi-Prep Kit NucleoBond® Xtra Midi Macherey-Nagel 
Mini-Prep Kit NucleoSpin® Plasmid (NoLid) Macherey-Nagel 
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Nitrile Gloves StarGuard Comfort StarLab 
Parafilm Parafilm M, 100mm Wide x 75 mm Length Bemis (StarLab) 
PCR tubes Multiply®-µStripPro Biosphere® Sarstedt 
PET membranes Hostaphan RN12® (12 µm thickness) Hoechst 
Pipette Tips TipOne 10/20 µl XL Graduated Tip (Refill) StarLab 
 TipOne 200 µl Yellow Bevelled Tip (Refill) StarLab 
 TipOne 1000 µl Blue Graduated Tip (Refill) StarLab 
 5000 µl Eppendorf-Type Graduated Macro Tip, Loose StarLab 
Plastic Syringes Omnifix® Luer Lock 10, 20 & 50 ml; Injekt®-F 1ml B. Braun 
Precast polyacrylamide gels Mini-PROTEAN
TM TGX (4-
20%) Bio-Rad 
Protease inhibitor tablets cOmplete protease inhibitor tablets Roche (Sigma Aldrich) 
Protein Ladder BlueStar Prestained Protein Marker Nippon Genetics 
Protein Stain for SDS PAGEs Roti®Blue 5x Carl Roth 
 FastGene® Qstain Nippon Genetics 
Purification columns HisTrap FF & HP, 1 ml & 5 ml  GE Healthcare (VWR) 
 StrepTrap HP 1ml & 5ml GE Healthcare (VWR) 
Reaction /Micro tubes 1.5 ml & 2 ml Sarstedt 
Round filters for bottles Cellulose Acetate Filter 0.45 µm (1106-47-N)  Sartorius 
Syringe filters 
Rotilabo® CME sterile. 
0.22 µm & 0.45 µm, outer 
diameter 33 mm  
Carl Roth 
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Table 26 Composition of standard buffers used in this work 
Buffer composition 
Buffer W 150 mM NaCl, 100 mM Tris-Cl pH=8 
Refolding buffer 200 mM KCl, 50 mM Tris-Cl pH=8, 0.5% (w/v) n-dodecyl β-D-maltoside (DDM). 
SDS Loading Dye 
200 mM NaPO4 pH=7.5, 4% (w/v) SDS, 
20%(v/v) Glycerol, 0.002% (w/v) 
bromphenolblue 
Buffer E Buffer W with 2.5 mM Desthiobiotin 
Inclusion body wash buffer  300 mM KCl, 50 mM Tris-Cl pH=8, 5 mM EDTA 
Triton wash buffer Inclusion body wash buffer with 0.5 %(v/v) Triton X-100  
Inclusion body denaturing buffer 500 mM KCl, 50 mM Tris-Cl pH=8, 8 M Urea 
Trace element solution 
3 nM (NH4)6Mo7O24, 0.4 µM H3BO3, 30 nM 
CoCl2, 10 nM CuSO4, 80 nM MnCl2, 10 nM 
ZnSO4, 1 mM MgSO4, 100 µM CaCl2, 1 µM 
FeSO4 
Antibiotic stocks (1000x) 100 mg/ml ampicillin, 50 mg/ml kanamycin 
His-Tag equilibration buffer 500 mM NaCl, 20 mM NaPO4, 20 mM Imidazole pH=7.4 
His-Tag Elution buffer 500 mM NaCl, 20 mM NaPO4, 300 mM Imidazole pH=7.4 
His-Tag Storage buffer 150 mM NaCl, 20 mM NaPO4 pH=7.4 
Inducer (1000x) 500 mM IPTG 
SDS PAGE running buffer (10x) 250 mM Tris, 1.92 M Glycine, 1% (w/w) SDS pH=8.8 
StrepTrap Regeneration buffer 1 mM HABA in buffer W 
TAE-buffer (50x) 2 M Tris, 1 M Acetic acid, 50 mM EDTA, pH=8.5 
TB buffer 
250 mM KCl, 15 mM CaCl22, 10 mM PIPES 
pH=6.7, 55 mM MnCl2 (add final), sterile 
filtered 
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Table 27 Composition of standard media used in this work 
Medium composition 
LB 10 g/l NaCl, 10 g/l Peptone, 5g/l yeast extract, pH=7.4 
LB agar LB supplemented with 1.5% (w/v) agar-agar 
SOB  
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
20 mM MgSO4, 0.5 % (w/v) yeast extract, 
2 % (w/v) peptone, pH=7.5 
SOC  SOB medium supplemented with 20 mM Glucose 
N-5052 autoinduction medium [202] with 
modifications 
0.6% (w/v) Na2PO4, 0.3% (w/v) KH2PO4, 
0.05% (w/v) NaCl, 0.1% (w/v) NH4Cl 
supplemented with 0.5% (v/v) Glycerol, 
0.05% (w/v) Glucose, 0.2% (w/v) Lactose 
and trace element solution after autoclaving 
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Protein sequences 
 
MBP-(TEVsite)-strep-AITVMV 
KIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRF
GGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALD
KELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKNKH
MNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGINAA
SPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEIMPNIPQM
SAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSENLYFQSSGWSHPQFEKSGGREYVRFAP*  
 
TVMV protease 
SKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHGEFKVKN
STQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVHKED
TSFWQHWITTKDGQCGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCKNWK
FNADKISWGSFTLVEDAPED* 
 
FKBP12 
VQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQM
SVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE*  
 
FRB 
ILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEW
CRKYMKSGNVKDLTQAWDLYYHVFRRI*  
 
ePDZ-b1 
SPELGFSISGGVGGRGNPFRPDDDGIFVTRVQPEGPASKLLQPGDKIIQANGYSFINIEHGQAVSLLK
TFQNTVELIIVREVGNGAKQEIRVRVEKDG*  
 
FN3 
GVSSVPTNLEVVAATPTSLLISWDAYRELPVSYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVD
YTITVYAHYNYHYYSSPISINYR*  
 
AG6 
MGDRGPEFMKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGP
DIIFWAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPP
KTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGL
TFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPF
VGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQK
GEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSENLYFQSSGWSHPQFEKSGGR
EYVRFAPGPGASVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEV
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IRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLEGLGGGSGGGSGGGSE
TILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQE
WCRKYMKSGNVKDLTQAWDLYYHVFRRISGGRGSSKALLKGVRDFNPISACVCLLENSSDGHSERL
FGIGFGPYIIANQHLFRRNNGELTIKTMHGEFKVKNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKF
RQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVHKEDTSFWQHWITTKDGQCGSPLVSIIDGNILGIH
SLTHTTNGSNYFVEFPEKFVATYLDAADGWCKNWKFNADKISWGSFTLVEDAPEDDFMAKKTVAAI
MDGGSHHHHHH*  
 
FKBP-FRB protease switch 2_B3 
MGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHD
RFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPA
LDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKN
KHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGIN
AASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEIMPNIPQ
MSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSENLYFQSSGWSHPQFEKSGGREYVRFAPGP
GVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQ
MSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLEGPPPPPPPGILWHEMWHEGLEEASR
LYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQA
WDLYYHVFRRIGPGSKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGE
LTIKTMHGEFKVKNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSV
SSLVSESSHIVHKEDTSFWQHWITTKDGQCGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVAT
YLDAADGWCKNWKFNADKISWGSFTLVEDAPEDGIA* 
 
CyPet-FKBP-TVMVsite-FRB-Ypet  
MGDRGPEFMSKGEELFGGIVPILVELEGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPT
LVTTLTWGVQCFSRYPDHMKQHDFFKSVMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIEL
KGIDFKEDGNILGHKLEYNYISHNVYITADKQKNGIKANFKARHNITDGSVQLADHYQQNTPIGDGP
VILPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITHGMDELYKGPGASVQVETISPGDGRTFPK
RGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAY
GATGHPGIIPPHATLVFDVELLKLEGGTSETVRFQSKLGGILWHEMWHEGLEEASRLYFGERNVKG
MFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFR
RISGGRGSSMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLLCTTGKLPVPW
PTLVTTLGYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRI
ELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGD
GPVLLPDNHYLSYQSALFKDPNEKRDHMVLLEFLTAAGITEGMNELYKGGHHHHHH* 
 
wtFhuA-strep 
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQAAVEPKEDTITVTAAPAPQESAWGPAATIAARQS
ATGTKTDTPIQKVPQSISVVTAEEMALHQPKSVKEALSYTPGVSVGTRGASNTYDHLIIRGFAAEGQS
QNNYLNGLKLQGNFYNDAVIDPYMLERAEIMRGPVSVLYGKSSPGGLLNMVSKRPTTEPLKEVQFK
AGTDSLFQTGFDFSDSLDDDGVYSYRLTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLS
YFQNEPETGYYGWLPKEGTVEPLPNGKRLPTDFNEGAKNNTYSRNEKMVGYSFDHEFNDTFTVRQ
NLRFAENKTSQNSVYGYGICSDPANAYSKQCAALAPADKGHYLARKYVVDDEKLQNFSVDTQLQSK
FATGDIDHTLLTGVDFMRMRNDINAWFGYDDSVPLLNLYNPVNTDFDFNAKDPANSGPYRILNKQ
KQTGVYVQDQAQWDKVLVTLGGRYDWADQESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTP
 
 
   113 
   
YFSYSESFEPSSQVGKDGNIFAPSKGKQYEVGVKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSV
EGGEIRARGVEIEAKAALSASVNVVGSYTYTDAEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGP
LSGLTLGTGGRYTGSSYGDPANSFKVGSYTVVDALVRYDLARVGMAGSNVALHVNNLFDREYVASC
FNTYGCFWGAERQVVATATFRFGSGGWSHPQFEK* 
 
SnoopCatcher-GGSSG-NBGFP-strep 
MKPLRGAVFSLQKQHPDYPDIYGAIDQNGTYQNVRTGEDGKLTFKNLSDGKYRLFENSEPAGYKPV
QNKPIVAFQIVNGEVRDVTSIVPQDIPATYEFTNGKHYITNEPIPPKGGSSGQVQLVESGGALVQPGG
SLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYL
QMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVSSKGGSWSHPQFEK* 
 
+sig∆c∆5L-2Link-SnoopTag6xHis 
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQALKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYR
LTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGNSEGSTYSRNEKMVGYS
FDHEFNDTFTVRQNLRFAENKTSQNSVYGNSEGSRKYVVDDEKLQNFSVDTQLQSKFATGDIDHTL
LTGVDFMRMRNDINAWFGYNSEGSSGPYRILNKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQ
ESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVG
VKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTD
AEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPLSGLTLGTGGRYTNSEGSYTVVDALVRYDLAR
VGMAGSNVALHVNSEGSQVVATATFRFGSKLGDIEFIKVNKLEHHHHHH* 
 
+sig∆c∆5L-10Link-SnoopTag6xHis 
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQALKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYR
LTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGNSEGSTYSRNEKMVGYS
FDHEFNDTFTVRQNLRFAENKTSQNSVYGNSEGSRKYVVDDEKLQNFSVDTQLQSKFATGDIDHTL
LTGVDFMRMRNDINAWFGYNSEGSSGPYRILNKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQ
ESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVG
VKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTD
AEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPLSGLTLGTGGRYTNSEGSYTVVDALVRYDLAR
VGMAGSNVALHVNSEGSQVVATATFRFGSSGASGGSGKLGDIEFIKVNKLEHHHHHH* 
 
6xHisSnoopTag-10Link-∆c∆5L 
MHHHHHHSGKLGDIEFIKVNKLSGSGASGGSGLKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYRL
TGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGNSEGSTYSRNEKMVGYSF
DHEFNDTFTVRQNLRFAENKTSQNSVYGNSEGSRKYVVDDEKLQNFSVDTQLQSKFATGDIDHTLL
TGVDFMRMRNDINAWFGYNSEGSSGPYRILNKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQE
SLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVGV
KYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTD
AEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPLSGLTLGTGGRYTNSEGSYTVVDALVRYDLAR
VGMAGSNVALHVNSEGSQVVATATFRF* 
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∆c∆5L6xHis 
MLKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYRLTGLARSANAQQKGSEEQRYAIAPAFTWRPD
DKTNFTFLSYFQNEPETGNSEGSTYSRNEKMVGYSFDHEFNDTFTVRQNLRFAENKTSQNSVYGNS
EGSRKYVVDDEKLQNFSVDTQLQSKFATGDIDHTLLTGVDFMRMRNDINAWFGYNSEGSSGPYRIL
NKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQESLNRVAGTTDKRDDKQFTWRGGVNYLFDN
GVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVGVKYVPEDRPIVVTGAVYNLTKTNNLMADPEG
SFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTDAEYTTDTTYKGNTPAQVPKHMASLWADYTF
FDGPLSGLTLGTGGRYTNSEGSYTVVDALVRYDLARVGMAGSNVALHVNSEGSQVVATATFRFGSG
LEHHHHHH* 
 
6xHisSnoopTag-+sig∆c∆5L 
MHHHHHHSGKLGDIEFIKVNKLSGMARSKTAQPKHSLRKIAVVVATAVSGMSVYAQALKEVQFKA
GTDSLFQTGFDFSDSLDDDGVYSYRLTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLSY
FQNEPETGNSEGSTYSRNEKMVGYSFDHEFNDTFTVRQNLRFAENKTSQNSVYGNSEGSRKYVVD
DEKLQNFSVDTQLQSKFATGDIDHTLLTGVDFMRMRNDINAWFGYNSEGSSGPYRILNKQKQTGV
YVQDQAQWDKVLVTLGGRYDWADQESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYS
ESFEPSSQVGKDGNIFAPSKGKQYEVGVKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGE
IRARGVEIEAKAALSASVNVVGSYTYTDAEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPLSGLT
LGTGGRYTNSEGSYTVVDALVRYDLARVGMAGSNVALHVNSEGSQVVATATFRF* 
 
+sig∆c∆5L-SmBiT866xHis 
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQALKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYR
LTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGNSEGSTYSRNEKMVGYS
FDHEFNDTFTVRQNLRFAENKTSQNSVYGNSEGSRKYVVDDEKLQNFSVDTQLQSKFATGDIDHTL
LTGVDFMRMRNDINAWFGYNSEGSSGPYRILNKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQ
ESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVG
VKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTD
AEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPLSGLTLGTGGRYTNSEGSYTVVDALVRYDLAR
VGMAGSNVALHVNSEGSQVVATATFRFGSVSGWRLFKKISLEHHHHHH* 
 
Strep-LgBiT 
MWSHPQFEKVFTLEDFVGDWEQTAAYNLDQVLEQGGVSSLLQNLAVSVTPIQRIVRSGENALKIDI
HVIIPYEGLSADQMAQIEEVFKVVYPVDDHHFKVILPYGTLVIDGVTPNMLNYFGRPYEGIAVFDGKK
ITVTGTLWNGNKIIDERLITPDGSMLFRVTINS* 
 
Colicin M(D226A)-sfGFP-strep 
METLTVHAPSPSTNLPSYGNGAFSLSAPHVPGAGPLLVQVVYSFFQSPNMCLQALTQLEDYIKKHGA
SNPLTLQIISTNIGYFCNADRNLVLHPGISVYDAYHFAKPAPSQYDYRSMNMKQMSGNVTTPIVALA
HYLWGNGAERSVNIANIGLKISPMKINQIKDIIKSGVVGTFPVSTKFTHATGDYNVITGAYLGNITLKT
EGTLTISANGSWTYNGVVRSYDAKYDFNASTHRGIIGESLTRLGAMFSGKEYQILLPGEIHIKESGKR
GSGGMRKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTLVTT
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LTYGVQCFARYPDHMKQHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIELKGIDF
KEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLP
DNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYKLEVDLQGDHGLSAWSHPQFEK* 
 
+sig∆c∆5L6xHis 
MARSKTAQPKHSLRKIAVVVATAVSGMSVYAQALKEVQFKAGTDSLFQTGFDFSDSLDDDGVYSYR
LTGLARSANAQQKGSEEQRYAIAPAFTWRPDDKTNFTFLSYFQNEPETGNSEGSTYSRNEKMVGYS
FDHEFNDTFTVRQNLRFAENKTSQNSVYGNSEGSRKYVVDDEKLQNFSVDTQLQSKFATGDIDHTL
LTGVDFMRMRNDINAWFGYNSEGSSGPYRILNKQKQTGVYVQDQAQWDKVLVTLGGRYDWADQ
ESLNRVAGTTDKRDDKQFTWRGGVNYLFDNGVTPYFSYSESFEPSSQVGKDGNIFAPSKGKQYEVG
VKYVPEDRPIVVTGAVYNLTKTNNLMADPEGSFFSVEGGEIRARGVEIEAKAALSASVNVVGSYTYTD
AEYTTDTTYKGNTPAQVPKHMASLWADYTFFDGPLSGLTLGTGGRYTNSEGSYTVVDALVRYDLAR
VGMAGSNVALHVNSEGSQVVATATFRFGSGLEHHHHHH* 
 
MBP-TVMVsite-TVMVp 
MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDR
FGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPAL
DKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKNK
HMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGINA
ASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEIMPNIPQ
MSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSNNNNNNNNNNLGIEGRISHMSMGGRETVR
FQSSKALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHGEFK
VKNSTQLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVH
KEDTSFWQHWITTKDGQCGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCK
NWKFNADKISWGSFTLVEDAPEDDFMAKKTVAAIMDGGSHHHHHH* 
 
TEV protease expression strain E. coli BL21(DE3)-RIL/pRK793, originating from David S. 
Waugh lab [438], and kindly provided by the Kolmar research group (TU Darmstadt).  
TEV-protease (as self-cleaving MBP-fusion):  
MKTEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHD
RFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPA
LDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKN
KHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGIN
AASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQ
MSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSNNNNNNNNNNLGIEGRGENLYFQGHHHH
HHHGESLFKGPRDYNPISSTICHLTNESDGHTTSLYGIGFGPFIITNKHLFRRNNGTLLVQSLHGVFK
VKNTTTLQQHLIDGRDMIIIRMPKDFPPFPQKLKFREPQREERICLVTTNFQTKSMSSMVSDTSCTFP
SSDGIFWKHWIQTKDGQCGSPLVSTRDGFIVGIHSASNFTNTNNYFTSVPKNFMELLTNQEAQQW
VSGWRLNADSVLWGGHKVFMVKPEEPFQPVKEATQLMNRRRRR* 
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SH3-TVMVp (as self-cleaving MBP-fusion) 
MGKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHD
RFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPA
LDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKN
KHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGIN
AASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQKGEIMPNIPQ
MSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSGGETVRFQSGGSGTGGAEYVRALFDFNGND
EEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYGSEGSTSGSGGGGSGAGSTKGSK
ALLKGVRDFNPISACVCLLENSSDGHSERLFGIGFGPYIIANQHLFRRNNGELTIKTMHGEFKVKNST
QLQMKPVEGRDIIVIKMAKDFPPFPQKLKFRQPTIKDRVCMVSTNFQQKSVSSLVSESSHIVHKEDTS
FWQHWITTKDGQCGSPLVSIIDGNILGIHSLTHTTNGSNYFVEFPEKFVATYLDAADGWCKNWKFN
ADKISWGSFTLVEDAPEDGGSWSHPQFEKGIA* 
 
GST-strep-NBGFP (used for pulldown experiment) 
MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQS
MAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDR
LCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPL
QGWQATFGGGDHPPKSDLEVLFQGPLGSGWSHPQFEKSGSMAQVQLVESGGALVQPGGSLRLSC
AASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSL
KPEDTAVYYCNVNVGFEYWGQGTQVTVSSKLERPHRD* 
 
MBP-eGFP6xHis (used for pulldown experiment, kindly provided by Wadim Weber) 
MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDR
FGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPAL
DKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGLTFLVDLIKNK
HMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPFVGVLSAGINA
ASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQ
MSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSNNNNNNNNNNEFGGSETVRFQSGSVSKGE
ELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSR
YPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQS
ALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKGTSGGHHHHHH* 
 
NBGFP-SpyCatcher002 
MGQVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYED
SVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVSSGGSGGSGVTTLS
GLSGEQGPSGDMTTEEDSATHIKFSKRDEDGRELAGATMELRDSSGKTISTWISDGHVKDFYLYPG
KYTFVETAAPDGYEVATAITFTVNEQGQVTVNGEATKGDAHTGGASPAGGWSHPQFEKGIA* 
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NBmCherry-SpyCatcher002 
MGQVQLVESGGSLVQPGGSLRLSCAASGRFAESSSMGWFRQAPGKEREFVAAISWSGGATNYADS
AKGRFTLSRDNTKNTVYLQMNSLKPDDTAVYYCAANLGNYISSNQRLYGYWGQGTQVTVSSGGSG
GSGVTTLSGLSGEQGPSGDMTTEEDSATHIKFSKRDEDGRELAGATMELRDSSGKTISTWISDGHV
KDFYLYPGKYTFVETAAPDGYEVATAITFTVNEQGQVTVNGEATKGDAHTGGASPAGGWSHPQFE
KGIA* 
 
NBAmylase-SpyCatcher002 
MGQVQLVESGGGSVQAGGSLSLSCAASTYTDTVGWFRQAPGKEREGVAAIYRRTGYTYSADSVKG
RFTLSQDNNKNTVYLQMNSLKPEDTGIYYCATGNSVRLASWEGYFYWGQGTQVTVSSGGSGGSGV
TTLSGLSGEQGPSGDMTTEEDSATHIKFSKRDEDGRELAGATMELRDSSGKTISTWISDGHVKDFYL
YPGKYTFVETAAPDGYEVATAITFTVNEQGQVTVNGEATKGDAHTGGASPAGGWSHPQFEKGIA* 
 
Tether Peptide (As MBP fusion) 
MGDRGPEFMKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGP
DIIFWAHDRFGGYAQSGLLAEITPDKAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPP
KTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYENGKYDIKDVGVDNAGAKAGL
TFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSKVNYGVTVLPTFKGQPSKPF
VGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELVKDPRIAATMENAQK
GEIMPNIPQMSAFWYAVRTAVINAASGRQTVDEALKDAQTNSSSENLYFQSGPPPPLPPKRRRGVP
TIVMVDAYKRYKGGSGGSETVRFQSGSTSGSGKPGSGEGSTKGWSHPQFEKGLPETGG* 
 
Immobilized Tether Peptide from N- to C-terminus:  
SGPPPPLPPKRRRGVPTIVMVDAYKRYKGGSGGSETVRFQSGSTSGSGKPGSGEGSTKGWSHPQFE
KGLPET-Azidopropanamin(Azp) 
 
sfGFP-6xHis   
MSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTLVTTLTYG
VQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIELKGIDFKEDG
NILGHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHY
LSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYKGTSGGHHHHHH* 
 
Addgene plasmid #62936 for expression of GFP(-30) was kindly provided by Markus Langhans. 
6xHis-GFP(-30) 
MGHHHHHHGGASKGEELFDGVVPILVELDGDVNGHEFSVRGEGEGDATEGELTLKFICTTGELPVP
WPTLVTTLTYGVQCFSDYPDHMDQHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVN
RIELKGIDFKEDGNILGHKLEYNFNSHDVYITADKQENGIKAEFEIRHNVEDGSVQLADHYQQNTPIG
DGPVLLPDDHYLSTESALSKDPNEDRDHMVLLEFVTAAGIDHGMDELYK* 
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mCherry-strep  
MGVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLPFAWDI
LSPQFMYGSKAYVKHPADIPDYLKLSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRG
TNFPSDGPVMQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYKAKKPVQLPG
AYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKGGASPAGGWSHPQFEKGLPETGG* 
 
Sortase A7M-6xHis 
MQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATREQLNRGVSFAKENQSLDDQNISIAGHTFIDRP
NYQFTNLKAAKKGSMVYFKVGNETRKYKMTSIRNVKPTAVEVLDEQKGKDKQLTLITCDDYNEETG
VWETRKIFVATEVKLEHHHHHH* 
 
Sortase A5M-strep 
MQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATREQLNRGVSFAEENESLDDQNISIAGHTFIDRP
NYQFTNLKAAKKGSMVYFKVGNETRKYKMTSIRNVKPTAVEVLDEQKGKDKQLTLITCDDYNEETG
VWETRKIFVATEVKLEWSHPQFEK* 
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Abbreviations  
Abbreviation  Meaning 
(v/v) Volume per volume 
(w/v) Weight per volume 
(w/w) Weight per weight 
+sig 33-aa Omp signal sequence of wtFhuA 
°C Degree Celsius 
µ Micro (as unit prefix) 
1D One dimensional 
2D Two dimensional 
3D Three dimensional  
6xHis 6x Histidine (purification tag) 
A Ampere (as unit) 
Å Ångström; 10-10 m 
A/D Analog/digital 
aa Amino acid 
aHL α-hemolysin 
AITVMV Autoinhibitory domain of TVMV protease 
ANA-peptide Quenched TVMV protease substrate, see section 2.10 Chapter 1 
AU Absorbance unit 
Azp Azidopropanamine 
BAM Beta-barrel assembly machinery 
bp basepair 
cAMP Cyclic adenosine monophosphate 
CD-spectroscopy Circular dichroism spectroscopy 
CfaN N-terminal part of a split-intein (Consensus from alignment) [456] 
CFP Cyan Fluorescent Protein 
CLSM Confocal Laser Scanning microscope 
Cryo-EM Cryo electron microscopy 
CuAAC Cu(I)-catalyzed azide-alkyne cycloadditions 
CV Column volume 
DBCO Dibenzocyclooctyne amin 
DDM n-Dodecyl-β-D-maltosid 
DMSO Dimethyl sulfoxide 
DNA Desoxyribonucleic acid 
dNTPs Desoxynucleoside triphospates 
DPhPC 1,2-diphytanoyl-sn-glycero-3-phosphocholine 
dsDNA Double stranded DNA 
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DTT Dithiothreitol 
e Charge of a proton  
E. coli Escherichia coli 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)- carbodiimide 
EDTA ethylenediaminetetraacetic acid 
ePDZ-b1 Enhanced PDZ domain [204] 
ExoIII Exonuclease III 
F Farad (as unit) 
f femto (as unit prefix) 
FAM 5-Fluorescein 
FD Functional domain 
FhuA Ferrihydroxamate uptake component A 
FKBP FKBP12, 12-kDa FK506 binding protein 
FN3 
10th fibronectin type III domain of human 
Fibronectin  
FRB FKBP12-rapamycin binding domain 
FRET Förster resonance energy transfer 
G Conductance (used in SSN context) 
GC buffer PCR buffer from New England biolabs  
GFP Green Fluorescent Protein 
GluSnFR Glutamate sensing fluorescent reporter 
GST Glutathione S-Transferase from Schistosoma japonicum 
h hours 
HIV Human immunodeficiency virus 
i position 
iFLinkC Iterative functional linker cloning 
IgG Immunoglobulin G 
IPTG isopropyl-β-D-thiogalactopyranosid 
ITC Isothermal titration calorimetry 
IUPAC International Union of Pure and Applied Chemistry 
I-V Current-Voltage 
KD Equilibrium dissociation constant 
Ki Equilibrium dissociation constant of inhibitor 
KM Michaelis constant 
kDa kilo Dalton 
kEV Kilo electron volt 
kJ Kilo Joule 
l liter 
L1, L2, L3 Linker position 1, 2, 3 
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LCR Ligase cycling reaction / Cycled ligation assembly 
LgBiT Large subunit of engineered split luciferase NanoBiT 
M Molar (as unit) 
m Milli (as unit prefix) or meter (as unit) 
max. maximum 
MBP Maltose binding protein 
mdeg Millidegree, measure for ellipticity in CD-measurements 
min Minutes 
min. minimum 
mol Amount of substance (unit) 
mRFP Monomeric red fluorescent protein 
MspA Mycobacterium smegmatis porin A 
MST Microscale thermophoresis 
n Number or nano (as unit prefix) 
N Number for independent experiments, e.g. N=3 
N2(l) Liquid nitrogen 
NB nanobody 
NBsubscript Nanobody specifically binding the analyte indicated in the subsript 
NHS N-Hydroxysuccinimide 
Nia Nuclear Inclusion protein A 
NTA nitrilotriacetic acid 
O/N overnight 
OD600 Optical density at 600 nm 
Omp Outer membrane protein 
ori Origin of replication 
p pico (as unit prefix) 
PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase Chain Reaction 
PDB Protein data bank 
PDZ Erbin PDZ domain 
PEG Poly(ethylene glucol) 
PET Poly(ethylene therephtalat) 
pET32/pET24 Refers to specific DNA plasmids 
pers. comm. Personal communication 
PFP Pentafluorophenol 
pH Measure for acidity or basicity of an aqueous solution 
PhD Doctor of Philosophy 
pI Isoelectric point 
PPII helix Poly-proline type II helix 
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PTFE Polytetrafluorethylene (Teflon) 
PVP Polyvinylpyrrolidone 
R2 Coefficient of determination  
RF Rectification Factor (definition in section 1.1, Chapter 4) 
RFU Relative fluorescence units 
RNA Ribonucleic acid 
rpm Rounds per minute 
rSAP Recombinant shrimp alkaline phosphatase 
RT Room temperature (≈ 24 °C) 
s Seconds 
S Siemens (as unit) 
SAM Self-assembled monolayer 
SDS Sodium dodecylsulfate 
sfGFP Superfolder GFP [342] 
sFvs Single chain variable fragments 
SmBiT86 Small subunit of engineered split luciferase NanoBiT (variant 86) 
SOC Scaffold oligo connector 
SPAAC Strain-promoted azide-alkyne cycloadditions 
SSNs Solid-state nanopores 
Strep StrepTag II (purification tag) 
Tether Peptide 
Immobilization peptide with the sequence 
SGPPPPLPPKRRRGVPTIVMVDAYKRYKGGS 
GGSETVRFQSGSTSGSGKPGSGEGSTKGWSHPQFEKGLPETGG 
TEV Tobacco etch virus 
TL-FhuA Tagless FhuA 
Tris Tris(hydroxymethyl)-aminomethan 
TU Technical University 
TVMV Tobbaco vein mottling virus 
TVMVp Tobacco vein mottling virus protease 
TVMVsite Cleavage site of TVMV protease 
V Volt (as unit) 
VHH Engineered single-domain antibody from camelids 
VNAR Engineered single-domain antibody from Chondrichthyes 
W Watt 
wt Wildtype 
xg times g-force 
YFP Yellow Fluorescent Protein 
Δ Difference (as unit prefix) 
ΔcΔ5L FhuA variant with deleted cork and 5 main loops 
ΔH Enthalpy difference 
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λ Wavelength 
Ω Ohm 
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Amino acid code 
Code Amino acid 
A Alanine 
C Cysteine 
D Aspartic acid 
E Glutamic acid 
F Phenylalanine 
G Glycine 
H Histidine 
I Isoleucine 
K Lysine 
L Leucine 
M Methionine 
N Asparagine 
P Proline 
Q Glutamine 
R Arginine 
S Serine 
T Threonine 
V Valine 
W Tryptophan 
Y Tyrosine 
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